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Abstract 
This thesis describes the functional characterisation of the two human FAM40 proteins, 
FAM40A and FAM40B, in cancer cells and endothelial cells. FAM40A and FAM40B were 
initially studied in PC3 cells (a prostate cancer cell line) to determine their effects on cell 
morphology, adhesion and migration. PC3 cells show distinct morphological phenotypes 
when depleted of FAM40A and FAM40B using RNAi (RNA interference). Knockdown of 
FAM40A causes cells to have a smaller spread area, but cells depleted of FAM40B are 
elongated. FAM40-depleted PC3 cells display an adhesion defect, and FAM40B depletion 
results in a cell spreading defect. Additionally, FAM40B knockdown in PC3 cells leads to a 
reduction in cell speed.  
FAM40A and FAM40B were identified as interacting partners for the CCM3 (cerebral 
cavernous malformation 3) protein in a previous biochemical study using mass 
spectrometry. CCM3 is mutated in a subset of patients with cerebral cavernous 
malformations (CCM). Patients display defects in the vascular endothelium of the central 
nervous system. The FAM40 proteins were found to form homo- and hetero- dimers, and 
interact with CCM3 and the serine/threonine kinases MST4 and STK25. Moreover, both 
FAM40 proteins and CCM3 can be phosphorylated in vitro by MST4. Knockdown of 
FAM40A, FAM40B and CCM3 in endothelial cells by RNAi causes an increase in stress 
fibres. FAM40B depletion also reduces endothelial barrier function. Furthermore, depletion 
of FAM40A, FAM40B and CCM3 results in defects in an in vitro angiogenesis assay. These 
results demonstrate the importance of the FAM40 proteins for endothelial cell physiology, 
and suggest they act as part of the CCM3-containing protein complex. 
Taken together, the FAM40 proteins have important roles in cancer cell motility and 
adhesion, and are regulators of endothelial cell function. In addition to being implicated in 
CCM, these proteins could regulate two major steps in cancer progression – cancer cell 
migration, and neovascularisation.  
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1 Introduction 
1.1 Cancer and cancer metastasis 
1.1.1 Cancer: a micro-evolutionary process 
The development of cancer can be modelled as a micro-evolutionary process (Alberts et al., 
2002), in which the cells in an organism are considered an ecosystem, and must collaborate 
for the overall good of the organism. A cancer cell is a ‘selfish cell’ which proliferates at the 
expense of other cells and so disrupts the cellular ecosystem. Cells send and receive 
signals from each other and their environment that modulate key processes such as 
proliferation, differentiation and apoptosis in a manner that ensures the overall good of the 
organism. Genetic lesions in genes that regulate these pathways may give cells a selective 
advantage, and along with multiple rounds of mutation be sufficient to cause cancer 
(Hanahan and Weinberg, 2011) 
One model for the mechanism by which cells become cancerous, is that they must obtain 
certain capabilities or hallmarks in order to overcome cellular control mechanisms that 
prevent the neoplastic process. These are self-sufficiency in growth signals, insensitivity to 
growth inhibitory signals, evasion of programmed cell death (apoptosis), limitless replicative 
potential, sustained angiogenesis, and tissue invasion and metastasis (Hanahan and 
Weinberg, 2011). Two hallmarks of particular relevance to this thesis include cancer 
metastasis which is discussed in section 1.1.2 and the link between tumorigenesis and 
angiogenesis which is discussed further in section 1.1.3.2. Mutations that confer these 
capabilities occur in genes termed either proto-oncogenes or tumour suppressors. Mutations 
in proto-oncogenes (resulting in an oncogene) represent ‘gain of function’ mutations in which 
the increased activity of the gene confers an increased risk of cancer. These genes usually 
represent stimulatory components of a regulatory pathway, are inherited as dominant alleles, 
and include the Ras and Myc oncogenes. For example, mutations in the Ras proto-
oncogene which was the first to be indentified (Goldfarb et al., 1982; Pulciani et al., 1982; 
Shih and Weinberg, 1982) confer ‘self-sufficiency in growth signals’ and allow cells to 
proliferate excessively. On the other hand, tumour suppressor genes usually represent 
inhibitory components of a regulatory pathway and cancer mutations of this class represent 
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‘loss of function’ mutations which are recessive in nature. For a cell to become cancerous 
both copies of the tumour suppressor gene usually have to be mutated, an idea termed the 
‘two-hit’ hypothesis (Knudson, 1971). An example is the RB1 (retinoblastoma 1) gene which 
blocks cell proliferation, cell division and regulates cell death (Chau and Wang, 2003).    
1.1.2 Cancer metastasis 
In the course of the development of a cancer, cells from the primary tumour may attain the 
capacity to escape the tumour body, invade adjacent tissue and establish distant colonies of 
tumour cells. This process is termed metastasis (Nguyen et al., 2009). The main cause of 
mortality in cancer is the dissemination of primary tumours (Hunter et al., 2008) and hence 
deciphering the underlying mechanisms of this process is important to improve therapeutic 
intervention. 
Metastasis is a complex process and simple oncogenic transformation is not sufficient to 
gain metastatic capability (Nguyen et al., 2009). While metastasis of solid tumours is a 
heterogeneous process depending on the cellular origin of a particular tumour, it generally 
consists of three steps; invasion of surrounding tissue, entry into lymphatic and blood 
vessels, and exit from blood vessels (reviewed in (Sahai, 2007)). These processes involve 
cell migration and adhesion which are discussed further in section 1.2. Changes in the 
expression of multiple genes are necessary to confer these properties. One step in attaining 
metastatic competency is to gain invasive capacity, and in tumours of epithelial origin this is 
commonly associated with a loss of E-cadherin (epithelial-cadherin) expression (Cavallaro 
and Christofori, 2004). E-cadherin is involved in the formation of adherens junctions between 
adjacent epithelial cells and aids in maintaining the quiescence of these cells (Hanahan and 
Weinberg, 2011). Loss of its expression allows the cells to escape from their epithelial site of 
origin and potentiates metastasis. 
A developmental program termed ‘epithelial to mesenchymal transition’ (EMT) is implicated 
in epithelial cell invasion and dissemination, a common feature of which is a reduction in E-
cadherin expression (Yang and Weinberg, 2008). The mesenchymal mode of cell migration 
is characterised by elongated cell morphology with defined cell polarity and the secretion of 
proteases to degrade the extra-cellular matrix (ECM) (Friedl and Wolf, 2003). The relevance 
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of this mode of invasion to metastasis is underlined by a study showing that mesenchymal 
cells are highly enriched in circulating tumour cells (Yu et al., 2013). Other modes of 
invasion have been linked to cancer metastasis and these include collective cell migration 
(discussed in (Friedl et al., 2012) and amoeboid migration in which cells show morphological 
plasticity and squeeze through gaps in the ECM using contractile force to generate motion 
(Friedl and Wolf, 2003). 
 
Figure 1.1 Modes of cancer cell invasion 
(A) In the mesenchymal mode of migration, cells form strong adhesions to the substrate and 
migrate by protrusion of a leading edge and degradation of the ECM by protease enzymes. 
(B) In amoeboid migration, cells show morphological plasticity and squeeze through gaps in 
the ECM using contractile force to generate motion.   
 
 
Cancer cell invasion relies on multiple interactions with both the surrounding ECM and 
neighbouring non-cancerous cells generally termed the tumour microenvironment (Calvo 
and Sahai, 2011). For example, cells of the tumour stroma have been found to secrete the 
chemokine CCL5 in response to signals from cancer cells. CCL5 acts on cancer cells to 
promote invasion (Karnoub et al., 2007). Another example is that of macrophages at the 
periphery of tumours producing matrix-degrading enzymes and so supporting local invasion 
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(Joyce and Pollard, 2009). These interacting networks could also hold the answer to why 
cancers of a certain origin can efficiently colonize only specific organs, an idea embodied in 
the ‘seed and soil’ hypothesis proposed by Stephen Paget in 1889 and revived by Hart and 
Fidler in 1980 (Hart and Fidler, 1980). The interaction of cancer cells with tumour-associated 
vasculature is of particular importance and relevance and is discussed in the following 
section. 
1.1.3 Cancer and the endothelium    
Two types of interactions between tumour cells and endothelial cells will be discussed in this 
section: tumour invasion of the endothelium and tumour angiogenesis. 
1.1.3.1 The endothelium plays a central role in cancer metastasis 
After cancer cells escape the primary tumour, they enter the vasculature (intravasation), and 
transit in the blood stream, having to withstand the shear stress caused by blood flow 
(Dadiani et al., 2006; Wyckoff et al., 2000). Cells then leave the vasculature (extravasation 
or trans-endothelial migration (TEM)), invade the underling matrix and establish metastases 
(Nguyen et al., 2009).   
Tumour-associated endothelial cells display distinct gene expression profiles when 
compared to normal endothelial cells. Differences in expressed cell surface markers, 
adhesion proteins and cell signalling could contribute to the metastatic process (Hanahan 
and Weinberg, 2011). For example, it was initially thought that cancer cells extravasate at 
certain sites by being trapped in capillaries due to size restriction (Ito et al., 2001). However, 
it is now known that this is also an active process in which both the cancer cells and 
endothelial cells express cell surface adhesion molecules that initiate extravasation. For 
example, endothelial E-selectin interacts with its ligand PSGL-1, expressed on prostate 
cancer cells and so favours extravasation (Dimitroff et al., 2005). It is also clear that cancer 
cells are able to induce signalling events in associated endothelial cells to facilitate 
extravasation. A recent study illustrates how signalling induced by invasive breast cancer 
cells results in the disruption of endothelial cell-cell junctions and subsequent endothelial cell 
retraction (Haidari et al., 2012). Cancer cells can also co-opt other cells to escape the 
vasculature, for example by recruiting leukocytes and subsequently using them to facilitate 
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their own exit from blood vessels. CCL2 has been shown to be able to recruit inflammatory 
monocytes to promote breast cancer metastasis (Qian et al., 2011). In addition, CCL2 
produced by tumour cells also increases the permeability of CCR2-expressing endothelium 
which contributes to increased levels of metastasis (Wolf et al., 2012). These studies point 
towards an interplay of signalling between cancer cells, endothelial cells and ancillary cells 
that affect vascular permeability and the invasive potential of tumour cells. 
1.1.3.2 Cancer and angiogenesis 
Just as normal tissues require oxygen and nutrients from the vasculature for their function 
and survival, the proximity of cancer cells to the vasculature is crucial for their propagation 
(Hanahan and Weinberg, 2011). While cancer cells can alter their energy metabolism to 
adapt to hypoxic conditions found in many tumours, they are usually highly dependent on 
angiogenesis to sustain themselves (Kroemer and Pouyssegur, 2008). Mechanisms of 
angiogenesis are discussed in section 1.5. This section deals with aspects of angiogenesis 
that are relevant to tumour progression. 
During embryogenesis, endothelial cells differentiate from stem cells and form blood vessels 
in a process termed vasculogenesis. In contrast, angiogenesis is the process by which blood 
vessels sprout from pre-existing ones (Potente et al., 2011). In the adult, the vasculature is 
largely quiescent except in physiological processes such as wound healing and female 
endometrial growth. Even in these processes, angiogenesis is induced only transiently. 
However, during tumour progression, an ‘angiogenic switch’ is almost always turned on 
highlighting how intricately linked this process is to the neoplastic process (Hanahan and 
Folkman, 1996). The tumour neovasculature is abnormal in structure and function and 
endothelial cells lack a cobblestone appearance. Vessels are leaky resulting in poor 
perfusion, and their loose arrangement facilitates cancer cell invasion and dissemination 
(Potente et al., 2011). A further interesting consequence is that the poor functioning of these 
vessels leads to the creation of a hypoxic microenvironment which could drive the selection 
of more malignant cells and further induces angiogenesis. For example, hypoxia promotes 
cancer invasion by inducing overexpression of the Met proto-oncogene (Pennacchietti et al., 
2003). 
Chapter 1                                                                                                                Introduction 
22 
   
Tumour angiogenesis is controlled by counter acting pro- and anti- angiogenic signals and 
an imbalance leads to an angiogenic switch (Bergers and Benjamin, 2003). These signals 
can either be soluble signalling factors released by cancer cells that bind to receptors on 
endothelial cells or can be derived from co-opted stromal cells (reviewed in (Hanahan and 
Weinberg, 2011). Vascular endothelial growth factor-A (VEGF-A) is an important pro-
angiogenic factor and a prime target for anti-angiogenic therapy (Ferrara, 2009). Its 
expression can be upregulated by both hypoxia and oncogene signalling (Carmeliet, 2005). 
Tumour angiogenesis is highly dependent on VEGF signalling responses which are 
coordinated to control endothelial cell proliferation/survival, and invasion/migration into 
surrounding tissue (reviewed in (Claesson-Welsh and Welsh, 2013)). Other pro-angiogenic 
factors are members of the fibroblast growth factor (FGF) family when their expression is 
chronically upregulated. Important examples of anti-angiogenic factors include 
thrombospondin-1 (TSP-1), angiostatin and endostatin. Some of these molecules can be 
detected in the circulation and could act as physiological regulators or as a defence 
mechanism against tumour neo-vascularisation (Ribatti, 2009). A range of bone marrow-
derived cells also contribute to tumour vascularisation. For example, tumour associated 
macrophages stimulate angiogenesis by producing VEGF (Lin et al., 2006). Endothelial 
progenitor cells might also contribute to tumour vascularisation in a manner that resembles 
vasculogenesis (Patenaude et al., 2010). 
1.2 Cell motility and the actin cytoskeleton 
Cell migration is a complex process that involves the integration of multiple signals and 
events both spatially and temporally (reviewed in (Ridley et al., 2003)). Cell motility 
contributes to many physiological processes such as angiogenesis, tissue repair, immune 
surveillance, embryonic morphogenesis and foetus implantation. Cell migration also 
contributes to pathological conditions such as cancer metastasis, chronic inflammation and 
vascular disease. 
Migrating cells need a mechanism by which they sense their environment which contributes 
to their steering system, an engine to provide the mechanical force that drives locomotion 
and traction to facilitate these processes and provide adhesive force. Single cells can 
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migrate using either a mesenchymal or amoeboid mode of migration (described in section 
1.1.2). Once cells determine the direction in which they are to move and establish polarity, 
movement is initiated by the extension of plasma membrane protrusions at the leading edge 
and the creation of adhesive contacts at the front of the cell by transmembrane adhesion 
molecules such as the integrins. This is co-ordinated with the detachment of adhesions, cell 
retraction and actin disassembly at the rear of the cell (Cain and Ridley, 2009).  
Protrusions extended at the leading edge include lamellipodia and filopodia (reviewed in 
(Ridley, 2011)). Lamellipodia are thin, sheet-like protrusions, and the dynamic behaviour of 
the actin cytoskeleton is central to providing the mechanical force for their extension 
(reviewed in (Pollard and Borisy, 2003). Actin in its monomeric form (termed globular or G-
actin) is soluble but when polymerised, forms insoluble filaments (filamentous or F-actin) 
(Cory and Ridley, 2002). Actin filaments display polarisation in that they possess a ‘fast 
growing’ barbed end and a ‘slow growing’ pointed end. The localised, directional 
polymerisation of actin at the leading edge is what drives membrane extension (reviewed in 
(Ridley et al., 2003). A number of regulatory proteins modulate various aspects of actin 
dynamics such as filament assembly, branching, bundling and disassembly. The nucleation 
of actin monomers into a trimer is a rate-limiting step in filament assembly. This process is 
stimulated by actin nucleators and important examples include the Wiskott Aldrich syndrome 
protein (WASP) family of proteins. These factors which include WASP itself and WASP-
family verprolin homology proteins (WAVEs) bind to and activate the Arp2/3 complex 
enhancing its capacity to induce actin polymerisation (Cory and Ridley, 2002). The Arp2/3 
complex causes branching of the actin network by binding to the sides of existing actin 
filaments and stimulating the formation of ‘dendritic’ actin filament networks.  
Other important actin nucleators that contribute to lamellipodium extension include members 
of the formin and Spire families (Ridley, 2011). Formins cause unbranched actin filament 
extension, and protect barbed ends from capping proteins which restrict actin 
polymerisation. Similarly, Spire family members cause nucleation of unbranched actin 
filaments. Additional regulators of actin polymerisation in mediating protrusions include 
proteins of the ADF/cofilin family, cortactin, filamin A and α-actinin. Cofilin mediates the 
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severing of existing filaments hence generating new barbed ends that can be used to prime 
further polymerisation. Profilin prevents self-nucleation of actin monomers by binding to 
them and also aids in targeting them to barbed ends to facilitate polymerisation. Cortactin 
stabilises actin branches while filamin A and α-actinin cross link filaments and so stabilise 
them (Ridley et al., 2003). 
 
Figure 1.2 Schematic illustrating dynamics of the actin cytoskeleton during 
membrane protrusion extension 
Actin polymerisation and depolymerisation are controlled by multiple actin regulatory 
proteins (refer to text for details). 
 
 
Filopodia differ from lamellipodia in that they are exploratory extensions of the plasma 
membrane that contain parallel bundles of F-actin. Fascin is an actin-bundling protein 
important for filopodial stability. There is some overlap in the machinery that regulates 
lamellipodium and filopodium generation. For example formins such as mDia proteins, 
WASP and the Arp2/3 complex regulate the formation of filopodia (Ridley, 2011).  
Protrusions such as lamellipodia and filopodia are stabilised by the formation of adhesions 
and are coordinated with contraction/retraction events. An important class of adhesion 
proteins are the integrins which are heterodimeric receptors consisting of α and β chains 
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(reviewed in (Luo et al., 2007). Integrins connect the cytoskeleton to the extra-cellular matrix 
and act as mechano-sensors by ‘outside-in signalling’ and can regulate adhesion by 
responding to intracellular signalling events referred to as ‘inside-out signalling’. Integrins 
cluster at sites of adhesion and recruit multiple proteins that bind to their cytoplasmic tail. 
Partners such as talin, vinculin and α-actinin play a role in the integrin-actin connection 
(Ziegler et al., 2008) while FAK (focal adhesion kinase) is responsible for generating a 
cascade of integrin-linked signalling (Mitra et al., 2005). Retraction of the rear of the cell is 
brought about by actomyosin contractility and is coordinated with adhesion disassembly in 
order for the cell to move forward. The integrin-actin connection plays a central role in 
transducing the contractile force generated, resulting in cell body contraction and tail 
retraction. Contractile forces are generated by cross-linking of myosin II and actin filaments. 
The myosins are a superfamily of molecular motor proteins (reviewed in (Sellers, 2000). 
Myosin II is a hexamer comprising of two heavy chains (MHC), two essential light chains and 
two regulatory chains (RLC). Myosin II hexamers assemble to form bipolar filaments which 
then bind actin at each end. Actomyosin contraction is generated by ATP-dependent sliding 
of myosin along the actin filaments, pulling the two filaments together. Myosin II activity is 
regulated by phosphorylation at multiple sites in the RLC. For example, the phosphorylation 
of the RLC at Threonine 18 and Serine 19 is known to increase actomyosin contractility 
(Watanabe et al., 2007). 
Cells can also use an alternative form of motion based on membrane blebbing. Blebs are 
membrane protrusions generated due to contractile activity of the actomyosin cortex. They 
are rapidly produced and retracted and examples of cells in which they are observed include 
some tumour cells (Sahai and Marshall, 2003) and Dictyostelium (Langridge and Kay, 2006). 
Blebbing is thought to be important for migration in three dimensional matrices, allowing 
cells to squeeze between ECM filaments (Fackler and Grosse, 2008).  
1.3 Rho GTPases: regulators of the cytoskeleton and cell motility 
The Rho family guanosine triphosphate (GTP) binding proteins (Rho GTPases) are central 
regulators of many of the events regulating cell motility that have been described. They are 
known to regulate actin cytoskeletal dynamics, adhesion organisation and 
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contraction/retraction events (Ridley et al., 2003). The Rho GTPases belong to the Ras 
superfamily of small GTPases and bind and hydrolyse GTP (EC 3.6.5.2) (Boulter et al., 
2012). These proteins are highly conserved in evolution and have been found in all 
eukaryotic genomes sequenced so far, including plants and fungi (Boureux et al., 2007; 
Heasman and Ridley, 2008). Since the discovery of the founding member Rho (Madaule and 
Axel, 1985) and delineation of its role in cytoskeletal remodelling (Ridley and Hall, 1992), 
these proteins have been found to be crucial regulators of the cytoskeleton. They also 
contribute to several other cellular processes such as control of gene transcription, cell cycle 
progression and cell polarity (Jaffe and Hall, 2005). There are 20 known genes encoding 
Rho GTPases in the human genome divided into 8 subfamilies based on sequence 
homology (Boureux et al., 2007).  
 
Figure 1.3 The Rho GTPase family tree 
The 20 Rho GTPase encoding genes are grouped into 8 subfamilies. Typical members of 
the family that possess intrinsic GTPase activity are highlighted in bold. The family tree was 
derived by phylogenetic analysis using human Rho GTPase protein sequences. Adapted 
from Figure 1 in Boureux et. al., 2007. 
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1.3.1 Regulation of Rho GTPase activity 
Most Rho GTPases act as molecular switches and cycle between an ‘active’ GTP-bound 
form and ‘inactive’ GDP-bound form. In their GTP-bound form, these proteins are able to 
bind to a variety of downstream effector proteins and so initiate cell signalling. The cycling of 
the Rho GTPase proteins between GTP and GDP bound forms is regulated by three sets of 
proteins: guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs) 
and guanine nucleotide dissociation inhibitors (GDIs). An additional important mechanism of 
regulation is the post-translational modification of Rho GTPase proteins. 
GEFs promote the exchange of bound GDP for GTP by catalysing the release of the GDP 
molecule and causing the formation of an unstable nucleotide free intermediate. As the 
cytosolic GTP level is higher than GDP levels, this intermediate is loaded with GTP 
(Rossman et al., 2005). GAPs downregulate Rho GTPase activity by stimulating GTP 
hydrolysis. While most Rho GTPases have intrinsic GTPase activity, this is too slow to be 
physiologically effective, and GAPs serve to accelerate GTP hydrolysis. The regulation of 
GEFs and GAPs is complex and integrates a variety of upstream signals. An interesting 
example is cross-talk between different Rho proteins via GEFs and GAPs. For example, 
active Rac1 can bind to and activate p190RhoGAP and so antagonizes RhoA activity 
(Bustos et al., 2008).  
Most Rho GTPases signal on membranes and to facilitate their localisation to membranes, 
they are post-translationally modified at the C-terminus by the addition of a lipid group. The 
CAAX consensus tetrapeptide motif (Cysteine-Aliphatic-Aliphatic-Variable) at the C-terminus 
of certain Rho GTPase proteins is required for prenylation. This can be a geranylgeranyl or 
farnesyl lipid. A lack of prenylation causes mislocalisation of Rho GTPase protein to the 
cytoplasm rendering them functionally inactive (Roberts et al., 2008). Some Rho GTPases 
are palmitoylated. For example, RhoU and RhoV are palmitoylated instead of being 
prenylated. The Rho BTBs lack the CAAX box completely (Aspenstrom et al., 2007). The 
third class of Rho regulatory proteins are GDIs which mask C-terminal prenyl lipid groups, 
preventing association of Rho GTPases with membranes and thus inhibiting their interaction 
with downstream effectors (Garcia-Mata et al., 2011).  
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In addition to lipid modification, Rho proteins can be regulated by various other post-
translational modifications. For example, RhoA is phosphorylated at serine 188 which is 
situated in a conserved polybasic region at the C-terminus. This phosphorylation event 
negatively regulates RhoA (Ellerbroek et al., 2003). The expression levels of Rho proteins 
including RhoA and Rac1 can be controlled by means of the ubiquitin-proteasome pathway 
(Nethe and Hordijk, 2010). In comparison, SUMOylation does not simply turn the Rho switch 
on or off but instead serves to fine tune the extent of activity. SUMOylation of Rac1 
increases the level of GTP loading and stabilises Rac1 activation (Castillo-Lluva et al., 
2010). In contrast to other Rho GTPases, atypical members of the Rho family such as Rnd3 
and RhoH are constitutively bound to GTP. Their activity is regulated by control of protein 
levels and phosphorylation (Aspenstrom et al., 2007). For example, RhoH is regulated at the 
level of transcription (Delestre et al., 2011), and Rnd3 is inactivated by phosphorylation 
(Riou et al., 2013). 
 
 
Figure 1.4 Regulation of Rho GTPase activity 
Schematic illustrating the regulation of Rho GTPase activity. Typical members of the Rho 
GTPase family cycle between an ‘active’ GTP-bound form and an ‘inactive’ GDP-bound 
form. GEFs facilitate the conversion of the GDP-bound form to the GTP-bound form. GAPs 
stimulate GTP hydrolysis and so downregulate Rho GTPase activity. Rho GDIs sequester 
several Rho proteins in the cytoplasm, preventing their association with membranes which is 
needed for their signalling. 
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1.3.2 Rho GTPase signalling 
Rho proteins in their GTP-bound active form interact with an array of downstream signalling 
partners including protein kinases, adapter proteins and actin-regulatory proteins (Bishop 
and Hall, 2000), and integrate information from a broad spectrum of upstream signals such 
as growth factors, chemokines and cell adhesion receptors (Sahai and Marshall, 2002). Of 
the 20 known human Rho GTPases, RhoA, Rac1 and Cdc42 have been the most intensively 
studied and were also the first to be characterised (Kozma et al., 1995; Nobes and Hall, 
1995; Ridley and Hall, 1992; Ridley et al., 1992). This section describes the effects these 
three proteins have on the actin cytoskeleton. The structure and function of stress fibres 
(contractile actomyosin filaments) is discussed in greater detail too.  
A main function of the Rho GTPases is to regulate the actin cytoskeleton, and as a 
consequence they are involved in processes that are dependent on the actin cytoskeleton 
such as cell migration, phagocytosis, vesicle trafficking, axon guidance and cytokinesis 
(Bishop and Hall, 2000). Initial evidence that RhoA and Rac1 regulate the assembly of actin 
filaments in response to extracellular cues was provided by studies in serum starved 
Swiss3T3 fibroblasts. In response to LPA (lysophosphatidic acid) RhoA was shown to be 
able to induce the formation of contractile actomyosin filaments (stress fibres) and associate 
focal adhesions (Ridley and Hall, 1992). Focal adhesions are macro-molecular complexes, 
and are sites of cell adhesion to the ECM. Rac1 was shown to promote the formation of 
membrane ruffles or lamellipodia in response to PDGF (platelet-derived growth factor), EGF 
(epidermal growth factor) or insulin. Rac1 was also shown to act via RhoA to induce 
contractile actomyosin filaments (Ridley et al., 1992). Subsequently, Cdc42 was shown to 
induce the formation of filopodia as well as indirectly inducing membrane ruffles by the 
activation of Rac1 (Kozma et al., 1995; Nobes and Hall, 1995).  
Even though Rac1 and Cdc42 elicit morphologically different protrusions (lamellipodia and 
filopodia respectively), they both stimulate actin polymerisation via the Arp2/3 complex 
(reviewed in (Bishop and Hall, 2000)). Activation of Rac1 is sufficient on its own to induce 
lamellipodium formation (Wu et al., 2009). Rac1 activates the WAVE complex, following 
which activated WAVE binds to and activates the Arp2/3 complex which initiates actin 
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polymerisation. Rac1 also acts via its target PAK (p21-activated kinase) and LIM kinase 
(LIMK) to phosphorylate and inhibit cofilin. Cofilin disassembles actin filaments, and hence 
this activity of Rac1 stabilises actin filaments. A model for cofilin action is that its enrichment 
at the cell membrane results in the generation of new barbed ends, resulting in increased 
actin polymerisation and extension of membrane protrusions (Tania et al., 2011). In addition, 
RhoA can either induce or inhibit lamellipodia formation. Loss of RhoA inhibits lamellipodia 
formation but too much activity at the leading edge stimulates contractility (Ridley, 2011). 
This indicates the need for precise spatio-temporal regulation of different Rho GTPases to 
bring about effective cell migration.  
Cdc42 also activates Arp2/3 but via WASP and N-WASP (neuronal WASP), and brings 
about the formation of filopodia. Filopodium formation is thought to require an initial Arp2/3 
nucleation step followed by an mDia2-mediated elongation event. However, this picture is 
complicated by the fact that filopodia can also form independently of the Arp2/3 complex via 
formins alone (Yang and Svitkina, 2011). Like Rac1, Cdc42 can act via PAK and LIMK to 
phosphorylate and inhibit cofilin (Bishop and Hall, 2000). Cdc42 also regulates cell polarity 
acting via its target Par6 and atypical protein kinase C (aPKC) (Etienne-Manneville and Hall, 
2003). 
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Figure 1.5 Rac1 and Cdc42 signalling involved in the formation of lamellipodia and 
filopodia 
Activated Rac1 and Cdc42 lead to cofilin inactivation via PAK and LIMK which serves to 
stabilise actin filaments. PAK also phosphorylates and inactivates MLC kinase, resulting in 
reduced actomyosin contraction. Both Rac1 and Cdc42 bring about actin nucleation and 
polymerisation via WAVE and WASP respectively. 
 
 
Stress fibres are a major structure regulated by RhoA signalling. Two effectors are required 
for RhoA-mediated induction of stress fibres and focal adhesions, ROCK (Rho-associated 
kinase) and mDia1 (an FH (formin homology) domain containing protein) (reviewed in 
(Bishop and Hall, 2000)). ROCK is a serine/threonine kinase that is activated upon binding 
to RhoA-GTP by a disruption of autoinhibitory, intramolecular interactions. There are two 
ROCK proteins, ROCK1 and ROCK2, and recent observations have indicated that they have 
different biological roles (Shi et al., 2013; Vega et al., 2011). However, for simplicity they will 
be referred to as ROCK. Two key substrates of ROCK are myosin light chain (MLC) and the 
myosin binding subunit of MLC phosphatase. Phosphorylation of MLC at serine 19 by ROCK 
stimulates the ATPase activity of myosin II and leads to the assembly of actomyosin 
filaments. ROCK also indirectly increases the pool of phosphorylated MLC (p-MLC) by 
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phosphorylating and inactivating MLC phosphatase. MLC is also phosphorylated by MLC 
kinase (MLCK) at threonine 18 and serine 19 (Watanabe et al., 2007). Hence, the 
phosphorylation of MLC and of MLC phosphatase can be used as a read-out of contractility 
to some extent. Activation of mDia1 by RhoA leads to it binding to profilin and so contributes 
to increased polymerisation of actin. A model of mDia1 function is that it initiates actin 
nucleation in a focal contact contributing to stress fibre extension from the cell membrane 
(Kovar, 2006). These two effectors are needed together for the assembly of stress fibres. 
Activation of ROCK alone in the absence of mDia1 results in the formation of thick, stellate 
stress fibres while mDia1 alone induces thin stress fibres. However, both proteins together 
induce structures resembling that formed upon Rho activation (Watanabe et al., 1999). 
Another important target of ROCK is LIMK which phosphorylates and inhibits cofilin. This 
serves to stabilise actin filaments and also contributes to the formation of stable stress fibres 
(Bishop and Hall, 2000).  
 
Figure 1.6 Signal transduction during RhoA-mediated stress fibre assembly 
RhoA induces stress fibres via its downstream effectors, ROCK and mDia. ROCK increases 
the pool of p-MLC leading to actomyosin filament assembly. ROCK also leads to cofilin 
inactivation via LIMK which serves to stabilise actin filaments. mDia activation leads to actin 
polymerisation.  
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1.3.2.1 Structure and function of stress fibres 
Stress fibres in non-muscle cells are essentially bundles of actomyosin filaments that are 
comparable to the highly ordered actomyosin structures seen in muscle cells (reviewed in 
(Pellegrin and Mellor, 2007)). Stress fibres are contractile structures comprising of bundles 
of about 10-30 actin filaments and myosin II. These filament bundles are held together by 
actin cross-linking proteins such as α-actinin which is arranged periodically along the bundle 
(Lazarides and Burridge, 1975). Stress fibres in non-muscle cells differ from muscle 
sarcomeres significantly with regard to the polarity of actin filaments (Cramer et al., 1997; 
Mseka et al., 2009). This is an important concept as it determines contractile properties of 
the bundled actin filaments. In muscle cells, each block of bundled actin filaments shows 
opposite polarity to the successive block to facilitate sliding contraction. The orientation in 
non-muscle stress fibres can be much more diverse. However, in motile cells most stress 
fibres show graded polarity wherein at the ends of the fibre, filament orientation is uniform 
(barbed ends pointing outwards) and at the centre the filament polarity is more 
heterogeneous. 
Stress fibres can also be classified on the basis of their assembly in relation to the entire 
cell. (reviewed in (Tojkander et al., 2012)). Ventral stress fibres lie at the base of the cell and 
are anchored to focal adhesions at each end. Dorsal stress fibres are attached to a focal 
adhesion at only one end with the other end terminating in a loose meshwork of actin 
filaments. The third class are transverse arcs which are bundles of actin that form behind the 
protrusive edge of a migrating cell. 
An important question to address in the context of the structure and assembly of stress 
fibres is what function do stress fibres have? Dorsal stress fibres have uniform polarity as 
they are formed by filament elongation from a fixed point. Hence, they may not have 
significant contractile functions and could instead be involved in myosin-based trafficking of 
vesicle cargos or proteins (DePina and Langford, 1999). They may also contribute to the 
cell’s rigidity and be an intermediate in the formation of ventral fibres. Transverse arcs are 
not anchored at either end and hence once again it is unclear if they could function as 
contractile structures. On the other hand ventral fibres are tethered at either end to focal 
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adhesions and are the major contractile machinery in many cells (Tojkander et al., 2012). 
For example, this function is necessary for tail retraction in migrating cells, and ventral stress 
fibres are aligned in the direction of motion in motile fibroblasts (Cramer et al., 1997).  
A function for stress fibres particularly relevant to this thesis is their role in the vasculature. 
In confluent endothelial cell monolayers few focal adhesions are present. Interestingly, 
adherens junctional complexes can substitute for focal adhesions and anchor stress fibres. 
Stress fibres form a supra-cellular network that could be important for coordinating 
endothelial function by providing mechanical linkage (Millan et al., 2010). These concepts 
and the relation between stress fibres and endothelial junction integrity are discussed further 
in section 1.4.2.3. Furthermore, stress fibres are induced upon shear stress in endothelial 
cells (Wojciak-Stothard and Ridley, 2003). They are thought to be required for endothelial 
cells to remain flat under flow, so reducing shear stress and have been suggested to provide 
rigidity to resist these forces (Pellegrin and Mellor, 2007). 
1.4 The vascular endothelium 
The endothelium is the innermost layer of blood and lymphatic vessels and is made up of a 
single layer of endothelial cells. An important function of the endothelium is to act as a 
mechanical barrier, separating blood and lymph from surrounding tissue. However, the 
endothelium has roles beyond this and is involved in the control of leukocyte diapedesis, 
immune reactions and inflammation, and regulates trans-endothelial passage of soluble 
macromolecules (Dejana, 2004). An added unique feature of the vascular endothelium is 
that it is subjected to constant blood flow and associated shear forces. Endothelial cells 
need to be able to respond to and resist these hemodynamic forces. An interesting example 
that serves to integrate many of the concepts discussed so far is RhoA and Rac1-mediated 
polarisation in response to shear stress. Shear stress leads to a RhoA-induced increase in 
stress fibres, followed by repolarisation of the cell in the direction of the shear force vector 
which is regulated by RhoA and Rac1 (Wojciak-Stothard and Ridley, 2003). A mechano-
sensory system in endothelial cells has been shown to mediate responses to shear stress 
(Allen et al., 2011; Tzima et al., 2005).  
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To fulfil these diverse functions, endothelial cells are highly responsive to their surroundings. 
For example, pro-inflammatory stimuli such as TNFα induce an increase in endothelial 
permeability (Wojciak-Stothard and Ridley, 2002). Changes in endothelial gene expression 
and/or surface protein expression in response to extracellular stimuli have also been noted. 
For example, E-selectin is an inducible endothelial-specific leukocyte adhesion molecule 
(Bevilacqua et al., 1987). Another example is shear stress-induced activation of the 
transcription factor c-Fos via RhoA (Shiu et al., 2003). In addition, endothelial cells are 
heterogeneous to fulfil specialised functions. For example, specialised structures are seen in 
cells of the renal glomerulus and liver which contain fenestrae, and in cells comprising the 
blood brain barrier which are enriched in tight junctions (described in section 1.4.1.2).  
1.4.1 Endothelial cell-cell junctions 
Endothelial cell-cell junctions being regions of contact between adjacent cells have 
significant roles in mediating endothelial permeability and do not just serve as points of 
attachment between cells. Furthermore, junction signalling is implicated in mediating 
angiogenesis, cell proliferation, shear stress responses and leukocyte diapedesis (Dejana, 
2004). Endothelial cells have junctional regions corresponding to adherens junctions (AJ) 
and tight junctions (TJ) and gap junctions (reviewed in (Dejana, 2004)). Junctions between 
endothelial cells have variable organisation which is less restricted as compared to junctions 
in epithelial cells. Furthermore, adjacent endothelial cells may overlap resulting in the 
formation of contact regions in these areas. AJ components in these areas are arranged in 
reticular domains and are termed reticular AJs (Fernandez-Martin et al., 2012). Adhesion in 
both AJs and TJs is mediated by transmembrane proteins that are capable of homophilic 
interactions. These junctional proteins mediate intracellular signalling and link junctions to 
the cytoskeleton via their cytoplasmic domains. These associations in addition to stabilising 
cell-cell contacts are required for the dynamic control of vascular permeability (described in 
section 1.4.2.3).  
1.4.1.1 The endothelial adherens junction 
VE-cadherin is a key transmembrane component of endothelial adherens junctions and is 
responsible for providing adhesive capacity by forming homophilic adhesions (reviewed in 
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(Dejana and Giampietro, 2012)). Single VE-cadherin bonds are of very low strength. VE-
cadherin anchorage to the perijunctional actin cytoskeleton is essential for its function and is 
thought to cluster VE-cadherin and increase its avidity, so stabilising adhesions 
(Baumgartner et al., 2003). The intracellular domain of VE-cadherin contains binding sites 
for p120-catenin, β-catenin and plakoglobin. Both β-catenin and plakoglobin can interact 
with α-catenin. Plakoglobin serves to link VE-cadherin to the vimentin cytoskeleton 
(Kowalczyk et al., 1998) while it is thought that complexes of VE-cadherin, β-catenin, α-
catenin and p120 catenin are involved in connecting to the actin cytoskeleton (Millan et al., 
2010). Endothelial cells express other cadherins such as N-cadherin and T-cadherin (Wallez 
and Huber, 2008). While abundant in the endothelium, N-cadherin is poorly localised to cell-
cell junctions (Salomon et al., 1992) and only does so in the absence of VE-cadherin 
(Navarro et al., 1998). Other studies show that N-cadherin is involved in interactions with 
perivascular cells like pericytes (Tillet et al., 2005). VE-cadherin-deficient embryos are still 
able to form electron dense junctions, implying functional redundancy between these 
different adhesion molecules (Gory-Faure et al., 1999). 
Recent observations have shed light on how adherens junctions form and stress the 
importance of the actin cytoskeleton for both junction formation and junction 
maintenance/regulation. A study using HUVECs (human umbilical vein endothelial cells) 
indicates that cell-cell interactions are initiated by lamellipodia of adjacent cells that meet 
and provides a mechanism by which cell-cell junctions form and mature (Hoelzle and 
Svitkina, 2012). Subsequent retraction of the lamellipodia results in the formation of 
filopodium-like bridges with F-actin in these structures bundled by fascin, and VE-cadherin 
accumulation at points of contact. Following this lamellipodia-filopodia transition, bridges 
mature into stress fibre-like structures with the incorporation of myosin II. These bridges link 
adjacent cells and leads to subsequent junction expansion. In epithelial cells, adherens 
junctions can either exist as linear adherens forming circumferential rings or as dynamic, 
punctate, discontinuous junctions such as those seen in neoplastic cells (Ayollo et al., 2009). 
In endothelial cells, a similar situation exists. Discontinuous AJs in endothelial cells are 
linked to stress fibres and serve to link the cytoskeleton of adjacent cells. This organisation 
plays an important role in regulating junction permeability and increases stress resistance 
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(Millan et al., 2010). By contrast, continuous AJs have a linear morphology and are 
associated with cortical F-actin which is required for the maintenance of mature cell-cell 
junctions (Garcia et al., 2001). The regulation of vascular permeability and the switch from 
continuous to discontinuous AJs will be discussed in section 1.4.2. 
1.4.1.2 The endothelial tight junction 
The major transmembrane, adhesive components of TJs are the claudin proteins. The 
claudins are a family of more than 20 proteins but only a few are expressed in the 
endothelium with claudin-5 being highly expressed in most cases (Dejana et al., 2009). 
These molecules form homophilic and heterophilic (with other claudin subtypes) interactions 
and low claudin expression is correlated with reduced blood brain barrier function (Nitta et 
al., 2003). Other transmembrane components of TJs include occludin and JAMs (junctional 
adhesion molecule). Occludin expression too has been correlated with barrier properties of 
the endothelium (Wallez and Huber, 2008). Important intracellular signalling mediators linked 
to claudin and occludin at tight junctions include the ZO proteins (ZO-1, 2 and 3) and afadin 
which link TJs to the actin cytoskeleton. Occludin has also been shown to be able to directly 
bind F-actin (Wittchen et al., 1999). ZO-1 can also bind to JAM, the adherens junction 
protein α-catenin and the gap junction protein connexin-43 (Harhaj and Antonetti, 2004). 
Hence, it is probable that different junction systems are interconnected and cooperate to 
regulate barrier integrity.  
In addition to these two important junctional structures, the nectin-afadin system contributes 
to cell-cell contacts. Nectin is a member of the immunoglobulin family of transmembrane 
proteins and interacts with afadin via its intracellular domain. Afadin interacts with ponsin 
and actin and so links nectins to the cytoskeleton (Reymond et al., 2001). Ponsin can bind to 
vinculin (Mandai et al., 1999) and as vinculin is a part of the intracellular cadherin complex 
(Wallez and Huber, 2008), this provides a link between the cadherin and nectin systems. 
Other homophilic adhesion molecules include PECAM-1 (platelet endothelial cell adhesion 
molecule – 1) and S-endo-1 which belong to the immunoglobulin family. These proteins are 
not part of any specialised junctional structure (Dejana, 2004). PECAM-1 is also found on 
leukocytes and platelets and is required for leukocyte transmigration (Mamdouh et al., 
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2003). A recent study indicates that PECAM-1 coordinates with AJs to maintain barrier 
function (Fernandez-Martin et al., 2012). 
 
Figure 1.7 Endothelial cell-cell junctions 
Junction systems in endothelial cells include tight junctions, adherens junctions, PECAM-1 
and the nectin-afadin system. AJs, TJs and nectin link to the actin cytoskeleton by means of 
intracellular partner molecules. 
 
Endothelial cell-cell junctions mediate cell signalling and respond to multiple inputs as well 
as inducing downstream signalling responses. For example, AJs are involved in contact 
inhibition of cell growth/proliferation. This can occur by a modulation of growth factor 
signalling by VE-cadherin. VE-cadherin in confluent cells is clustered at junctions and forms 
a complex with VEGFR2 (vascular endothelial growth factor receptor 2) leading to a 
downregulation of its activity (Grazia Lampugnani et al., 2003). VE-cadherin signalling is 
also able to protect resting, confluent cells from pro-apoptotic stimuli (Carmeliet et al., 1999) 
1.4.2 Mechanisms regulating endothelial permeability 
The permeability of the endothelium reflects the extent to which trans-endothelial passage of 
soluble molecules and/or cells is allowed. The control of permeability is vital to physiological 
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events such as inflammation. There are two mechanisms by which vascular permeability can 
be mediated, termed the transcellular and paracellular pathways.  
The paracellular route of endothelial permeability regulation is mediated by endothelial cell-
cell junction complexes, which act as a barrier to restrict the passage of fluid from the lumen 
through the intercellular space. The disruption of junctions is also implicated in the passage 
of cells through the endothelium. This process is regulated by homophilic interactions 
between molecules present on the endothelial surface and invading cells, which dictates the 
passage of cells through cell-cell contacts. This is usually accompanied by junction 
rearrangement and cell retraction (Dejana, 2004).   
The transcellular pathway refers to passage through the endothelial cell body and involves 
vesicular transport systems, fenestrae and biochemical transporters (Dejana et al., 2009). 
For example, transcellular structures like vesiculo-vacuolar organelles form a series of 
interconnected vesicles that span the endothelial cell and provide a trans-endothelial 
passage (Dvorak et al., 1996). Leukocytes too are able to use a transcellular mechanism to 
achieve diapedesis (Carman and Springer, 2004; Millan et al., 2006). Similarly, cancer cells 
have been observed to intravasate by the transcellular route (Khuon et al., 2010). 
1.4.2.1 Adherens junctions and regulation of vascular permeability 
VE-cadherin plays a central role in regulating permeability. This is supported by an increase 
in vascular permeability in response to an injection of VE-cadherin blocking antibodies in 
mice (Corada et al., 1999). Phosphorylation of VE-cadherin is an important mechanism by 
which its function is regulated, and results in disruption of adherens junctions and an 
increase in monolayer permeability (reviewed in (Harris and Nelson, 2010)). For example, 
invasive breast cancer cells can induce tyrosine phosphorylation of VE-cadherin to facilitate 
invasion through the vasculature (Haidari et al., 2012). Hemodynamic forces result in the 
tyrosine phosphorylation of VE-cadherin via Src kinase in veins, and it is thought that this 
serves as a priming mechanism to sensitize veins to other permeability inducing agents such 
as inflammatory cytokines (Orsenigo et al., 2012). Several phosphatases interact with VE-
cadherin including VE-PTP (vascular endothelial-protein tyrosine phosphatase). VE-PTP 
expression enhances VE-cadherin function and reduces vascular permeability (Nawroth et 
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al., 2002). Phosphorylation of other components of adherens junctions such as p120 
catenin, β-catenin and plakoglobin also correlates with increased permeability (Harris and 
Nelson, 2010).  
Regulation of VE-cadherin availability at the cell surface is another way to regulate its 
function (Harris and Nelson, 2010). The association of p120 catenin with VE-cadherin 
prevents the endocytosis of VE-cadherin and is needed for maintaining barrier function. 
VEGF is known to increase vascular permeability by phosphorylation of VE-cadherin on 
serine 665. Phospho-S665 VE-cadherin is a docking site for β-arrestin which leads to VE-
cadherin endocytosis and degradation (Gavard and Gutkind, 2006). In addition, trafficking of 
VE-cadherin to the cell surface has to be properly accomplished. Myosin-X is a motor 
protein that transports VE-cadherin along filopodial actin filaments causing accumulation at 
filopodial tips. Blocking myosin-X activity abolishes VE-cadherin export to cell edges 
(Almagro et al., 2010).  
Furthermore, VE-cadherin function can be regulated by regulation of its expression and 
proteolytic cleavage. Tumour cells and leukocytes can secrete proteases that digest VE-
cadherin and so increase vascular leakage (Dejana et al., 2009).  
1.4.2.2 Tight junctions and the regulation of vascular permeability 
A wide range of signals including growth factors, cytokines and hormones regulate TJ 
function to increase vascular permeability (reviewed in (Harhaj and Antonetti, 2004)). 
Stimulation by inflammatory cytokines like TNFα causes the disruption of TJs. Long term 
stimulation of endothelial cells with TNFα leads to reduced localisation of occludin and JAM-
A at TJs (McKenzie and Ridley, 2007). JAM-C is particularly interesting because unlike other 
adhesion proteins loss of JAM-C function reduces permeability. JAM-C is thought to regulate 
permeability by crosstalk with VE-cadherin (Orlova et al., 2006). The claudins too are 
implicated in vascular permeability. Loss of claudin-5 in mice leads to a size-selective loss in 
blood brain function against molecules less than 800 kDa in size (Nitta et al., 2003). Finally, 
phosphorylation of ZO-1 resulting in its reduced localisation to TJs, is linked to enhanced 
vascular permeability and has been proposed to be one of the ways by which VEGF 
increases vessel leakage (Antonetti et al., 1999). In summary, the loss of function and/or 
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mislocalisation of most of the key components of TJs results in increased paracellular 
permeability. 
1.4.2.3 Vascular permeability and the actin cytoskeleton 
Endothelial permeability is linked to the cytoskeleton due to the close association between 
junction complexes and the cytoskeleton. In addition to stress fibres, cortical F-actin is 
implicated in barrier function. Rho GTPases play a significant role in modulating endothelial 
permeability (reviewed in (Wojciak-Stothard and Ridley, 2002)). Increased centripetal 
tension as a result of actomyosin-induced contractility results in the disruption of cell-cell 
contacts. This is commonly associated with an increase in stress fibres which have been 
shown to be associated with AJs (Millan et al., 2010). A general model could involve 
increased contractility of stress fibres and/or of the perijunctional cortical F-actin leading to 
an increase in tensile force, which subsequently causes a physical breakdown of junctions. 
The importance of the actin cytoskeleton in mediating permeability is highlighted by F-actin 
disrupting agents leading to increased permeability, and F-actin stabilising agents that 
prevent this (McKenzie and Ridley, 2007). In addition, inhibition of ROCK activity increases 
permeability (McKenzie and Ridley, 2007). These observations point to the requirement of a 
‘contractile sweet spot’ for optimal barrier function. It is likely that too little or too much 
contractility causes destabilisation of cell-cell junctions.  
Thrombin induction of endothelial permeability involves RhoA. RhoA-induced contractility by 
induction of stress fibres correlates with increased vascular permeability, and is in part 
responsible for the endothelial response to thrombin (Wojciak-Stothard et al., 2001). RhoA 
activity spatially associated with actin filaments, is linked to thrombin-induced disruption of 
junctions (Szulcek et al., 2013). Rac1-mediated control of endothelial permeability is 
complex, and Rac1 can have barrier-strengthening or barrier-weakening functions. It is likely 
that the functions of Rac1 are dependent on the stimulus and conditions. For example, Rac1 
inhibits thrombin-induced RhoA activation (Rosenfeldt et al., 2006), suggesting a junction 
strengthening function. Conversely, Rac1 can weaken junctions by inducing VE-cadherin 
internalisation after VEGF stimulation by PAK activity (Gavard and Gutkind, 2006). Depletion 
of Rac1 also reduces TNFα-induced permeability (Cain et al., 2010). In addition, Rac1 
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activity causes loss of VE-cadherin function via ROS (reactive oxygen species) generation 
(van Wetering et al., 2002).  
Other proteins also affect junctions. For example, while dominant negative Cdc42 reduces 
thrombin-induced stress fibres and contractility, it does not prevent the associated increase 
in permeability (Wojciak-Stothard et al., 2001). However, its activity is needed for the 
restoration of junctions after thrombin stimulation in vitro and in vitro (Kouklis et al., 2004). In 
some cases, the altered permeability can be independent of associated cytoskeletal 
changes. A pertinent example is that of TNFα stimulation of endothelial cells. While RhoA-
associated contractility results in early changes to F-actin and cell morphology, long term 
increased permeability instead correlates with the disassembly of tight junctions (McKenzie 
and Ridley, 2007). Another mechanism by which permeability is mediated involves 
regulation of cortical F-actin. For example, sphingosine 1-phosphate activates PAK via 
Rac1, which phosphorylates and activates LIMK. This results in the downregulation of cofilin 
activity and leads to an enhancement of the F-actin cortical ring, stabilising cell-cell junctions 
(Garcia et al., 2001). Similarly, the Ras family GTPase Rap1 is thought to control VE-
cadherin based junctions by controlling the cortical actin cytoskeleton (Cullere et al., 2005). 
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Figure 1.8 Signal transduction pathways regulating junction integrity in endothelial 
cells 
RhoA activation leads to enhanced contractility and is associated with a breakdown of cell-
cell junctions. Rac1 can have barrier-strengthening or barrier-weakening functions 





Angiogenesis is the process by which new blood vessels form from pre-existing ones and 
involves endothelial cell activation, proliferation, migration and vessel maturation (reviewed 
in (Potente et al., 2011)). This section will focus on links between angiogenesis, cell-cell 
junctions and the cytoskeleton. 
In the adult, the vasculature is largely quiescent except in physiological processes such as 
wound healing and female endometrial growth. Signals that drive angiogenesis are largely 
derived either from secreted, soluble factors or from the ECM (the role of the ECM in 
angiogenesis is reviewed in (Senger and Davis, 2011)). VEGF is a ‘master regulator’ of 
angiogenesis (Herbert and Stainier, 2011) and is the major angiogenic stimulus in the adult 
organism. Blood vessels are covered on their basal surface with a basement membrane of 
which the main constituents are laminin and collagen type IV. One of the first steps in 
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angiogenesis is the degradation of this membrane so that the underlying endothelial cells 
are free to enter the sprouting phase. VEGF can induce degradation of the basement 
membrane (Chang et al., 2009). Cell-cell junctions also have to be destabilised in order for 
cells to enter the sprouting phase. RhoA and ROCK signalling has been found to mediate 
vascular hyperpermeability downstream of VEGF (Sun et al., 2006). In addition, VEGF 
destabilises junctions by promoting VE-cadherin internalisation (Gavard and Gutkind, 2006).  
The next stage is termed sprouting angiogenesis and involves two major types of cells, tip 
cells and stalk cells. Tip cells lead newly sprouting vessels, are highly motile and are 
induced by VEGF. Stalk cells on the other hand are less motile but proliferate to generate 
the trunk of the new vessel, establish junctions with neighbouring cells and are subsequently 
responsible for lumen formation. Tip cells navigate by the extension of filopodia. VEGF 
stimulation promotes filopodium formation via Cdc42, and also stimulates Rac1 activity at 
the leading edge promoting lamellipodium extension (De Smet et al., 2009). Endothelial cells 
in general use mechanisms discussed in section 1.2 to migrate. The p110α catalytic subunit 
of PI3K (phosphoinositide 3-kinase) is important for endothelial cell motility and regulates tail 
release of migrating cells through RhoA (Graupera et al., 2008). Another mediator of 
endothelial cell motility is RhoJ, which is a member of the Cdc42 subfamily of Rho GTPases 
and highly expressed in endothelial cells (Kaur et al., 2011). Depletion of RhoJ impairs the 
migration of endothelial cells in a scratch-wound assay.  
Sprouting leads initially to the formation of cords which essentially are coalesced chains of 
endothelial cells. RhoA-mediated formation of stress fibres and induction of spindle 
morphology is needed for alignment of cells into cords (Liu and Senger, 2004). A lumen has 
to then form in the vessel trunk which can occur either by cord hollowing (cell shape and 
cell-cell junctions are altered to create a lumen between adjacent cells and is thought to rely 
on cytoskeletal contraction) or cell hollowing (intracellular vacuoles coalesce and fuse with 
vacuoles in other cells to form a lumen) (Potente et al., 2011). Depletion of Rac1, Cdc42 
(Koh et al., 2008) and RhoJ (Kaur et al., 2011) impairs endothelial cell tube and lumen 
formation in in vitro assays. Cdc42 is required for cells to acquire apical-basal polarity during 
lumen formation. 
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VE-cadherin expressed on the surface of tip cell filopodia is thought to promote anastomosis 
between different vascular branches leading to the establishment of a vascular plexus. In 
addition to its importance in junction formation, VE-cadherin signalling has been implicated 
in the cessation of the sprouting phase. Activation of VE-cadherin signalling by the 
engagement of junctions leads to increased actomyosin contractility by activation of ROCK 
and increased levels of p-MLC2 at intercellular junctions. VE-cadherin signalling antagonizes 
VEGF signalling and so abrogates Rac1-mediated sprouting (Abraham et al., 2009). This is 
consistent with a study that demonstrates that local downregulation of cortical myosin II 
activity permits endothelial cell branching and migration (Fischer et al., 2009). Interestingly, 
ERK (extracellular signal regulated kinase) signalling can downregulate ROCK signalling to 
promote cell survival and sprouting (Mavria et al., 2006). ERK is a mitogen activated protein 
kinase (MAPK) involved in cell migration, growth, and proliferation (Roskoski, 2012). 
Actomyosin contractility induced by VE-cadherin signalling is also needed for the uniform 
distribution of VE-cadherin itself at cell-cell junctions leading to a positive feedback loop 
being set up (Abraham et al., 2009). 
 
Figure 1.9 Signal transduction involved in the control of sprouting 
Interplay between VE-cadherin and VEGF signalling mediates sprouting during 
angiogenesis. VE-cadherin signals via ROCK to induce contractility and the cessation of 
sprouting. ERK signals to downregulate ROCK and so promotes sprouting. VEGF signalling 
drives Rac1-mediated migration and sprouting. 
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It is likely that precise spatial and temporal regulation of Rac activity determines how it acts 
in endothelial cells. While Rac1 activity is needed for migration and sprouting, it is also 
essential for vascular maturation and in quiescent endothelial cells for the proper 
organisation of cell-cell junctions (Senger and Davis, 2011). For the establishment of a 
functional vasculature, the vascular network has to mature by pruning and remodelling of 
branches, while individual endothelial cells become quiescent and acquire a ‘phalanx’ 
phenotype in which junctions are strengthened and VEGF signalling is reduced. 
 
Figure 1.10 Simplified overview of angiogenesis 
Schematic highlighting the primary steps in angiogenesis. Endothelial cells respond to pro-
angiogenic stimuli leading to formation of vascular sprouts, and the subsequent maturation 
and establishment of a vascular network (refer to text for details). 
 
 
1.6 Identification of the FAM40 proteins as regulators of cell 
morphology and migration 
Large-scale RNA interference (RNAi) screens offer a powerful way to identify, and elucidate 
the functions of novel genes (Mohr and Perrimon, 2012). Phenotypes that arise as a result of 
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gene expression knockdown using RNAi can provide clues to gene function. This can be 
achieved by comparing with other genes that induce a similar phenotype. RNAi screen 
results can be analysed further to construct signalling networks. For example, by comparing 
the morphologies of cells that were depleted of various Rho GAPs with those of cells 
overexpressing various Rho GTPases, predictions of Rho GAP/GTPase regulatory 
pathways could be made (Nir et al., 2010). 
The Drosophila FAM40 orthologue was one of many genes identified in a RNAi screen for 
genes affecting the ‘actinome’ in Drosophila S2 cells (Rohn et al., 2011). The actinome is 
defined as the set of genes that contribute to the regulation of the actin cytoskeleton. 
Members of the known actinome were used to identify novel regulators by comparative 
screening. Hits in this screen were organised by phenotypic attributes including cell shape, 
cell size, cell number, actin content/organisation and microtubule content/organisation. To 
identify a conserved set of actin regulators that performed similar functions across different 
species, a second RNAi screen was performed in HeLa cells using human orthologues of 
genes identified as hits in Drosophila. Using data from these two screens a list of conserved 
novel regulators of the actinome was compiled. For example, the SCF E3 ubiquitin ligase 
complex, previously not linked to actin regulation was identified as an upstream regulator of 
actin polymerisation controlled by Rac. S2 cells depleted of the Drosophila FAM40 
orthologue (CG11526) present with an ‘asymmetric lamella’ phenotype. However, CG11526 
was not included in the list of conserved regulators of the actinome as knockdown of the 
human FAM40 orthologues gave a different phenotype as compared to the Drosophila 
orthologue. FAM40B-depleted HeLa cells present with bright regions of peripheral F-actin 
associated with lamellipodia and filopodia. A reduction in thick F-actin cortical bundles and in 
cell-cell adhesions is also observed (Bai et al., 2011).  
Data from this initial RNAi screen were used by our laboratory to conduct a second RNAi 
screen in a cancer cell line, PC3 (derived from prostate cancer metastasis to the bone) to 
identify novel regulators of cytoskeletal organisation, cell morphology and migration (Bai et 
al., 2011). The genes selected for this second screen altered the shape of Drosophila S2 
cells and had unknown functions in Drosophila. A further bioinformatics and data mining 
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analysis was done to narrow down this selection to 16 genes.  This essentially consisted of 
evidence of their function (including homologues in other species) from public databases 
that hinted at a link to cytoskeletal regulation. These 16 Drosophila genes corresponded to 
26 homologous human proteins and included human FAM40A and FAM40B. Knockdown of 
FAM40A and FAM40B in PC3 results in distinct morphological phenotypes. (Bai et al., 
2011). These phenotypes will be discussed further in chapter 4. The striking phenotypes 
they bring about upon RNAi knockdown is why they were selected for further 
characterisation.  
 
Figure 1.11 Schematic of the procedure used to select FAM40A and FAM40B for 
functional characterisation 
The FAM40 proteins were initially selected for functional characterisation based on their 
Drosophila orthologue being a hit in a genome-wide cell morphology RNAi screen. A 
subsequent study in PC3 cells led to effects on cell morphology upon FAM40 depletion. 
 
 
1.6.1 The FAM40 proteins 
The FAM40 (FAMily with sequence similarity 40) proteins are a family of proteins found in 
many eukaryotes including fungi. Interestingly no homologues could be found in plants. Two 
FAM40 homologues exist in humans, FAM40A and FAM40B, which also go by the names 
STRIP1 (striatin interacting protein 1) and STRIP2 respectively. FAM40A and FAM40B have 
61% amino acid identity and have the same overall domain architecture. Two domains can 
be identified in the human FAM40 proteins, the N-terminal N1221-like domain and the C-
terminal DUF3402 (domain of unknown function 3402). The sequence of the N-terminal 
domain is similar to a hypothetical protein product of a yeast ORF (open reading frame) 
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termed N1221 (conserved domains database, NCBI). Both these domains are functionally 
uncharacterised and do not bear resemblance to any other known domains. In addition, the 
N-terminal sequence of FAM40A is proline-rich which could be important for mediating 
interactions with other proteins (Kay et al., 2000). 
 
Figure 1.12 Schematic illustrating FAM40 domain architecture 
Both FAM40A and FAM40B contain two domains, an N-terminal N1221-like domain and a 
C-terminal DUF3402 domain. 
 
 
Functions and interacting partners of FAM40 homologues in other species may be relevant 
for the understanding of human FAM40 function. The yeast homologue of the FAM40 
proteins is Far11 (Factor Arrest 11), which is involved in pheromone signalling in 
Saccharomyces cerevisiae (Kemp and Sprague, 2003). Far11 is part of a multi-protein 
complex involving other Far proteins (Far3, 7-11) that causes G1 cell cycle arrest in 
response to pheromone. The exact function of Far11 in the complex is not known but it has 
been suggested that it may be involved in cell fusion during mating. This is based on an 
orthologue present in Neurospora crassa (Ham2), mutants of which display a significant 
defect in hyphal fusion (Xiang et al., 2002). A recent study has implicated Far11 in an 
independent role, as a mediator of human caspase-10 function in S. cerevisiae. 
Heterologously expressed human caspase-10 in S. cerevisae requires Far11 for its toxicity. 
Caspases are proteolytic enzymes and are key regulators of apoptotic cascades in cells. 
Far11 was shown to be required for the induction of autophagy and regulation of the DNA 
damage response pathway (Lisa-Santamaria et al., 2012).  
Additionally, the Far complex has been shown to antagonise TORC2 (target of rapamycin 
complex 2) signalling in S. cerevisae. Far11 mutants suppress the lethality of TORC2 
mutants (Pracheil et al., 2012). TOR kinase is an important regulator of cell growth and 
metabolism. Knockdown of components of the mammalian equivalent mTORC2 
(mammalian TORC2) results in actin cytoskeletal changes in cultured cells and affects cell 
motility (Cybulski and Hall, 2009). The Far protein complex interacts with Rho4 protein 
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(determined using BioGRID (Stark et al., 2006)) and thus it is possible it is involved in actin 
filament polarization and the establishment of cell polarity (Levin, 2005). Additionally Far11 
is known to interact with Rom2 (determined using BioGRID (Stark et al., 2006)), which is a 
GEF for the Rho GTPase Rho1 in S. cerevisiae (Ozaki et al., 1996). Rho1 controls polarised 
actin distribution and cell wall expansion in S. cerevisiae (Levin, 2005). The human homolog 
of Rho1 is Rho, with RhoA being its closest relative.  
The Caenorhabditis elegans FAM40 homologue is FARL-11 (Factor Arrest Like-11). A 
mutant for this gene suppresses the lethality of conditional dynein heavy chain mutants in 
addition to associated spindle length and cytokinesis abnormalities (O'Rourke et al., 2007). 
This suggests that FARL-11 is a negative regulator of dynein, and hence might be involved 
in cargo transport along microtubules.  
1.6.2 The STRIPAK complex 
The FAM40 proteins were identified in an interaction map around the protein phosphatase 
2A (PP2A) catalytic subunit by an affinity purification/mass spectrometry approach 
(Goudreault et al., 2009). Interacting partners identified were in turn cloned and used as 
baits in subsequent affinity purification steps to construct a high density protein interaction 
map. This led to the identification of a novel multi-protein complex termed the STRIPAK 
(striatin interacting phosphatase and kinase) complex of which the FAM40 proteins are a 
part of. Interestingly, analogues of the human STRIPAK complex are present in other 
species too. The Far complex in S. cerevisiae bears resemblance to the human STRIPAK 
complex while a Drosophila STRIPAK complex (Ribeiro et al., 2010) and a STRIPAK 
homologue in filamentous fungi (Bloemendal et al., 2012) have been defined too. This 
suggests the presence of an evolutionarily conserved protein complex.  
PP2A is a serine/threonine phosphatase and has been described to have diverse functions 
including the control of cell growth, proliferation and differentiation. PP2A is also involved in 
regulating the cytoskeleton and misregulation of PP2A activity disrupts both the actin and 
microtubule cytoskeleton (reviewed in (Sontag, 2001)). In addition, PP2A regulates 
endothelial cell motility (Young et al., 2002), and so might be involved in angiogenesis. The 
functional PP2A enzyme is a trimer consisting of a catalytic subunit (PP2A C), a scaffolding 
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subunit (PP2A A) and a regulatory subunit (PP2A B). Two isoforms exist for each of the A 
and C subunits while 15 B subunits have been identified. It is thought that these regulatory B 
subunits determine the diversity and specificity of PP2A biological activity, and are important 
for substrate recruitment (Goudreault et al., 2009). The striatin proteins are a class of 
regulatory subunit proteins, and striatin (STRN), striatin 3 (STRN3) and striatin 4 (STRN4) 
are also components of the STRIPAK complex.  
Striatins are highly expressed in the nervous system and have been implicated in calcium-
dependant neuronal signalling. As they are highly expressed in dendritic spines, it has been 
suggested that they have a key role in bridging calcium signalling pathways and 
phosphatase pathways in dendritic spines (Benoist et al., 2006). Mob3 is another component 
of the STRIPAK assembly and its homologue in filamentous fungi is essential for vegetative 
cell fusion and sexual development (Bernhards and Poggeler, 2011). The Drosophila Mob3 
homologue has been implicated in regulating synapse formation and axonal transport. 
Mutants also display disrupted microtubule organisation in the nervous system (Schulte et 
al., 2010). All members of the GCKIII (germinal centre kinase III) family of Ste20 kinases 
(STK24, STK25 and MST4) are components of this complex and their functions will be 
elaborated on in section 1.7. In addition, a recent study has identified another germinal 
centre kinase MINK1 (misshapen like kinase 1) as a component of the STRIPAK complex. 
MINK1 can interact with STRN4 and is needed for abscission of the cytoplasmic bridge 
between daughter cells during cytokinesis (Hyodo et al., 2012). The presence of both a 
phosphatase and a kinase in the same complex could imply the STRIPAK complex acting as 
an on/off switch in regulating protein phosphorylation and dephosphorylation. On the other 
hand, the phosphatase and kinases could regulate each other. An example of this has been 
described wherein PP2A downregulates STK24 activity using striatin as an organising 
scaffold (Gordon et al., 2011). The other significant component of STRIPAK is CCM3 
(cerebral cavernous malformation 3), mutations in which lead to vascular malformations in 
the brain (Riant et al., 2010). Cerebral cavernous malformations and the role of CCM3 are 
discussed in section 1.8. 
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Table 1.1 Key components of the STRIPAK complex  
 
Table derived from (Goudreault et al., 2009) except where indicated. 
  
Protein name Biological role 
FAM40A / FAM40B Refer to chapter 4 / chapter 5 
PP2A Protein dephosphorylation 
GCKIII kinases (STK24, STK25, MST4) Protein phosphorylation, apoptosis, 
proliferation, cell migration  
(refer to section 1.7) 
CCM3 Implicated in CCM (refer to section 1.8) 
Striatin / Striatin 3 / Striatin 4 Calcium signalling, synaptic function 
Mob3 Roles in trafficking, synaptic function 
CTTNBP2 Dendritic spinogenesis, synaptic function 
(Chen et al., 2012) 
 
Insight into the functions of the FAM40 proteins may be obtained by understanding the 
functions of STRIPAK as a multi-protein complex. For example, the human STRIPAK 
complex has been implicated in Golgi polarisation. Cells depleted of CCM3 fail to reorient 
their Golgi apparatus and centrosome towards the wound edge in wound healing assays 
with SaOS2 cells (derived from primary osteosarcoma) (Fidalgo et al., 2010). CCM3 
prevents degradation of the GCKIII kinases via the proteasome. This action stabilises them 
at the Golgi where STK25 phosphorylates 14-3-3ζ. The authors postulate that this 
phosphorylation event contributes to the establishment of cell polarity. On a separate note, it 
is interesting to note that the Drosophila FAM40 homologue binds to aPKC (atypical protein 
kinase C) (determined using BioGRID (Stark et al., 2006)), a key mediator of cell polarity 
(Etienne-Manneville and Hall, 2003). Hence, CCM3 could contribute to CCM pathogenesis 
by regulating endothelial cell migration.  
This function of the STRIPAK complex at the Golgi is supported by a second study which 
demonstrates that MST4 localisation is controlled in opposite ways by CCM3 and striatin 
(Kean et al., 2011). MST4 is normally localised to the Golgi and to punctate structures in the 
cytoplasm. Depletion of striatin leads to increased cytosolic localisation of MST4 while 
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depletion of CCM3 increases its localisation to the Golgi. This control of MST4 localisation 
correlated with opposite effects on Golgi positioning. The study additionally proposes that 
striatin acts as a core scaffold in the STRIPAK complex, and can bind both CCM3 and PP2A 
directly. CCM3 then binds to the GCKIII kinases and recruits them to the complex.  
Another theme in STRIPAK function is the control of cell fusion as described in Sordaria 
macrospora (Bloemendal et al., 2012). Furthermore, the Neurospora crassa FAM40 
orthologue (Ham2), Mob3 orthologue and striatin orthologue (Ham3) have been implicated in 
cell-cell fusion (Fu et al., 2011). Directed growth of hyphae is required during cell-cell fusion 
in fungi and hence the STRIPAK complex could mediate this function by affecting Golgi 
positioning and cell polarity as in human cells.  
The Far complex in yeast shows an interesting parallel with the human STRIPAK complex, 
and could represent a yeast STRIPAK complex. In addition to the FAM40 proteins having a 
yeast homologue (Far11), Far8 bears resemblance to striatin proteins (Goudreault et al., 
2009). Furthermore, Far11 has been shown to interact with the yeast PP2A A subunit Tpd3 
(Goudreault et al., 2009; Pracheil et al., 2012)) and the yeast PP2A C subunits Pph21 and 
Pph22 (Lisa-Santamaria et al., 2012). In budding yeast, a role for this complex in mediating 
cell fusion has been proposed as well. The Far complex may act to stop premature entry into 
mitosis by inducing G1 arrest upon pheromone activation, and so allow mating cells enough 
time to fuse (Kemp and Sprague, 2003).  
Finally, the Drosophila STRIPAK complex has been proposed to be the phosphatase 
complex that antagonizes Hippo signalling. The Hippo pathway consists of a kinase cascade 
and controls tissue size during development by limiting cell proliferation and promoting 
apoptosis (Ribeiro et al., 2010). 
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Figure 1.13 Functions of the STRIPAK complex 
Schematic illustrating functions of the STRIPAK complex in different species. Based on 
these observations, three functional themes have been derived. These include control of cell 
polarity, establishment of cell-cell contact and regulation of cell proliferation. 
 
 
1.7 The GCKIII family of kinases 
The GCKIII group of serine/threonine kinases are a subfamily of the GCK (germinal centre 
kinase) family of kinases which in turn comprise one of the two subfamilies of mammalian 
Ste20 kinases (Ling et al., 2008). The Ste20 kinases in yeast are MAP4Ks (mitogen 
activated kinase kinase kinase kinases) in the mating pathway.  The other Ste20 kinase 
subfamily is the PAK (p21 activated kinase) subfamily. While GCKs and PAKs share 
homology and are grouped in the same family, they are structurally distinct. For example, 
the kinase domain in PAKs is at the C-terminus while in GCKs it is at the N-terminus. 
Furthermore, GCKs do not possess a CRIB (Cdc42/Rac interactive binding) domain and do 
not interact directly with Rho GTPases. 
The GCKIII subfamily comprises the three family members STK24 (also termed MST3), 
STK25 (also termed SOK1/YSK1) and MST4. Regulation of kinase activity can occur by 
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autophosphorylation and proteolytic cleavage. For example, autophosphorylation on Thr 178 
is essential for STK24 activity and its mutation abolishes kinase activity (Lu et al., 2006). A 
crystal structure for MST4 with an ATP-mimetic inhibitor suggests dimerisation is involved 
during autophosphorylation (Record et al., 2010). Caspase-induced cleavage of STK24 
during apoptosis increases kinase activity and causes its translocation to the nucleus. By 
contrast, MST4 is not recognised by caspases (Huang et al., 2002).  
Overexpressed STK24 has been shown to be able to activate ERK which mediates cell 
proliferation and growth (Zhou et al., 2000), but does not activate JNK (c-Jun N-terminal 
kinase) or p38 MAPK (Schinkmann and Blenis, 1997). JNK, p38 MAPK and ERK are 
different families of MAPKs (Yang et al., 2013). STK24 can also phosphorylate and activate 
NDR (nuclear Dbf2-related) kinase which is involved in the control of cell cycle progression 
and morphology (Stegert et al., 2005). Overexpression of STK25 does not lead to the 
activation of the JNK, ERK or p38 MAPK pathways (Osada et al., 1997). On the other hand, 
MST4 has been shown to activate the ERK pathway and can induce cell growth and 
transformation (Lin et al., 2001). This is supported by another study showing that the 
interaction of CCM3 with MST4 mediates ERK signalling (Ma et al., 2007). In addition, MST4 
plays a role in prostate cancer progression and has been shown to promote the proliferation 
of prostate cancer cell lines in vitro and in vivo (Sung et al., 2003). 
In addition to controlling growth and proliferation by mediating MAPK signalling, the GCKIII 
kinases have been implicated in the control of apoptosis. Activation of STK24 is correlated 
with an induction of apoptosis. Ectopic expression of full length or caspase-cleaved STK24 
leads to DNA fragmentation (Huang et al., 2002) and contributes to hypoxia-induced 
apoptosis (Wu et al., 2011). Similarly, STK25 has been linked with causing apoptosis (Costa 
et al., 2012; Nogueira et al., 2008; Zhang et al., 2012). Both pro-apoptotic and anti-apoptotic 
functions have been ascribed to MST4. The interaction between CCM3 and MST4 is 
implicated in protecting cells from oxidative stress by preventing cell death (Fidalgo et al., 
2012). Conversely, a second study suggests a pro-apoptotic function for MST4 (Dan et al., 
2002). 
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The GCKIII kinases are also mediators of cell migration. In general, GCKIII kinase activity 
negatively regulates migration. Downregulation of STK24 increases the migration of MCF7 
breast cancer cells and is associated with a decrease in tyrosine phosphorylation of the focal 
adhesion protein, paxillin (Lu et al., 2006). Similarly, depletion of STK25 in MCF7 cells 
enhances their migration and is associated with FAK (focal adhesion kinase) 
phosphorylation (Chen and Cho, 2011). The orientation of the Golgi is important for cell 
migration (Mellor, 2004). It is also proposed that STK25 can regulate cell motility by 
phosphorylating 14-3-3ζ and so affecting Golgi organisation (discussed in section 1.6.2) 
(Preisinger et al., 2004). MST4 is targeted to the Golgi apparatus and so could mediate cell 
migration by modulating Golgi function too (Preisinger et al., 2004). The same study 
reported that wild type MST4 impaired the invasion of HEK293T (human embryonic kidney 
293 T-antigen) cells into collagen I.  
In summary, the GCKIII kinases have roles in regulating cell proliferation, growth and 
apoptosis, and are regulators of cell migration. 
Table 1.2 Summary of GCKIII kinase functions 
GCKIII kinase Functions 
STK24 Activates ERK, induction of apoptosis, 
impairs cell migration 
STK25 Induction of apoptosis, impairs cell 
migration 
MST4 Activates ERK, has pro- and anti- apoptotic 
functions, impairs cell invasion 
 
1.8 Cerebral Cavernous Malformations (CCM) 
Cerebral cavernous malformations are a class of vascular malformations in the central 
nervous system (CNS) (reviewed in (Cavalcanti et al., 2012; Faurobert and Albiges-Rizo, 
2010). CCMs have an incidence of 0.4% - 0.5% in the general population and are 
responsible for 5% - 15% of all vascular malformations in the CNS. CCM3, one component 
of the STRIPAK complex, is implicated in this disease and perturbs endothelial physiology. 
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This provided the rationale to investigate FAM40 function in endothelial cells. Hence, it is 
important to understand the aetiology and characteristics of CCM in order to put FAM40 
function in perspective. This section provides an overview of CCM stressing links with 
vascular permeability and angiogenesis.  
CCMs are ‘slow-flow’ lesions in the CNS and patients present with densely packed vascular 
sinusoids surrounded by a collagen matrix. CCM clusters consist of capillary channels that 
are grossly dilated and lined by a single layer of endothelium. In addition, there is a 
breakdown of the blood brain barrier, and CCMs lack intact tight junctions (Cavalcanti et al., 
2012). Symptoms associated with CCM include haemorrhage, seizures and neurological 
deficits. Three genes have been linked with this disease termed CCM1, CCM2 and CCM3. 
CCM can occur both sporadically (~80% of cases) or be inherited in a familial context (~20% 
of cases). The pattern of inheritance in CCM is autosomal dominant, and it is estimated that 
about 80% of all CCM patients with a genetic form of CCM harbour a mutation in CCM1, 
CCM2 or CCM3. These mutations result in a loss of function of the mutated allele (Riant et 
al., 2010). 
All three CCM genes affect vasculogenesis and endothelial development. For example, mice 
that completely lack CCM2 activity have severely impaired vascular development leading to 
embryonic death. However, CCM2+/- mice survive into adulthood (Whitehead et al., 2009). 
CCM usually manifests in adulthood and so it is possible that the functioning of an existing 
vascular network is affected, in addition to defects in endothelial development (Leblanc et 
al., 2009). In support of this role for the CCM genes, endothelial cells from CCMs express 
higher levels of VEGF, display neo-angiogenesis and increased proliferation (Leblanc et al., 
2009). VEGF increases paracellular permeability and so could contribute to CCM 
pathogenesis. These features imply that endothelial cells in CCMs have broken free of 
control mechanisms that maintain quiescence. Taken together, CCM can be regarded as a 
disease of vascular development and endothelial quiescence. 
CCM1, CCM2 and CCM3 proteins interact physically. CCM1 and CCM3 can both bind to 
CCM2 but not with each other (Faurobert and Albiges-Rizo, 2010). CCM1 is a Rap1 effector 
and activation of Rap1 causes association of CCM1 with cell-cell junctions (Glading et al., 
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2007), and CCM1 localised at endothelial cell-cell junctions plays a role in mediating 
vascular permeability (Gingras et al., 2012). This study also suggests that the interaction of 
CCM2 with CCM1 is important for CCM2 localisation to junctions. Depletion of CCM1 by 
RNAi in cultured endothelial cells leads to an increase in RhoA activity, p-MLC levels and 
number of stress fibres and is associated with increased permeability (Stockton et al., 2010). 
Hence, CCM1 serves to keep RhoA activity in check and prevents an increase in endothelial 
permeability. CCM2 knockdown induces a similar phenotype, placing both genes upstream 
of the RhoA/ROCK axis.  Furthermore, the two proteins have to interact to carry out these 
functions and disruption of this interaction abrogates their capacity to maintain junction 
integrity (Stockton et al., 2010). Like CCM1 and CCM2, CCM3 has been shown to be 
important for maintaining junction integrity by preventing stress fibre induction and 
associated contractility  (Zheng et al., 2010).  
In addition, CCM2 co-immunoprecipitates with Rac1 (Whitehead et al., 2009) and so could 
facilitate Rac1-mediated stabilisation of cell-cell junctions (Beckers et al., 2010). Depletion of 
CCM2 also leads to a decrease in levels of activated Cdc42, which along with its effects on 
the actin cytoskeleton is thought to impair lumen formation during vascular development 
(Whitehead et al., 2009). Another key molecule in CCM1/CCM2 signalling is HEG1 (heart of 
glass 1) which is an endothelial-specific transmembrane receptor. Loss of HEG1 function too 
leads to impairment in lumen formation and disruption of endothelial junctions. HEG1 binds 
to CCM1 and this interaction has been suggested to be important for CCM1 localisation to 
junctions, and so facilitates CCM1 function in conserving junction integrity (Gingras et al., 
2012). It has been shown that HEG1 couples to CCM2 via CCM1 at endothelial junctions 
(Kleaveland et al., 2009). CCM2L (CCM2 like), a CCM2 paralog has been recently identified 
as a novel component of the HEG1-CCM pathway that competes for HEG1 with CCM2 
(Rosen et al., 2013; Zheng et al., 2012). 
CCM3 differs from the other CCM proteins in that it appears to signal by distinct 
mechanisms. The GCKIII kinases interact with CCM3 (Ceccarelli et al., 2011), and this 
interaction is central for CCM3 signalling with GCKIII kinases being downstream effectors of 
CCM3 function (Zheng et al., 2010). Wild type CCM3 can bind STK24, STK25 and MST4 
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while mutant CCM3 protein (with a mutation linked to CCM) fails to do so. Expression of 
mutated CCM3 in zebrafish results in vascular development defects and proves that CCM3 
is functionally coupled to the GCKIII kinases. Loss of STK25 and CCM3 function leads to 
vascular development defects in zebrafish and confers a barrier defect in cultured 
endothelial cells. The study goes on to demonstrate that STK24 and STK25 act downstream 
of CCM3 to downregulate RhoA activity, preventing loss of barrier function. However, it is 
not clear if CCM3 signals via RhoA as a second study failed to detect increased RhoA 
activity upon CCM3 depletion by RNAi (Chan et al., 2011). This view of an independent 
CCM3 function is supported by the fact that vascular anomalies observed upon CCM3 
knockdown in zebrafish are distinct from those following either CCM1 or CCM2 knockdown 
(Yoruk et al., 2012). CCM3 could also contribute to CCM through its role in regulating Golgi 
positioning and organisation via the GCKIII kinases (discussed in section 1.6.2). This 
function could have implications for junction formation. Furthermore, CCM3 is the only CCM 
protein that is a member of the STRIPAK complex which again suggests an independent 
role for it in CCM. 
 
 
Figure 1.14 A model for CCM gene function 
CCM1/CCM2 and CCM3 may signal by independent pathways which converge in yielding a 
common pathology. It is proposed that CCM1/CCM2 signal via RhoA while CCM3 signals 
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1.9 Aims 
The aim of this project is to investigate the functions and regulation of the human FAM40 
proteins.  
• The first aim is to carry out a biochemical characterisation of human FAM40A and 
FAM40B. This includes the identification of interacting partners and protein 
modifications such as phosphorylation. 
• Previous work in our laboratory utilised an RNAi screening approach in PC3 
prostate cancer cells to identify the FAM40 proteins as novel regulators of cell 
morphology and migration. The second aim is to functionally characterise the 
FAM40 proteins in PC3 cells by investigating their effects on cell morphology, 
migration and adhesion. 
• The FAM40 proteins are members of the STRIPAK complex which also contains 
CCM3. This led to the hypothesis that the FAM40 proteins are important for 
endothelial cell physiology. The third aim is to investigate their effects on F-actin 
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2 Materials and Methods 
2.1 Materials 
Chemicals for solutions were purchased from Sigma-Aldrich unless otherwise stated.  
2.1.1 Reagents and kits 
Accutase Millipore 
ATP Calbiochem 
[γ-32 P]-ATP (# BLU002A500UC) Perkin-Elmer 
Cell permeable C3 transferase  tebu-bio 
Cell Tracker TM Green, CMFDA Invitrogen 
Cell Tracker TM Orange, CMRA Invitrogen 
Complete, mini EDTA-free protease inhibitor cocktail Roche Applied Science 
Colloidal Coomassie Brilliant Blue-G Sigma-Aldrich 
Coverslips (13 mm) VWR 
Cell dissociation solution Sigma-Aldrich 
Spectra/Por dialysis tubing 
(MW cut-off 12,000 – 14,000) 
Spectrum Laboratories 
Dulbecco’s modified eagle medium (DMEM) 
(+ 4500 mg/L glucose, + L-Glutamine, + 25 mM HEPES, 
+ 110 mg/L sodium pyruvate) 
Gibco 
Dulbeccos’s modified eagle medium (DMEM) : F12  
(1:1 mix, + L-Glutamine + 15 mM HEPES) 
Lonza 
6X DNA loading dye Fermentas 
DNA-free kit Ambion 
Dried, skimmed milk Marvel 
EBM-2 bullet kits Lonza 
ECL reagent GE Healthcare 
0.4 cm Electroporation cuvettes Bio-Rad 
Foetal calf serum Invitrogen 
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Fibronectin Calbiochem 
FITC-dextran (molecular weight 42,000) Sigma-Aldrich 
Fluorescent mounting media  DAKO 
Gateway® LR Clonase TM II Enzyme mix Invitrogen 
Glutathione sepharose beads GE Healthcare 
Immobilon-P PVDF membrane Millipore 
Immobilon-FL PVDF membrane Millipore 
Isopropyl-β-D-thiogalactopyranoside Sigma-Aldrich 
1 kb DNA ladder Invitrogen 
jetPRIME® transfection kit Polyplus transfection 
Lipofectamine TM Invitrogen 
Lysozyme Sigma-Aldrich 
BD Matrigel TM basement membrane matrix BD Biosciences 
Mouse Anti-HA agarose beads Sigma-Aldrich 
Mouse IgG agarose Sigma-Aldrich 
Recombinant MST4 enzyme (GST tagged) Invitrogen 
Nu PAGE® 4-12 % Bis-Tris Gel Invitrogen 
Oligofectamine TM Invitrogen 
Oligonucleotide primers Eurogentec 
Opti-MEM + GlutaMax TM Gibco 
ORISTM assay stoppers Platypus technologies 
EndoFree Maxiprep kit Qiagen 
QIAprep Miniprep kit Qiagen 
Phosphate buffered saline (PBS)  
(-) CaCl2 / MgCl2 or (+) CaCl2 / MgCl2 
Gibco 
Phosphatase inhibitor cocktail (Set 2 and Set 4) Calbiochem 
Penicillin / Streptomycin Gibco 
Precision Master Mix Primer Design 
Precision PlusProtein TM standards Bio-Rad 
ProQ ® Diamond Phospho-protein blot stain kit Invitrogen 
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Rabbit Anti-myc agarose beads Sigma-Aldrich 
Rabbit IgG agarose Sigma-Aldrich 
RNeasy Mini kit Qiagen 
Roswell Park Memorial Institute (RPMI) 1640 media 
(+ L-Glutamine, + 25 mM HEPES) 
Gibco 
Streptavidin agarose Pierce 
Sulfo-NHS-Biotin Pierce 
SulfoLink coupling resin Pierce 
SuperScript® VILO TM cDNA synthesis kit Invitrogen 
Tris(2-carboxyethyl) phosphine hydrochloride (TCEP) Sigma-Aldrich 
Thrombin Sigma-Aldrich 
Transwells (8 µm pore size) Greiner bio-one 
Transwell Permeable Supports, 0.4 µm pore size,  
12 mm 
Costar 
Trizol  Invitrogen 
Trypsin / EDTA 0.05% Gibco 
H-1152 Rho Kinase inhibitor Calbiochem 
Y-27632 Rho Kinase inhibitor Calbiochem 
X-ray film Fujifilm 
 
2.1.2 Buffers and solutions 
Table 2.1 Buffers and solutions 
Buffer Composition 
IP lysis buffer 20 mM Tris-HCl pH 8.0 
1% Triton X-100 
130 mM NaCl 
1 mM DTT 
10 mM NaF 
Complete mini EDTA-free protease inhibitor 
Phosphatase inhibitor cocktail 
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0.5% sodium deoxycholate 
0.1% SDS 
25 mM NaF 
Complete mini EDTA-free protease inhibitor 
Phosphatase inhibitor cocktail 
Rho lysis buffer 50 mM Tris-HCl pH 7.5 
1 mM EDTA 
500 mM NaCl 
10 mM MgCl2 
0.1 % SDS 
1 % Triton X-100 
10 % Glycerol 
0.5% sodium deoxycholate 
0.5% β-mercaptoethanol 
25 mM NaF 
1 mM sodium orthovanadate (Na3VO4) 
1 mM phenylmethyl sulfonyl fluoride (PMSF)  
Complete mini EDTA-free protease inhibitor 
Laemmli lysis buffer 80 mM Tris-HCl pH 7.5 
10% Glycerol 
2% SDS 
1 mM DTT 
10 mM NaF 
10 mM glycerol phosphate 
1 mM Na3VO4 
1 mM PMSF 
Complete mini EDTA-free protease inhibitor 
4X SDS sample buffer 4% SDS 
160 mM Tris-HCl pH 6.8 
20% Glycerol 
10 mM DTT 
0.006% Bromophenol blue 
NuPAGE® MES SDS running 
buffer 
50 mM MES 
50 mM Tris base 
0.1% SDS 
1 mM EDTA 
pH 7.3 
NuPAGE® MOPS SDS running 
buffer 
50 mM MOPS 
50 mM Tris base 
0.1% SDS 
1 mM EDTA 
pH 7.7 
Transfer buffer 25 mM Tris 
192 mM Glycine 
20% Methanol 
pH 8.3 
Tris-buffered saline with Tween 
(TBST) 
20 mM Tris-HCl pH 7.6 
140 mM NaCl 
0.1% Tween-20 
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Stripping buffer 70 mM Tris 
20 mM NaCl 
pH 2.3 
STE buffer 10 mM Tris-HCl pH 8.0 
150 mM NaCl 
1 mM EDTA 
Complete mini EDTA-free protease inhibitor 
50X TAE buffer 2 M Tris 
0.05 M EDTA pH 8.0 
57.1 ml/L glacial acetic acid 
TE buffer 10 mM Tris-HCL pH 8.0 
1 mM EDTA  
Electroporation buffer 120 mM KCl 
10 mM K2PO4/KHPO4 pH 7.6 
25 mM HEPES pH 7.6 
2 mM MgCl2 
0.5% Ficoll 400 
Kinase assay buffer 50 mM Tris-HCl pH 7.5 
10 mM MgCl2 
1 mM DTT 
High salt wash buffer 0.5 M NaCl 
10 mM Tris-HCl pH 7.5 
FACS buffer PBS (+) CaCl2 (+) MgCl2 
1% FCS 
Peptide affinity chromatography buffers 
Peptide coupling buffer 50 mM Tris 
5 mM EDTA pH 8.5 
Wash solution 1.0 M NaCl 
0.005% NaN3 
Binding buffer 25 mM Tris-HCl pH 7.2 
150 mM NaCl 
Elution buffer 0.2 M glycine-HCl pH 2.5 
Neutralisation buffer 1 M Tris-HCl pH 9.0 
ProQ staining solutions 
Fix solution 7% acetic acid 
10% methanol 
ProQ phosphoprotein blot stain ProQ reagent (Invitrogen) diluted 1/1000 in 
ProQ Diamond blot stain buffer (Invitrogen) 




2.1.3.1 Primary antibodies 
Table 2.2 Primary antibodies 
Antibody 
(clone) 




mouse WB 1/1000 BD Biosciences 
#610468 
Chapter 2                                                                                               Materials and Methods                                                                  
66 
   
β1-integrin 
(12G10) 
mouse IF 1/100 Abcam 
#ab30394 
Cdc42 rabbit WB 1/1000 Cell Signaling  
#2462 
FAM40A rabbit WB 1/1000 Generated by Genosphere 
Biotechnologies 
FAM40B rabbit WB 1/500 Generated by Genosphere 
Biotechnologies 
FAM40B rabbit WB 1/250 Sigma-Aldrich 
#HPA019657 
GAPDH mouse WB 1/5000 Millipore 
#MAB374 
GFP rabbit WB 1/500 Santa Cruz Biotechnology 
#sc-8334 








c-myc mouse IF 1/200 Santa Cruz Biotechnology 
#sc-40 
c-myc rabbit WB 1/500 Santa Cruz Biotechnology 
#sc-789 
MLC2 rabbit WB 1/500 Santa Cruz Biotechnology 
#sc-15370 








mouse WB 1/1000 Upstate 
#05-389 
RhoA mouse WB 1/500 Santa Cruz Biotechnology 
#sc-418 
α-tubulin mouse WB 1/1000 Sigma-Aldrich 
#T6199 
VE-cadherin mouse IF 1/100 BD Biosciences 
#555289 
Vinculin mouse IF 1/100 Sigma-Aldrich 
#V9131 
 
2.1.3.2 Secondary antibodies 
Table 2.3 Secondary antibodies 
Antigen Species Conjugate Dilution Supplier 
mouse IgG sheep HRP 1/5000 GE Healthcare 
#NA931V 
rabbit IgG donkey HRP 1/5000 GE Healthcare 
#NA934V 
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goat IgG rabbit HRP 1/5000 DAKO 
#P0449 





1/300 Molecular Probes 
#A11001 





1/300 Molecular Probes 
#A21235 





1/300 Molecular Probes 
#A11008 












1/500 Molecular Probes 
#A22283 
DAPI  DAPI 1/10000 Molecular Probes 
# D3571 
 
2.1.4 siRNA oligonucleotides 
Table 2.4 siRNA oligonucleotides 
siRNA Serial 
number 








D-021516-01 5’-GCAGCAAAUUUAUAGGUUA-3’ Dharmacon 
FAM40A #2 
(siGenome) 
D-021516-02 5’-GCAUGAAUGUUCUAAGACA-3’ Dharmacon 
FAM40A #3 
(siGenome) 
D-021516-03 5’-GCUGAUGACUCUCGAGAAG-3’ Dharmacon 
FAM40A #4 
(siGenome) 
D-021516-04 5’-UAGCGGACGUCUUGCCUGA-3’ Dharmacon 
FAM40A #5 
(siGenome) 
D-021516-17 5’-CAGCACAAGUACACGUCGA-3’ Dharmacon 
FAM40B #1 
(siGenome) 
D-025451-01 5’-GAAGGCAACUCCUCACUAA-3’ Dharmacon 
FAM40B #2 
(siGenome) 
D-025451-02 5’-UAAAGCAGCACAAGUAUAU-3’ Dharmacon 
FAM40B #3 
(siGenome) 
D-025451-03 5’-GGGCCAACAUUGAGGCUUU-3’ Dharmacon 
FAM40B #4 
(siGenome) 
D-025451-04 5’-UGCCGGAGCUUACUACUGA-3’ Dharmacon 
FAM40B #5 
(siGenome) 
D-025451-17 5’-UGACUGGGCUUACGGGAAU-3’ Dharmacon 
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CCM3 #1 
(siGenome) 
s22176 5’-GUGAUACUCUGAAAACGUAtt-3’ Ambion 
CCM3 #2 
(siGenome) 
s22177 5’-AGAAAAUCCAGGUCUCACAtt-3’ Ambion 
FAM40A pool #1 - individual oligos #1 - #4 
FAM40B pool #1 - individual oligos #1 - #4 
FAM40A pool #2 - individual ologos #1, #3, #4, #5 
FAM40B pool #2 - Individual oligos #1, #2, #3, #5 
 
2.1.5 Primers 
2.1.5.1 Q-PCR primers 
Table 2.5 Q-PCR primers 
Gene Sequence  
(5’ to 3’) 
Annealing 
temp. used  
Conc. in 
reaction 
FAM40A F: ACCTAGATGCCTTCAACGAG 
R: ATCACTTCATCCCGTTCCAG 











65⁰C 500 nM 
GAPDH F: GTGAAGGTCGGAGTCAACG 
R: TGAGGTCAATGAAGGGGTC 







60⁰C 50 nM 
 
2.1.5.2 Sequencing primers 
Table 2.6 Sequencing primers 
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Table 2.7 Vectors 
Vector Source 
pENTRY-FAM40A (with STOP) Dr. Stefan Wiemann 
pENTRY-FAM40B_long (with STOP) Dr. Stefan Wiemann 
pENTRY-STK24 (with STOP) Dr. Stefan Wiemann 
pENTRY-STK25 (with STOP) Dr. Stefan Wiemann 
pENTRY-MST4 (with STOP) Dr. Stefan Wiemann 
pENTRY-CCM3 (with STOP) Dr. Stefan Wiemann 
pDEST-HA (N-terminal tag) Dr. Matthias Krause 
pDEST-myc (N-terminal tag) Dr. Matthias Krause 
pHA-Ubiquitin Dr. Matthias Krause 
pEGFP-E-cadherin Dr. Maddy Parsons 
pHA-TrkA Dr. Uwe Drescher 
pHA-14-3-3 Dr. Philippe Riou 
 
2.1.7 Software 
Table 2.8 Software 
Software Supplier 
Illustrator CS4 Adobe 
Metamorph Molecular Devices 
ImageJ National Institutes of Health 
LSM + ZEN Zeiss 
Cell Profiler Broad Institute 
 
2.2 Methods: molecular biology 
2.2.1 Transformation of competent Escherichia coli (E. coli) 
100 ng of plasmid DNA or 5 µl of Gateway LR reactions (section 2.2.4) were added to 100 µl 
of competent DH5α cells (Invitrogen) and the mixture placed on ice for 30 min. The 
suspension was heat-pulsed at 42⁰C for 45 sec and then placed on ice for 5 min. After 
addition of 500 µl of antibiotic free LB (Luria broth), the cells were allowed to grow at 37⁰C 
for 1 h. 100 µl of transformed plasmid DNA suspensions and the entire amount of Gateway 
LR reaction suspensions were plated onto LB agar plates containing the appropriate 
antibiotic for selection (100 µg/ml ampicillin). 
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2.2.2 Purification of plasmid DNA from bacteria 
QIAprep Miniprep kits were used for small scale production of plasmid DNA (used for DNA 
sequencing (see 2.2.6) and restriction digestion (section 2.2.4)). Steps were carried out at 
room temperature unless otherwise stated. 5 ml of LB containing antibiotic for selection was 
inoculated with a single colony from an LB agar plate and incubated overnight at 37⁰C. 
Cells from 1.5 ml of this starter culture were pelleted by centrifugation at 17,000 g for 1 min 
and resuspended in 250 μl of Buffer A (50 mM glucose, 25 mM Tris-HCl, pH 8.0, 10 mM 
EDTA, 10 μg/ml RNase A). After complete resuspension, 250 μl lysis buffer (200 mM NaOH, 
1% SDS) was added and the suspension mixed gently. After 5 min of incubation with lysis 
buffer, 350 μl neutralisation buffer (3 M KAc, 2 M acetic acid) was added and the suspension 
mixed thoroughly. Cell debris and proteins were pelleted by centrifugation at 17,000 g for 10 
min. The supernatant was added to QIAprep spin columns and centrifuged at 17,000 g for 1 
min. Bound DNA was washed with 750 μl wash buffer (750 mM NaCl, 50 mM MOPS, pH 
7.0, 15% isopropanol (v/v)) and the DNA eluted with 50 μl water by centrifugation of the 
column for 1 min at 17,000 g. 
Qiagen EndoFree Maxiprep kits were used for larger scale purification of plasmid DNA. A 5 
ml starter culture was used to inoculate 200 ml of LB containing antibiotic for selection. After 
overnight incubation at 37⁰C, bacterial cells were pelleted at 4,000 rpm in a Sorvall RC5C 
centrifuge (Rotor SLA-1500) for 15 min. The bacterial pellet was resuspended, lysed and 
neutralised as described in the miniprep protocol except that 10 ml volumes of buffers were 
used in each step. To clarify the lysed cell suspension, the lysate was applied to filter-
syringes provided in the kit, left for 10 min and pressed through the filter into 50 ml tubes. 
1.5 ml of endotoxin removal buffer was added and the supernatant incubated on ice for 30 
min, following which it was applied to columns pre-equilibrated with the equilibration buffer 
(250 mM NaCl, 50 mM MOPS, pH 7.0, 15% isopropanol (v/v),15% Triton X-100). After 
washing twice with wash buffer (1 M NaCl, 50 mM MOPS, pH 7.0, 15% isopropanol (v/v)) 
and DNA elution (elution buffer: 1.25 M NaCl, 50 mM Tris-HCl, pH 8.5, 15% isopropanol), 
the DNA was precipitated by adding 0.7 volumes of isopropanol (v/v). DNA was pelleted by 
centrifugation at 2,700 g for 60 min at 4⁰C. The pellets were washed with 5 ml 70% ethanol 
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and air dried. Pellets were resuspended in 200-500 µl of ddH2O and the DNA concentration 
determined. 
2.2.3 Determining of DNA concentration 
DNA concentration was determined spectrophotometrically at 260 nm, using a Nano-Drop 
system (ND-1000, www.nanodrop.com) to determine optical density. The DNA concentration 
was determined using the following formula: concentration of DNA= OD260 x 50 μg/ml. 
2.2.4 Gateway cloning 
The Gateway cloning system from Invitrogen utilises the site-specific recombination 







The Gateway cloning system was used to generate expression vectors of FAM40A, 
FAM40B, STK24, STK25 and CCM3 tagged with either HA or myc at the N-terminus. The 
cDNA of these genes present in an entry clone were made to recombine in a LR reaction 
with a destination vector containing the required tag (pDEST-HA or pDEST-myc) (see Table 
2.7). Gateway LR reactions were set up at room temperature as follows: 
Component 
Entry clone (150 ng) 
Volume 
1-7 µl 
Destination vector (150 ng/µl) 1 µl 
TE buffer, pH 8.0 to 8 µl 
 
Figure 2.1 Schematic of the Gateway cloning system 
The DNA of interest is flanked by specific recombination sequences which allow it to be shuttled 
across various vector systems in the presence of appropriate recombination enzymes. The toxic 
gene ccdB is used as a negative selection marker. 
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The LR clonase II enzyme (provided in the Gateway® LR Clonase TM II Enzyme mix kit) was 
thawed on ice for 2 min, vortexed briefly and 2 µl of the enzyme was added to the reaction 
prepared. The reaction mix was mixed by vortexing gently and incubated at 25⁰C for 1 h. 1 
µl of Proteinase K solution (provided in the kit) was added to the reaction mix. Incubation at 
37⁰C for 10 min was done to terminate the reaction. The Gateway cloning technique was 
used to generate the plasmids pHA-FAM40A, pHA-FAM40B, pmyc-FAM40A, pmyc-
FAM40B, pmyc-STK24, pmyc-STK25, pmyc-MST4 and pmyc-CCM3.  
The generated expression clones were verified by checking for insert release after digestion 
with the restriction enzyme BsrGI (New England Biolabs (NEB)) which cuts within the attB 
sequence. Restriction enzyme reactions were setup using 15 µl miniprep DNA, 2 µl NEB 
Buffer 2, 2µl BsrGI enzyme and 1 µl H2O. Restriction reactions were incubated at 37⁰C for 1 
h and subsequently resolved on a 1% agarose gel. 
2.2.5 Agarose gel electrophoresis 
A 1% (w/v) agarose gel was made by mixing an appropriate volume of agarose with 1X TAE 
buffer. The mixture was heated until the agarose was completely dissolved. After the mixture 
had cooled down, it was supplemented with 0.5 µg/ml ethidium bromide and poured into a 
gel chamber with a well comb and left to solidify. DNA samples (along with a molecular 
weight marker) with 1X DNA loading dye were loaded and electrophoresis was performed at 
10-15 V/cm2 until the samples were resolved. DNA bands were visualised using a UV 
transilluminator. 
2.2.6 Sequencing 
100 ng of plasmid DNA (in ddH2O) and appropriate sequencing primers (see Table 2.6) at a 
concentration of 2 pmol/μl in a volume of 15 µl were sent to MWG (www.eurofinsdna.com) 
for DNA sequencing. 
2.2.7 Quantitative PCR 
2.2.7.1 Extraction of total RNA and DNase treatment 
Quantitative PCR was used to determine the knockdown of gene expression by siRNA. Total 
RNA was extracted 72 h after siRNA transfection using either the RNeasy mini kit (Qiagen) 
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according to the manufacturer’s instructions or with Trizol. For extraction using Trizol, cells 
were harvested using trypsin and pelleted by centrifugation in a microfuge tube. 1 ml of 
Trizol was added to the pellet and incubated for 5 min at room temperature. 200 µl of 
chloroform was added and the tubes shaken vigorously for 15 sec and left at room 
temperature for 3 min. Samples were then centrifuged at 17,000 g for 15 min at 4⁰C and the 
upper phase transferred to a fresh tube. 250 µl of isopropanol was added to precipitate the 
RNA. After 10 min incubation on ice the samples were centrifuged at 17,000 g for 15 min. 
RNA pellets were washed twice with 75% ethanol following which they were air dried and 
resuspended in RNase-free water. Samples were incubated at 55⁰C for 10 minutes to 
facilitate solubilisation of RNA. The RNA samples (extracted using Trizol or the RNAeasy 
mini kit) were then eliminated of genomic DNA using DNase treatment (DNA free kit, 
Ambion). The purified RNA was incubated with 1X DNase buffer and 1 µl DNase enzyme for 
30 min at 37⁰C. The enzyme was inactivated by adding 5 μl of DNase inactivation beads 
followed by incubation at 37°C for 2 min. After centrifugation (10,000 g for 1 min) the 
supernatant was transferred to a fresh tube and stored at -80°C. 
2.2.7.2 cDNA synthesis 
The concentration of purified RNA was determined spectrophotometrically at 260 nm, using 
a Nano-Drop system (ND-1000, www.nanodrop.com) to determine optical density. The RNA 
concentration was determined using the following formula: concentration of RNA= OD260 x 
40 μg/ml. The OD260/OD280 ratio was used as a measure of RNA purity. The SuperScript® 
VILO TM cDNA synthesis kit (Invitrogen) was used to synthesise cDNA using the purified 
RNA as a template. Reactions were set up on ice as follows: 
Component 
5X VILO TM Reaction mix 
Volume 
4 µl 
10X Superscript® Enzyme mix 2 µl 
RNA (1 µg) x µl 
DEPC-treated water to 20µl 
 
Chapter 2                                                                                               Materials and Methods                                                                  
74 
   
The reaction mix was incubated at 25⁰C for 10 min and then at 42⁰C for 60 min. Reactions 
were terminated by incubation at 85⁰C for 5 min. The cDNA was stored at -20⁰C until further 
use. 
2.2.7.3 Q-PCR using SYBR green 
The synthesised cDNA was used in Q-PCR reactions to quantitatively determine levels of 
expression of the gene of interest using SYBR green detection chemistry (mastermix from 
Primer Design). SYBR green is a fluorescent dye which binds double stranded DNA. Its 
fluorescent signal is proportional to the amount of double stranded DNA and hence can be 
used as a measure of DNA quantity. Real-time monitoring of the signal enables the 
determination of PCR reaction kinetics which is used to quantify the initial amount of 
template present in the reaction. Reactions set up for each condition (in quadruplicate) 
included 3 µl of cDNA (diluted 1/65 with RT-PCR grade water (Ambion)), 3 µl primer mix 
(forward and reverse primers at concentrations specified in Table 2.5) and 6 µl Q-PCR 
mastermix. GAPDH was used as a reference gene in each reaction. The amplification cycle 
used was an initial 10 min denaturation at 90⁰C, 40 cycles of denaturation (10 sec at 95⁰C) 
and annealing/extension (30 s, refer to Table 2.5 for temperatures used for specific primer 
pairs). One cycle of 95°C for 15 sec, 60°C for 20 sec and 95°C for 15 sec was used to 
generate the melting curve. 
Data was acquired using either an ABI Prism 7000 system (Applied Biosystems) or the 
MX3005p system (Agilent technologies) and analysed with ABI7000 SDS analysis software 
or with MxPro QPCR software respectively. Cycle to threshold (CT) values were determined 
for each condition (with GAPDH and gene of interest primers). The CT value is defined as 
the PCR cycle number at which the fluorescence signal crosses a certain preset threshold 
level in the logarithmic amplification phase of the PCR reaction. The CT value is inversely 
proportional to the initial amount of template in the reaction. The efficiency of each primer 
pair was initially assessed by amplification of serial dilutions of cDNA template. To calculate 
the efficiency, 10-fold dilutions of the cDNA template were made and CT values for each 
sample determined. A graph was plotted of the determined CT values against the dilution 
factor (logarithmic scale: -1, -2, -3 etc.). The slope of the graph was determined and 
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efficiency of the primer pair was calculated as (10^(-1/slope) – 1) * 100). PCR efficiencies of 
between 90% and 110% were considered acceptable (apparent efficiencies of above 100% 
are an artefact of the manner in which efficiencies are calculated). A melting curve analysis 
was included to verify the specificity of amplification.  
Cycle to threshold values (CT) were normalised to GAPDH levels and % mRNA expression 
normalised to control siRNA calculated as (100 / (2 ^ (CT shift))).  
CT shift = CT siRNA knockdown sample – CT siRNA control sample 
[CT siRNA knockdown sample = CT gene of interest primer – CT GAPDH primer, CT siRNA 
control sample = CT gene of interest primer – CT GAPDH primer] 
2.3 Methods: cell biology 
2.3.1 Cell culture 
2.3.1.1 Growing and passaging of cells 
PC3 cells were grown in Roswell Park Memorial Institute 1640 medium (RPMI), COS7 cells 
in Dulbeccco’s modified Eagle’s medium (DMEM) and CHO cells (Flp-In TM CHO, Invitrogen 
provided by Dr. Andrew Beavil) in DMEM:F12 (1:1 mix) medium. Media were supplemented 
with 10% foetal calf serum (FCS), penicillin (100 IU/ml) and streptomycin (100 µg/ml). Cells 
were maintained in an incubator at 37⁰C and 5% CO2. When the cells reached 80% 
confluency, they were passaged using trypsin-EDTA. The media was removed and the cells 
washed once with 1 ml PBS. The PBS was aspirated and 1 ml of trypsin-EDTA per 75 cm2 
tissue culture flask at 37⁰C was added for 3 min or until cells detached. Trypsin-EDTA was 
inactivated by adding 9 ml of media. Cells were split at between 1:2 and 1:10 and the 
medium changed every 2-3 days. 
Pooled human umbilical vein endothelial cells (HUVECs) obtained from Lonza or PromoCell 
were cultured in EBM-2 medium containing the appropriate growth factors (EGM-2) and 
supplemented with 2% foetal bovine serum. Cell culture dishes were coated with 10 µg/ml 
fibronectin for 1 h at 37⁰C prior to cell seeding. Cells were passaged when they reached 
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confluency as described previously and split at between 1:3 and 1:4. Cell medium was 
changed every 2 days and HUVECs used until passage 4. 
2.3.1.2 Freezing and thawing of cells 
PC3, COS7 and CHO cells were harvested using trypsin and pelleted by centrifugation at 
200 g for 5 min. 2-3 x 10 ^ 6 cells were resuspended in 1 ml of freezing media (90% FCS, 
10% DMSO) and aliquoted into cryovials. Cryovials were frozen down at -80⁰C in a cryo 
freezing container overnight to allow gradual cooling. Cryovials were transferred to liquid 
nitrogen for long term storage. 
Cells were thawed by removing cryovials from liquid nitrogen and immersing in a 37⁰C 
waterbath to allow rapid thawing. Contents of each cryovial were transferred to a 75 cm2 
tissue culture flask and 10 ml media added. The medium was removed the next day and 
fresh medium added to the cells.  
2.3.2 siRNA transfection of cells 
PC3 cells were reverse transfected with siRNAs (small interfering RNAs) using 
Lipofectamine 2000. Lipofectamine 2000 and siRNA were diluted separately in Opti-MEM, 
incubated for 5 min at room temperature, mixed and incubated for a further 20 min at room 
temperature for lipid-siRNA complexes to form (details in Table 2.9). siRNA was used at a 
final concentration of 50 nM and lipid-siRNA complexes were allowed to form in tissue 
culture dishes. Cells for transfection were harvested in parallel, counted and seeded at an 
appropriate concentration onto the lipid-siRNA complexes in an appropriate volume of 
medium (details in Table 2.9). Complete growth media was used for the transfections. 24 h 
later the medium was changed and the cells used for downstream experiments. 
Table 2.9 Transfection conditions for PC3 cells 
Culture 
vessel 
siRNA (µl of 











per well  
(including 
complexes) 
96 well (tissue 
culture 
untreated) 
0.375 in 25 0.25 in 25 80,000 150 µl 
24 well 1.25 in 50 1 in 50 100,000 500 µl 
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6 well 5 in 250 5 in 250 500,000 2 ml 
10 cm dish 12 in 500 18 in 500 700,000 5 ml 
 
HUVECs were transfected using Oligofectamine in wells of a 6 well plate. 24 h before 
transfection, 10 ^ 5 cells were seeded per well. On the day of transfection, growth medium in 
each well was replaced with 800 µl of Opti-MEM. Individual siRNAs (20 µM stock) were 
diluted in Opti-MEM (2.5 µl in 185 µl per condition, 2.5 µl + 2.5 µl in 185 µl for double 
transfections) so as to reach a concentration of 50 nM in the final transfection mix. 
Oligofectamine was diluted in Opti-MEM (4 µl in 15 µl) and the two prepared solutions were 
incubated at room temperature for 5 min. The two solutions were then mixed and lipid-siRNA 
complexes allowed to form for 20 min at room temperature. This mixture was then added 
drop-wise to cells in one well (in 800 µl of medium). After 5-6 h, 500 µl of EGM-2 medium 
containing 12% FCS was added to each well (final FCS concentration of 4%). The following 
day, medium was changed to EGM-2 containing 2% FCS and the cells used for downstream 
experiments. Mock transfections in all experiments were performed by replacing siRNA with 
growth media in the transfection mixes. 
2.3.3 DNA transfection of cells 
DNA transfection of PC3 cells was done using the jetPRIME® transfection kit (Polyplus 
transfection) according to the manufacturer’s instructions. 30,000 cells were seeded onto 
Matrigel-coated glass coverslips (100 µg/ml at 37⁰C for 1 h) or uncoated glass coverslips the 
day before transfection. The transfection mix was prepared by adding 0.5 µg of plasmid DNA 
to 50 µl of jetPRIME® buffer. After vortexing for 10 sec, 1 µl of jetPRIME® transfection 
reagent was added to the mix. After vortexing further for 10 sec, the mix was incubated at 
room temperature for 10 min and added to cells on each coverslip in 0.5 ml of medium. After 
24 h cells were fixed in 4% PFA at room temperature for 20 min and used for 
immunofluorescence (section 2.3.13). 
DNA/siRNA double transfection of COS7 cells was done using the jetPRIME® transfection 
kit. 100,000 cells were seeded in each well of a 6 well plate the day before transfection. 
Cells were transfected with 50 nM of FAM40A or FAM40B targeting siRNA. The transfection 
mix was prepared by adding 5 µl of siRNA (20 µM stock) to 200 µl of jetPRIME® buffer. After 
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mixing gently, 4 µl of jetPRIME® transfection reagent was added to the mix. After vortexing 
for 10 sec, the mix was incubated at room temperature for 10 min and added to cells in each 
well in 2 ml of medium. After 24 h, cells were transfected with pHA-FAM40A or pHA-
FAM40B plasmid DNA. The transfection mix was prepared by adding 500 ng of plasmid 
DNA to 200 µl of jetPRIME® buffer. After vortexing for 10 sec, 1 µl of jetPRIME® 
transfection reagent was added to the mix. After vortexing further for 10 sec, the mix was 
incubated at room temperature for 10 min and added to cells in each well in 2 ml of medium. 
Medium was changed after 24 h and after a further 24 h cells were used to make lysates for 
anti-HA immunoblotting. 
HUVECs were transfected with plasmid DNA using Amaxa nucleofection. HUVECs were 
trypsinised and washed once with PBS (+ Ca/Mg) and resuspended in HUVEC 
electroporation buffer (Amaxa) (10 ^ 6 cells in 100 µl of buffer per condition). 3 µg of plasmid 
DNA was mixed with the cell suspension and transferred to an electroporation cuvette. 
Nucleofection was carried out with an Amaxa Nucleofector TM (Amaxa, Cologne, Germany) 
using program A-34 according to the manufacturer’s instructions. After nucleofection, cells 
from each sample were transferred to two fibronectin-coated glass coverslips (for confluent 
monolayers) or four coverslips (for sub-confluent monolayers). In siRNA/DNA co-transfection 
experiments, 500,000 siRNA-transfected cells were used in each nucleofection and the 
entire sample transferred to a single coverslip. Cells on coverslips were fixed in 4% PFA at 
room temperature for 20 min and used for immunofluorescence staining. 
2.3.4 Electroporation of COS7 cells 
COS7 cells grown in 175 cm2 flasks were split at a ratio of 1:2 the day before transfection. 
The cells were detached using trypsin and washed once with electroporation buffer (120 mM 
KCl, 10 mM K2PO4/KHPO4 pH 7.6, 25 mM HEPES pH 7.6, 2 mM MgCl2, 0.5% Ficoll 400). 
Cells from one 175 cm2 flask were used for 3 transfections. After the wash, cells for each 
transfection were resuspended with 250 µl of electroporation buffer and mixed with 3-5 µg of 
plasmid DNA in a 0.4 cm electroporation cuvette. Cells were left on ice for 10 min and 
electroporated using a Genepulser II system (Bio-Rad) at 250 V, 975 µF. After 
electroporation, cells were placed on ice for 5 min and then at room temperature for 5 min. 
Chapter 2                                                                                               Materials and Methods                                                                  
79 
   
Electroporated cells were transferred to 10 cm dishes with DMEM medium. Medium was 
changed after 24 h. Cells were used in downstream experiments 24 h or 48 h after 
transfection.  
2.3.5 Generation of stable CHO cell lines 
CHO cells stably expressing HA-FAM40A, HA-FAM40B or EGFP-E-cadherin were 
generated by transfection with pHA-FAM40B, pHA-FAM40B or pEGFP-E-cadherin 
respectively. These vectors contained a neomycin resistance gene and selection of stable 
cell clones was done by treatment with geneticin sulphate (G418). 
Cells were seeded in 6 well dishes the day before DNA transfection at a density of 2 x 10 ^ 5 
cells per well. Transfection was done using the jetPRIME® transfection kit (Polyplus 
transfection) according to the manufacturer’s instructions. The transfection mix was 
prepared by adding 2 µg of plasmid DNA to 200 µl of jetPRIME® buffer. After vortexing for 
10 sec, 4 µl of jetPRIME® transfection reagent was added to the mix. After vortexing further 
for 10 sec, the mix was incubated at room temperature for 10 min and added to cells in one 
well of a 6 well dish in 2 ml of medium. After 24 h, transfected CHO cells were harvested 
and cells from each well were diluted in 10 ml of medium. Cells from this diluted suspension 
were seeded sparsely onto individual 10 cm dishes (5 µl, 12 µl and 25 µl volumes) to 
facilitate picking of individual colonies at a later stage. After a further 24 h, fresh medium 
was added supplemented with 1 mg/ml G418. Selection with G418 was carried out for 2 
weeks with the medium being changed every 3 days. A dish of control CHO cells was 
included to ensure the efficacy of the antibiotic. At the end of the selection period, resistant 
cell colonies were picked using trypsin-soaked cloning discs, and validated for stable 
expression of protein using immunofluorescence (section 2.3.13) and western blotting 
(section 2.4.2). 
2.3.6 Treatment of cells with inhibitors 
HUVECs were treated with the ROCK inhibitors H-1152 and Y-27632 in EGM-2 medium. 
Inhibitors were prepared as stock solutions in sterile water. H-1152 was used at a 
concentration of 5 µM for 10 min and Y-27632 at 10 µM for 24 h. HUVECs were treated with 
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4 µg/ml C3 transferase in EGM-2 medium for 2 h. Treatment of HUVECs with thrombin was 
done for 10 min at a concentration of 1 U/ml. 
2.3.7 Migration assays 
2.3.7.1 Random migration assay 
PC3 cells were transfected with siRNAs targeting FAM40A and FAM40B. 24 h after 
transfection, cells were harvested and seeded onto wells of a 24 well plate. Tissue culture 
wells were coated with 100 µg/ml Matrigel for 1 h at 37⁰C before cell seeding. 15,000 cells 
were seeded per well and fresh medium was added which contained 1% FCS. Time-lapse 
movies were made over a period of 14 h using a Nikon TE2000-E microscope with a Plan 
Fluor 10X objective (Nikon) and a Hamamatsu Orca-ER digital camera. Image series were 
captured at 37°C and 5% CO2 at 10 frame/min using Metamorph software. Cells in movies 
were tracked using the manual tracker plugin in ImageJ (http://rsb.info.nih.gov/ij/) and the 
migration velocity calculated using the ibidi chemotaxis and migration plugin in ImageJ 
(www.ibidi.com). 
2.3.7.2 ORIS TM migration assay 
The ORISTM assay (Platypus technologies) (Figure 2.2) is a migration assay in which 
stoppers are introduced into a well of a 96-well plate preventing cells from seeding onto a 
central, annular ‘detection zone’. Stoppers are removed after cells have adhered following 
which migration is monitored. The extent of migration was quantified by the % area of the 
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For ORIS assays with PC3 cells, the cells were stained with Cell Tracker TM Green, CMFDA 
(Invitrogen). Cells were stained for 20 min at 37˚C (dilution of dye at 1/ 1,000 in PBS + 
Ca/Mg). Following this, cells were pelleted by centrifugation at 200 g for 5 min and incubated 
in growth media for a further 20 min. 80,000 stained PC3 cells per condition were 
transfected in 96-well plates with siRNA pools targeting FAM40A or FAM40B (as detailed in 
section 2.3.2). After 24 h, cells from each well of the 96-well plate were used to seed two 
wells of the ORIS plate (with seeding stoppers introduced). Cells were seeded onto Matrigel-
coated (100 µg/ml for 1 h at 37⁰C) plates in media containing 1% FCS. After a further 24 h, 
the stoppers were removed and images were acquired of the fluorescent cells at t=0h (point 
at which stoppers were removed) and t=24h. 
ORIS assays with HUVECs were carried out using cells transfected with siRNAs targeting 
FAM40A and FAM40B. 24 h after transfection, cells were stained with Cell Tracker TM 
Orange, CMRA (Invitrogen). Cells were stained for 40 min at 37˚ C (dilution of dye at 1/40 0 in 
growth media). Following this, cells were pelleted by centrifugation at 200 g for 5 min and 
incubated in growth media for a further 40 min. Stained cells were used to seed wells of the 
ORIS plate (with seeding stoppers introduced). 30,000 cells were used to seed each well. 
Cells were seeded onto fibronectin-coated (10 µg/ml for 1 h at 37⁰C) plates in growth media. 
Figure 2.2 Schematic of the ORIS TM assay (adapted from 
www.platypustech.com) 
In the ORIS assay, migration of cells is assessed by measuring their capacity to 
migrate into a central, annular migration zone that is created by the introduction of 
cell seeding stoppers. 
Chapter 2                                                                                               Materials and Methods                                                                  
82 
   
After a further 24 h, the stoppers were removed and images were acquired of the fluorescent 
cells at t=0h (point at which stoppers were removed) and t=24h. 
Conditions were seeded in triplicate and the mean calculated. Images were acquired using a 
Nikon TE2000-E microscope with a Plan Fluor 4X objective (Nikon) and a Hamamatsu Orca-
ER digital camera. 
2.3.8 Adhesion and spreading assays 
2.3.8.1 Adhesion assay 
For adhesion assays with PC3 cells, cells were transfected with siRNA pools targeting 
FAM40A and FAM40B. 48 h after transfection, cells were stained with Cell Tracker TM 
Green, CMFDA (Invitrogen). Cells were stained for 20 min at 37˚ C (dilution of dye at 1/1,000 
in PBS + Ca/Mg). Following this, cells were pelleted by centrifugation at 200 g for 5 min and 
incubated in growth media for a further 20 min. Cells were then detached non-enzymatically 
(Cell dissociation reagent, Sigma-Aldrich) and resuspended in media containing low serum 
(1% FCS). Adhesion assays were carried out on Matrigel-coated (100 µg/ml at 37⁰C for 1 h) 
plastic or on uncoated plastic. 25,000 cells were added to each well of a black 96 well plate 
with a clear bottom. After 15 min adhesion, cells were washed with one change of PBS and 
fluorescent readings taken as a measure of cell adhesion capacity (using a Perkin Elmer 
plate reader (PerkinElmer, Cambridge, UK) at 485 nm excitation and 523-535 nm emission). 
A control where cells were not washed was included to normalise for total cell number. Each 
condition was done in triplicate and the mean fluorescence calculated. 
Adhesion assays with HUVECs were done with cells transfected with siRNAs targeting 
FAM40A and FAM40B. 72 h after transfection, cells were stained with Cell Tracker TM 
Green, CMFDA (Invitrogen). Cells were stained for 40 min at 37˚C (dilution of dye at 1/400 in 
growth media). Following this, cells were pelleted by centrifugation at 200 g for 5 min and 
incubated in growth media for a further 40 min. HUVECs were detached by washing with 
PBS (-Ca/Mg), addition of 250 μl Accutase per well (of a 6 well dish) to just cover the cells, 
incubation for 3 min. 2 ml medium was added to each well and cells were pelleted by 
centrifugation at 200 g for 5 minutes. Adhesion assays were carried out on a 1:1 mix of 
Matrigel and PBS (+ Ca/Mg). 40 µl of this mix was added to each well of a black 96 well 
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plate with a clear bottom and allowed to polymerise at room temperature for 1.5 h. 25,000 
cells were added to each well of the plate and after 5 min adhesion, cells were washed with 
one change of PBS and fluorescent readings taken as a measure of cell adhesion capacity 
(using a Perkin Elmer plate reader (PerkinElmer, Cambridge, UK) at 485 nm excitation and 
523-535 nm emission). A control where cells were not washed was included to normalise for 
total cell number. Each condition was done in triplicate and the mean fluorescence 
calculated. 
2.3.8.2 Spreading assay 
For spreading assays, PC3 cells transfected with siRNA pools targeting FAM40A or 
FAM40B were harvested non-enzymatically 72 h after transfection into media containing 1% 
FCS. 20,000 cells were seeded onto each well of a Matrigel-coated (100 µg/ml at 37⁰C for 1 
h) 24 well plate. After 30 min incubation at 37˚C , cells were fixed in 4% PFA at room 
temperature for 20 min and stained with phalloidin-Alexa546 (1/500 in PBS) for 1 h at room 
temperature. Cells were washed 3 times with PBS and fluorescent images acquired using a 
Nikon TE2000-E microscope with a Plan Fluor 10X objective (Nikon) and a Hamamatsu 
Orca-ER digital camera. Cell spread area was determined using ImageJ software and the 
mean calculated for each condition in each experiment. 
2.3.9 Permeability assay with HUVECs 
HUVECs were transfected with siRNAs and after 48 h were harvested with trypsin and 
plated onto fibronectin-coated (10 µg/ml at 37⁰C for 1 h). Transwell TM filters (12 mm 
diameter, 0.4 μm pore size, Costar) to form confluent monolayers. 10 ^ 5 cells were plated 
onto each filter and were left to form junctions for 24 h. After 24 h, 1.5 ml of growth media 
was added to the lower chamber and 0.5 ml of growth media containing 0.1 mg/ml FITC 
dextran (molecular weight 42 kDa) was added to the apical chamber. A sample of medium 
(200 µl) was removed from the lower chamber to measure permeability after 80 min and 
added to wells in a black 96 well plate with a clear bottom. Fluorescence of the removed 
sample of medium was used as a measure of permeability. Fluorescence was measured 
using a microplate analyser (Fusion-FA; PerkinElmer; excitation, 485 nm; detection, 523-535 
nm). Each condition was performed in triplicate and the mean fluorescence was calculated. 
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2.3.10 Loop-formation angiogenesis assay 
HUVECs were transfected with siRNAs and after 48 h were harvested with trypsin and 
seeded onto a gel consisting of polymerised Matrigel matrix. To create the Matrigel layer, 
Matrigel at a concentration of atleast 9 mg/ml was diluted 1:1 with PBS (+ Ca/Mg). 300 µl of 
this mixture was spread out onto each well of a 6 well dish and allowed to polymerise at 
room temperature for 1.5 h. HUVECs were seeded onto the Matrigel layer at a density of 2 x 
10 ^ 5 cells per well and loops were allowed to form for 24 h. Loops formed were imaged by 
phase-contrast microscopy or by fluorescence microscopy after staining with Phalloidin-
Alexa546 (at a dilution of 1/500 for 1 h at room temperature after cells were fixed with 4% 
PFA for 20 min and permeabilised with 0.1% Triton X-100 for 1 min, solutions were made in 
PBS). Loop formation was quantified by counting the number of loops formed per imaged 
field. The mean value for multiple fields was used for statistical analysis. Images were 
acquired using a Nikon TE2000-E microscope with a Plan Fluor 4X or 10X objective (Nikon) 
and a Hamamatsu Orca-ER digital camera. Time-lapse movies were also made by phase-
contrast imaging using the 4X objective at 37⁰C and 5% CO2. Images were captured using 
Metamorph software. A frame rate of 1 frame/30 min was used for 24 h and movies were 
initiated 1 h after seeding cells onto Matrigel. 
2.3.11 CHO cell aggregation assay 
CHO cells stably expressing HA-FAM40A, HA-FAM40B, EGFP-E-cadherin and control cells 
were harvested using non-enzymatic cell dissociation solution (Sigma-Aldrich). Cells were 
tested for their capacity to aggregate by incubation of cell suspensions at 37⁰C and 5% CO2 
for 8 h with gentle mixing every 30 min. Cell suspensions at a density of 2 x 10 ^ 6 cells per 
ml in a total volume of 2 ml were used. Aggregation assays were carried out in 15 ml 
polystyrene tubes. A sample containing a heterogeneous mix of HA-FAM40A and HA-
FAM40B expressing cells (1:1 mix ratio) was included to test for trans, hetero-dimerisation. 
At the beginning (t=0 h) and end (t=8 h) of the incubation period, an aliquot of each 
suspension was taken and loaded into a hemocytometer chamber. Images of random fields 
were taken using a Nikon Eclipse TS100 microscope with a 10X objective (Nikon) and a 
QIClick digital camera (QImaging). For each condition in each experiment, 5 individual fields 
were imaged. The number of ‘particles’ (N) was counted in each image with a ‘particle’ 
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defined as being either a single cell or a clump of multiple cells. The ratio of mean N at t=0 h 
and mean N at t=8 h (N0 / N8) was used as a measure of cell aggregation in each 
experiment. 
2.3.12 Flow cytometry 
COS7 cells were transfected with pDEST-HA, pHA-FAM40A, pHA-FAM40A or pHA-TrkA 
(used as a positive control). Flow cytometry was used to assess if these proteins were 
expressed on the cell surface. 24 h or 48 h after transfection, cells (one well of a 6 well dish 
per condition) were harvested using non-enzymatic cell dissociation solution (Sigma-
Aldrich). Cells were washed with FACS buffer (PBS + Ca/Mg with 1% FCS) and pelleted by 
centrifugation at 200 g for 5 min. Cells were then incubated with the primary antibody (rat 
anti-HA, Roche, 1/100)) diluted in FACS buffer for 1 h on ice. Cells were washed thrice with 
FACS buffer using centrifugation at 200 g for 5 min to remove unbound antibody. Incubation 
of cells with secondary antibody (anti-rat IgG Alexa488, 1/200) diluted in FACS buffer for 1 h 
on ice was done following which cells were washed 3 times with FACS buffer and 
centrifugation done at 200 g for 5 min. For each condition, a control was included where 
cells were stained with secondary antibody alone. The fluorescence of cells was measured 
using a BD FACSCalibur flow cytometer at an excitation wavelength of 495 nm and an 
emission wavelength of 519 nm. 10,000 data points were acquired for each condition in 
each individual experiment. Data was analysed using Flow Jo software.  
2.3.13 Immunofluorescence 
PC3 cells were seeded onto uncoated glass coverslips or coverslips coated with Matrigel 
(100 µg/ml at 37⁰C for 1 h). Cells treated with siRNA were grown in media containing 1% 
while other cells were grown in normal growth media (containing 10% FCS). HUVECs were 
seeded onto glass coverslips coated with fibronectin (10 µg/ml at 37⁰C overnight). After 
attachment of cells and at the point when the experiment was to be terminated, cells were 
fixed in 4% paraformaldehyde (PFA) for 20 min at room temperature. Fixed cells were 
washed 3 times in PBS and then permeabilised as required with 0.1% Triton X-100 in PBS 
for 1 min at room temperature. After washing 3 times with PBS, coverslips were blocked in 
3% BSA in PBS for 20 min at room temperature to prevent non-specific binding of 
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antibodies. Primary antibodies were diluted in 1% BSA (bovine serum albumin) in PBS and 
40 µl pipetted onto parafilm. Coverslips were inverted onto the antibody drop and incubated 
at room temperature for 2 h or at 4⁰C overnight. When staining for the active form of β1-
integrin (12G10 antibody, Abcam # ab30394), the fixation, permeabilisation and staining 
steps were performed at 4⁰C. Fluorophore-conjugated secondary antibodies, DAPI and 
phalloidin were prepared in the same way as the primary antibodies. Coverslips were 
washed 3 times with PBS and inverted onto the secondary antibody drop. Incubation was 
done at room temperature for 2-3 h. Following this final incubation, coverslips were washed 
a minimum of 5 times with PBS and mounted onto glass slides using fluorescent mounting 
medium (DAKO). Slides were incubated at 37⁰C for 5 min to allow the mounting media to 
solidify and then stored at 4⁰C until image acquisition.  
Table 2.10 Reseeding of siRNA-transfected cells for immunofluorescence 
Cell type Reseeded after 
transfection at (h) 
Number of cells 
used per coverslip 
at 72 h after 
transfection 
PC3 24 h 12,000 sub-confluent 
HUVEC 48 h 1.5-2 x 10^5 confluent 
HUVEC 48 h 40,000 sub-confluent 
 
For immunofluorescence staining of HUVEC loop assay samples, loops were allowed to 
form for 24 h (details in section 2.3.10) on 100 µl of matrix in a 8 µl transwell. Samples were 
fixed with 4% PFA in PBS for 20 min at room temperature and washed 3 times with PBS. 
Cells were permeabilised with 0.1% Triton X-100 in PBS for 10 min at room temperature. 
After washing 3 times with PBS, samples were incubated with 3% BSA in PBS for 1 h to 
reduce background fluorescence. Samples were incubated with phalloidin-Alexa546 and 
DAPI in 3% BSA in PBS for 2 h at room temperature followed by 3 PBS washes. The filter 
was then cut away from the transwell and inverted onto a glass coverslip. The coverslip was 
mounted onto a glass slide and the gap between the coverlip and glass side sealed using a 
rubber o-ring and microscope grease. Slides were stored at 4⁰C until image acquisition. 
2.3.14 Confocal microscopy 
A Zeiss LSM510 confocal laser-scanning microscope with an EC Plan-Neofluar 40x/1.30 Oil 
DIC M27 or a Plan-Apochromat 63x/1.40 Oil DIC M27, and ZEN software was used to take 
Chapter 2                                                                                               Materials and Methods                                                                  
87 
   
images of fluorescently stained cells. Images were taken at a resolution of 1024X1024 pixels 
using an average of 2 frames. The range finder function in the ZEN software was used to 
adjust the gain and offset to avoid saturation and high background in images. Images in 
each experiment were acquired using the same gain and offset settings if comparison 
between images was required. Lasers and filters used are shown in Table 2.11. 
Table 2.11 Lasers and filters used for confocal microscopy 
Fluorophore Laser Excitation 
(nm) 
Emission (nm) Filter (nm) 
Alexa 488 Argon 488/494 520/517 Bandpass 
505-530 
Alexa 546 Helium/Neon 556 573 Bandpass 
560-615 
Alexa 647 Helium/Neon 650 668 Longpass 
650 
DAPI Diode 405-30 405 430 Bandpass 
420-480 
 
2.3.15 Analysis of confocal images 
2.3.15.1 Analysis of cell morphology using Cell Profiler 
The Cell Profiler image analysis software (www.cellprofiler.org) was used to analyse the 
morphology of FAM40A and FAM40B-depleted cells. A pipeline of individual modules was 
used to quantify the morphology of cells. Modules are arranged linearly with the output of 
one module being the input for another. Objects in images were identified by thresholding of 
the fluorescent signal and by setting appropriate size restrictions. The DAPI staining was 
initially used to identify locations of individual cells and provides a positional cue. A 
subsequent module used the F-actin staining to identify cell boundaries using positional 
cues determined earlier (DAPI staining) as an input. A separate module was then used to 
compute shape parameters of the identified cells. Values for cell area and eccentricity (a 
measure of elongation; ratio between foci distance and major axis length) were exported to 
Microsoft Excel and analysed.  
2.3.15.2 Quantification of HUVEC stress fibres 
Stress fibres were quantified by manually assigning a subjective score to each cell. 
Quantification was done by assigning a score to each cell based on the stress fibre content 
in the centre of the cell; 0 – few or no stress fibres, 1 – upto 50% of the cell centre contains 
Chapter 2                                                                                               Materials and Methods                                                                  
88 
   
stress fibres, 2 – 50% to 75% of the cell centre contains stress fibres, 3 – greater than 75% 
of the cell centre contains stress fibres. Cells were visualised using a Zeiss LSM510 
confocal laser-scanning microscope with an EC Plan-Neofluar 40x/1.30 Oil DIC M27 
objective and epifluorescence. 
2.3.15.3 Analysis of HUVEC focal adhesions using Cell Profiler 
Individual cells were first identified using the process detailed in section 2.3.15.1. Vinculin 
staining was used to identify individual adhesions by thresholding the fluorescent signal and 
applying appropriate size restrictions. A subsequent module then related the identified 
adhesions to cells identified earlier. Focal adhesion shape parameters and numbers were 
then computed by a separate module. Data was exported to Microsoft Excel and analysed. 
2.4 Methods: biochemistry 
2.4.1 Preparation of cell lysates 
Cells in tissue culture dishes were washed twice with cold PBS (+ Ca/Mg) and then lysed on 
ice in a suitable volume of either IP lysis buffer or RIPA buffer (75 µl per well of a 24 well 
plate (10 ^ 5 cells seeded the day before lysis), 150 µl per well of a 6 well plate and 800 µl 
per 10 cm dish). Cells were scraped into microfuge tubes and incubated on ice for 10 min. 
Samples were cleared by centrifugation at 17,000 g at 4⁰C for 30 min and the supernatant 
transferred to a new microfuge tube. An appropriate volume of 4X SDS sample buffer was 
added to the lysates, which were then boiled and either used immediately or stored at -20⁰C. 
Lysis of HUVECs with Laemmli lysis buffer was also used in experiments to check for p-
MLC2 (phosphorylated myosin light chain 2) levels by western blotting. Cells in 6 well dishes 
were lysed by adding 150 µl of lysis buffer to each well on ice. After a 5 min incubation step, 
cells were scraped into microfuge tubes and snap frozen in liquid nitrogen. Frozen samples 
were then boiled for 5 min and sonicated on ice (15 sec sonication at an amplitude of 50% 
(Sonics Vibra VC-130 sonicator)). Samples were cleared by centrifugation at 17,000 g at 
4⁰C for 30 min and the supernatant transferred to a new microfuge tube. An appropriate 
volume of 4X SDS sample buffer was added to the lysates which were then boiled and either 
used immediately or stored at -20⁰C. 
Chapter 2                                                                                               Materials and Methods                                                                  
89 
   
2.4.2 SDS-PAGE and western blotting 
Prepared cell lysates were applied to NuPAGE 4-12% Bis-Tris gels and resolved using a 
constant voltage of 120 V in either NuPAGE MES or MOPS buffer. After gel electrophoresis, 
proteins were transferred onto Immobilon-P PVDF membranes (Millipore). Membranes were 
activated by incubation with 100% methanol for 1 min. The gel and membrane were then 
equilibrated in 1X transfer buffer and sandwiched between 6 layers of Whatman paper, 2 
sponges and inserted into a transfer cassette. The cassette was placed in a Mini-Protean 
transfer system (Bio-Rad) filled with 1X transfer buffer. Electrophoretic transfer of proteins 
onto the membrane was achieved at a constant voltage of 100 V for 2 h at 4⁰C. After 
electrophoresis, membranes were blocked in blocking solution (5% skimmed milk powder in 
TBST or 5% BSA in TBST) for 1 h at room temperature. Incubation with primary antibody 
was then done (in blocking solution at the appropriate dilution) at room temperature for 1 h 
or at 4⁰C overnight. Membranes were washed 3 times with TBST for 10 min each wash and 
incubated with the secondary antibody. Secondary antibody (in blocking solution) was 
incubated at room temperature for 2 h. Unbound antibody was removed by washing 3 times 
with TBST and the HRP signal determined using an enhanced chemiluminescence (ECL) 
detection kit according to the manufacturer’s instructions and X-ray film (Fujifilm). Bands on 
immunoblots were quantified by densitometric analysis using ImageJ software. 
Stripping of western blots was achieved by washing membranes 3 times with stripping buffer 
for 10 min for each wash at room temperature. Membranes were subsequently washed 3 
times with TBST and blocked, reprobed with primary and secondary antibody and developed 
according to the described western blotting protocol. 
2.4.3 Immunoprecipitation 
Immunoprecipitation of overexpressed protein was done using lysates prepared from COS7 
cells transfected with plasmid DNA containing the gene of interest tagged with either the HA 
or myc epitope. 48 h after transfection, COS7 cells in 10 cm dishes were washed twice with 
cold PBS (+ Ca/Mg) and 800 µl of IP lysis buffer was added. Cells were scraped into 
microfuge tubes and incubated on ice for 10 min. Samples were cleared by centrifugation at 
17,000 g at 4⁰C for 30 min and the supernatant transferred to a new microfuge tube. A small 
Chapter 2                                                                                               Materials and Methods                                                                  
90 
   
aliquot of the total cell lysate (usually 40 µl) was kept to check total protein levels by 
immunoblotting. Cell lysates were precleared by incubation with 40 µl of non-immune IgG 
agarose beads (pre-washed with IP lysis buffer) per sample for 1 h at 4⁰C with rotation. 
Tubes were spun at 17,000 g at 4⁰C for 1 min and the supernatant transferred to a new 
microfuge tube. Lysates were then incubated with 20 µl of anti-HA or anti-myc agarose 
beads as appropriate (pre-washed with IP lysis buffer) per sample for 3 h at 4⁰C with 
rotation. Beads were washed 5 times with high salt IP lysis buffer (containing 250 mM NaCl) 
using low speed centrifugation steps (1,000 g for 1 min at 4⁰C). After the last wash, protein 
was eluted from the beads by boiling with 4X SDS sample buffer. These samples were 
resolved together with total lysate samples by SDS-PAGE and immunoblotted for the HA 
and/or myc epitope, or processed further as needed.  
2.4.4 Rho GTPase activity assays 
To detect GTP loading of Rho GTPase proteins, a biochemical affinity method involving the 
selective pulldown of GTP loaded protein from whole cell lysates was used. A GST fusion of 
the Rho binding domain of rhotekin (RBD) was used to assess RhoA activity and a GST 
fusion of the p21-binding domain (PBD) of PAK1 (p21-activated kinase) was used to test 
Rac1 and Cdc42 activity. 
2.4.4.1 Preparation of GST-RBD and GST-PBD beads 
Bacteria containing pGEX-2T plasmids encoding either GST-RBD or GST-PBD were 
inoculated from glycerol stocks into 100 ml of LB containing 100 µg/ml ampicillin (LB-Amp). 
The culture was allowed to incubate overnight at 37°C with shaking and then diluted 1/20 in 
fresh LB-Amp. This culture was incubated at 37⁰C with shaking until it reached an OD of 1.0. 
Protein expression was then induced by addition of 0.5 M isopropyl β-D-
thiogalactopyranoside (IPTG). Cultures were now incubated at 30⁰C for a further 2 h. 
Bacterial cells were then pelleted in 50 ml tubes by centrifugation at 1,000 g for 30 min at 
4⁰C. Pellets were stored at -40⁰C for future use or were lysed immediately. 
For lysis, the required number of bacterial cell pellets was used (e.g. 4 pellets were used for 
6 conditions in each assay). Pellets containing the same GST fusion protein were 
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resuspended in ice cold STE buffer and homogenised by passing repeatedly through a 19G 
needle. Lysis of cells was initiated by adding 100 µg/ml lysozyme and incubating on ice for 
30 min with gentle mixing. Dithiothreitol (DTT) at a concentration of 5 mM, 1% Tween-20 
and 0.03% sodium dodecyl sulphate (SDS) was added to the cell suspension which was 
then mixed gently. The suspension was centrifuged at 16,000 g for 20 min at 4⁰C and the 
supernatant transferred to a fresh tube. 40 µl of glutathione sepharose beads per condition 
(prewashed in STE buffer) was added to the supernatant and incubated at 4⁰C for 1 h with 
rotation. Beads were then washed 3 times with ice cold STE buffer and  finally resuspended 
in an equal volume (compared to bead bed volume) of STE buffer. 
2.4.4.2 Pulldown assay 
For assays with PC3 cells, one 10 cm dish was used per condition and for assays with 
HUVECs, one 6 well plate was used per condition. Cells were lysed with Rho lysis buffer 
(800 µl per 10 cm dish, 150 µl per well of a 6 well plate) and scraped into microfuge tubes. 
Lysates were centrifuged at 17,000 g at 4⁰C for 30 min and the supernatant transferred to a 
new tube. A small aliquot of the lysate was kept to immunoblot for total Rho protein as a 
loading control. Lysates were then incubated with 40 µl of GST-RBD or GST-PBD beads for 
1 h at 4⁰C with rotation. Beads were pelleted by centrifugation at 1,000 g for 1 min and 
washed with ice cold Rho lysis buffer. A total of 3 washes were done and protein was eluted 
from the beads by boiling with 4X SDS sample buffer. These samples were resolved 
together with total lysate samples by SDS-PAGE and immunoblotted for the Rho protein of 
interest. Quantification of protein levels on western blots was done by densitometry using 
the software ImageJ. 
2.4.5 Surface biotinylation assay 
Sulfo-NHS-Biotin is a water soluble biotinylation reagent and reacts with primary amine 
groups. The membrane impermeable nature of this molecule makes it suitable to specifically 
label cell surface proteins, and so can be used to test if a protein is transmembrane.  COS7 
cells were transfected with pHA-FAM40A, pHA-FAM40B or pHA-14-3-3 (used as a negative 
control) plasmid DNA. 48 h after transfection, cells were washed twice with cold PBS (+ 
Ca/Mg) and incubated with 600 µg/ml sulfo-NHS-biotin in PBS (5 ml per 10 cm dish) for 20 
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min at 4⁰C. Cells were washed twice with PBS and blocked with cell culture medium (DMEM 
with 10% FCS) on ice for 20 min. After a PBS wash, cells were lysed by adding 800 µl of 
RIPA buffer. Cells were scraped into microfuge tubes and the lysates passed through a 19G 
needle several times. After 10 min incubation on ice, samples were cleared by centrifugation 
at 17,000 g at 4⁰C for 30 min and the supernatant transferred to a new microfuge tube. A 
small aliquot of the total cell lysate (40 µl) was kept to check total protein levels by 
immunoblotting. The remaining supernatant was incubated with glutathione sepharose 
beads (40 µl per sample, prewashed with RIPA buffer) for 1 h at 4⁰C with rotation to reduce 
non-specific binding. Beads were pelleted by centrifugation at 17,000 g for 1 min at 4⁰C and 
the supernatant transferred to a new microfuge tube. Strepdavidin agarose beads (20 µl per 
sample, prewashed with RIPA buffer) were added to the supernatants which were then 
incubated at 4⁰C for 2 h with rotation. Beads were washed 5 times with RIPA buffer using 
low speed centrifugation steps (1,000 g for 1 min). After the last wash, protein was eluted 
from the beads by boiling with 4X SDS sample buffer. These samples were resolved 
together with total lysate samples by SDS-PAGE and immunoblotted for the HA epitope. 
2.4.6 In vitro kinase assays 
COS7 cells were electroporated with pHA-FAM40A, pHA-FAM40B or pmyc-CCM3 (2 dishes 
per condition of which one was used for ‘no kinase enzyme’ control samples). 
Electroporation with pDEST-HA or pDEST-myc was also done and lysates from these cells 
were used in ‘kinase enzyme only controls’. 48 h after transfection, cells were lysed and 
overexpressed protein was immunoprecipitated (section 2.4.3 for details). Beads with 
immunoprecipitated protein were washed twice with IP lysis buffer, once with high salt wash 
buffer (0.5 M NaCl, 10 mM Tris-HCl pH 7.5) and twice with kinase assay buffer, with 
centrifugation at 1,000 g for 1 min between washes. After the final wash, beads were 
resuspended with kinase mix (20 µl kinase assay buffer, 1 µl of 1 mM ATP, 0.5 µl of [γ-32 P]-
ATP). In addition, 0.5 µg of recombinant MST4 was added to the mix in the test and ‘kinase 
enzyme only control’ samples. Samples were incubated at 30⁰C for 30 min with gentle 
vortexing every 10 min. 20 µl of 4X SDS sample buffer was added and the samples boiled. 
Samples were resolved by SDS-PAGE and the gels stained with colloidal coomassie to 
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verify the presence of immunoprecipitated protein (section section 2.4.8). Gels were 
exposed to X-ray film to detect signal corresponding to phosphorylated protein by 
autoradiography.  
2.4.7 Purification of FAM40A and FAM40B antibodies 
Rabbit anti-FAM40 and anti-FAM40B antisera were generated by immunising rabbits with 
peptide haptens conjugated to keyhole limpet hemocyanin (KLH) (peptide hapten used for 
anti-FAM40A generation: N-MEPAGGPGPLIVNC, peptide hapten used for anti-FAM40B 
generation: N-GTGGPPANGNGNGGC). Two individual rabbits were immunised per hapten 
and the final antisera had an antibody titre > 1:10,000. Antisera were produced by 
Genosphere Biotechnologies, Paris, France (www.genosphere-biotech.com).   
50 ml of antisera was produced per rabbit and 10 ml was used to purify anti-FAM40A and 
anti-FAM40B antibodies by peptide affinity purification. Peptides used for immunisation were 
conjugated by means of their terminal cysteine residue to SulfoLink coupling resin (Pierce) 
to generate the final chromatography resin. This was then used as a bait to isolate anti-
FAM40A and anti-FAM40B from total rabbit serum. 1 mg of the peptide was dissolved in 2 
ml of coupling buffer and 1.25 mM TCEP (reducing agent) added. The mixture was 
incubated at room temperature for 30 min. To prepare the chromatography resin, 2 ml of 
SulfoLink coupling resin (1 ml bed volume) was added to chromatography spin columns. 
Columns were spun at 1,000 g for 1 min at room temperature to remove the storage buffer. 
2 ml of coupling buffer was added and the columns spun as mentioned. This wash step was 
repeated 2 more times. After the last spin, 2 ml of reduced peptide solution prepared earlier 
was added to the column. Contents were incubated at room temperature for 15 min with 
gentle mixing. A further incubation at room temperature for 30 min without mixing was done. 
The column was washed with 4 changes of 2 ml wash solution and then with 2 changes of 
coupling buffer. Non-specific binding sites on the resin were blocked by adding 50 mM 
cysteine in 2 ml of coupling buffer to the column. Contents were incubated at room 
temperature for 15 min with gentle mixing. A further incubation at room temperature for 30 
min without mixing was done. Columns were spun to remove the cysteine solution and 
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washed 3 times with binding buffer. Columns were stored at 4⁰C with addition of 0.05% 
sodium azide or used immediately. 
10 ml of rabbit antiserum was cleared of any particulate matter by centrifugation at 3,000 g 
at 4⁰C for 30 min and the supernatant diluted with 10 ml of binding buffer. The serum was 
then batch-bound with the prepared chromatography resin in 50 ml tubes at 4⁰C overnight. 
The serum with the resin was then added to the chromatography column and allowed to 
drain out while the resin was retained in the column. Steps were carried out at 4⁰C. The 
resin in the column was washed a minimum of 5 times with 2 ml of binding buffer. Protein 
was eluted with 2 ml of elution buffer into tubes containing 100 µl of neutralisation buffer. 
The elution step was repeated 4 more times (total volume of ~ 10 ml eluted antibody). Eluted 
antibody was dialysed into binding buffer using a 12,000 – 14,000 cut-off membrane at 4⁰C 
overnight. The purified antibody was concentrated by ammonium sulphate precipitation. 10 
ml of saturated ammonium sulphate was added slowly to the 10 ml of antibody solution and 
the mixture (50% saturation ammonium sulphate) incubated with stirring overnight at 4⁰C. 
Centrifugation at 3,000 g at 4⁰C for 30 min was done and the pellet resuspended in 1,000 µl 
(anti-FAM40A purification) or 500 µl (anti-FAM40B purification) of binding buffer. Dialysis 
with binding buffer was done overnight as described earlier. Purified antibody solution was 
resolved by SDS-PAGE along with a BSA protein standard to determine its purity and 
concentration. The antibody solution was aliquoted and stored at -20⁰C.  
2.4.8 ProQ staining 
COS7 cells were transfected with pHA-FAM40A or pHA-FAM40B plasmid DNA. 48 h after 
transfection, cells were lysed and total protein resolved by polyacrylamide gel 
electrophoresis. Proteins in gels were transferred onto Immobilon-FL PVDF membranes (low 
fluorescence PVDF membrane, Immobilon) as described in section 2.4.2. After 
electroblotting, membranes were allowed to dry completely, following which they were pre-
wet with methanol. Proteins on membranes were fixed by incubation with fix solution for 10 
min. Membranes were washed 4 times with distilled water (5 min each wash) following which 
they were stained using the ProQ phosphoprotein blot stain for 15 min. Membranes were 
washed in destain solution 3 times (5 min each wash) and after the final wash, allowed to 
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dry completely. Phosphoproteins on stained blots were visualised by imaging with a UV 
transilluminator.  
2.4.9 Colloidal coomassie staining of gels 
After electrophoresis, proteins gels were fixed for 30 minutes in 7% acetic acid, 40% 
methanol. The colloidal coomassie blue concentrate (Sigma-Aldrich) was diluted 1:5 in 
deionised water and immediately before staining 4 parts of this solution was combined with 1 
part methanol to prepare the working staining solution. Gels were stained overnight at room 
temperature. Gels were destained for 5 min with 25% methanol, 7% acetic acid and then 
with 25% methanol, 2% acetic acid until bands appeared in good contrast against the 
background. 
2.5 Methods: statistical analysis 
Statistical analysis was carried out using data from 3 or more independent experiments. An 
unpaired, two-tailed Student’s t-test was used as a test of statistical significance and was 
performed either using Microsoft Excel or GraphPad Prism (www.graphpad.com). A 
parametric t-test was employed if the data were normally distributed, and a non-parametric t-
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3 The FAM40 proteins – insights from biochemical and 
bioinformatics analysis 
3.1 Introduction 
There are only two reports in the literature that address the biochemical and functional 
characterisation of human FAM40A and FAM40B (Bai et al., 2011; Goudreault et al., 2009). 
To understand better the physiological roles of the FAM40 proteins, it is important to 
understand their biochemical features. This will serve to put their functions in perspective 
and aid in generating hypotheses as to how they may fulfil these functions. For example, 
interacting partners and protein modifications such as phosphorylation may be important 
determinants in cell signalling. This chapter aims to describe the biochemical properties of 
the human FAM40 proteins. Antibodies targeting the human FAM40 proteins were 
generated and purified, but they were unable to detect endogenous protein. Hence, the 
majority of the analysis presented is based on overexpressed proteins tagged with an 
epitope tag. Furthermore, data available on public databases and computational resources 
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3.2 Results 
3.2.1 The FAM40 proteins interact with members of the STRIPAK complex 
The STRIPAK complex was identified by an affinity chromatography/mass spectrometry 
analysis to generate an interaction network around the catalytic subunit of PP2A (Goudreault 
et al., 2009). The FAM40 proteins are members of this complex and hence other STRIPAK 
complex members could be important as FAM40 signalling partners. Co-
immunoprecipitation experiments were therefore carried out to determine if FAM40A or 
FAM40B interact with other members of the STRIPAK complex. Specifically, their interaction 
with CCM3 and the GCKIII family kinases (STK24, STK25 and MST4) was tested. Using 
affinity chromatography/mass spectrometry, the interaction of FAM40A with CCM3, STK24, 
STK25 and MST4 has been previously reported (Goudreault et al., 2009). Hence, this 
experiment serves to validate these results as well as to test if FAM40B behaves similarly.  
As antibodies that recognise endogenous FAM40 proteins were not available, 
overexpressed proteins tagged with epitope tags were used in these experiments. FAM40A 
and FAM40B were tagged with HA at the N-terminus while CCM3, STK24, STK25 and 
MST4 were tagged with myc at the N-terminus. Multiple transcripts exist for both FAM40A 
and FAM40B (NCBI Protein database, http://www.ncbi.nlm.nih.gov/protein), and the longest 
isoforms were used in all experiments. COS7 cells were co-transfected with HA-FAM40A or 
HA-FAM40B and myc-STK24, myc-STK25, myc-MST4 or myc-CCM3. Immunoprecipitation 
with anti-HA revealed that both FAM40A and FAM40B are capable of interacting with CCM3, 
STK25 and MST4 (Figure 3.1). No interaction with STK24 was detected with either FAM40A 
or FAM40B. This could be because only a low level of STK24 expression was achieved. 
Furthermore, exogenously expressed STK25 and MST4 appeared to be susceptible to 
degradation indicated by the number of lower molecular weight bands. These results provide 
a first indication of potential signalling partners for FAM40A and FAM40B. 
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Figure 3.1 FAM40A and FAM40B interact with CCM3 and the GCKIII family kinases, 
STK25 and MST4 
COS7 cells were co-transfected with pDESTHA (empty vector) or pHA-FAM40A or pHA-
FAM40B and pmyc-STK24 or pmyc-STK25 or pmyc-MST4 or pmyc-CCM3. After 48 h, cells 
were lysed and cell lysates were incubated with anti-HA epitope agarose beads. Proteins 
interacting with the FAM40 proteins were visualized by immunoblotting with an antibody to 
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3.2.2 The FAM40 proteins form homodimers and interact with each other 
Immunoprecipitation of overexpressed FAM40A and FAM40B revealed a higher molecular 
weight band (indicated by asterisks in Figure 3.2A and B) in addition to the band that 
corresponds to full length FAM40A and FAM40B (indicated by arrows in Figure 3.2A and B). 
This higher molecular weight band had a size approximately twice that of full length protein. 
Hence, it was hypothesised that this band corresponds to a dimeric form of FAM40A and 
FAM40B. To validate this, co-immunoprecipitation experiments were carried out with 
overexpressed FAM40A and FAM40B differentially tagged with the HA and myc epitope. 
Myc-FAM40A and myc-FAM40B co-immunoprecipitated with HA-FAM40A and HA-FAM40B 
(Figure 3.2B). These results indicate that both FAM40A and FAM40B form homodimers as 
well as interact with each other. The fact that the ‘dimer band’ appeared even under 
denaturing conditions indicates a strong interaction. Homodimerisation and 
heterodimerisation can occur simultaneously indicated by the presence of ‘dimer bands’ in 
the ‘IP lanes’ too (Figure 3.2B). Moreover, higher molecular weight bands or smears in 
addition to the dimer band were observed. These bands could be suggestive of post-
translational modifications of the FAM40 proteins.  
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Figure 3.2 FAM40A and FAM40B form homo- and hetero- dimers 
(A) COS7 cells were transfected with pDESTHA (empty vector), pHA-FAM40A or pHA-
FAM40B. After 48 h cells were lysed and incubated with anti-HA epitope agarose beads. 
Panel (B) shows the results of a co-immunoprecipitation experiment in which COS7 cells 
were co-transfected with pDESTHA or pHA-FAM40A or pHA-FAM40B and pmyc-FAM40A or 
pmyc-FAM40B. After 48 h cells were lysed and incubated with anti-HA epitope agarose 
beads. Dimerising partners were detected by immunoblotting with an antibody to the myc 
epitope. Monomeric protein is indicated by arrows and the dimeric form is indicated by 
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3.2.3 The FAM40 proteins are putative transmembrane proteins 
Several lines of evidence prompted an investigation into whether the FAM40 proteins could 
have transmembrane domains. The cellular localisation of proteins has implications for their 
function and hence is important to determine. Previous studies have predicted that both 
Far11 (the S. cerevisae FAM40 homologue) (Kemp and Sprague, 2003) and Ham2 (the 
Neurospora crassa FAM40 homologue) (Xiang et al., 2002) are putative transmembrane 
proteins using bioinformatic analysis. In addition, the N-terminal N1221 domain of the human 
FAM40 proteins is similar to a hypothetical protein product of a yeast ORF which is also 
predicted to contain several transmembrane regions (conserved domains database, NCBI). 
Hence, the sequences of both human FAM40A and FAM40B were checked for the presence 
of transmembrane protein features using publically available prediction software.  
The signal peptide is a protein sorting signal that targets proteins for insertion into the 
endoplasmic reticulum (ER) and subsequent translocation to the plasma membrane. No 
signal peptide was detected for either FAM40A or FAM40B, as determined by SignalP 
(http://www.cbs.dtu.dk/services/SignalP/) and MEMSAT-SVM (http://bioinf.cs.ucl.ac.uk/). 
However, FAM40A was predicted to enter the non-classical secretory pathway or secretion 
without a signal peptide using SecretomeP (http://www.cbs.dtu.dk/services/SecretomeP/) 
(Figure 3.3A). In addition, both FAM40A and FAM40B were predicted to contain 
transmembrane segments by TopPred (http://mobyle.pasteur.fr/), MEMSAT3 
(http://bioinf.cs.ucl.ac.uk/), TMPred 
(http://www.ch.embnet.org/software/TMPRED_form.html), and MEMSAT-SVM 
(http://bioinf.cs.ucl.ac.uk/). The MEMSAT-SVM program differs in that it attempts to predict 
both signal peptides and transmembrane topology. A cartoon generated by MEMSAT-SVM 
is shown in Figure 3.3B and C as an example. These programs were not used to generate a 
conclusive prediction of FAM40 localisation and topology, but to provide an initial indication 
to prompt further analysis.  
To further investigate the possible transmembrane nature of FAM40A and FAM40B, a cell 
surface biotinylation assay was used. Briefly, HA-FAM40A and HA-FAM40B were 
overexpressed in COS7 cells following which all cell surface proteins were labelled using a 
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membrane-impermeable biotinylation reagent. Labelled proteins were isolated by 
streptavidin pulldown and probed for the presence of FAM40A and FAM40B. FAM40A and 
FAM40B were present in the streptavidin pulldown samples (Figure 3.3D), suggesting that 
certain regions of these proteins are exposed to the cell exterior. 14-3-3 is a cytoplasmic 
protein (Aitken, 2006) and HA-14-3-3 was used as a negative control.  Conversely, HA-TrkA 
was used as a positive control (TrkA is a neurotrophin receptor (Yoon et al., 1998)). The 
negative control (HA-14-3-3) was detected in the streptavidin pulldown sample in the 
experiment shown in Figure 3.3D, and although the intensity of the negative control band 
was less than that of biotin-labelled HA-FAM40A and HA-FAM40B, and the expression 
levels of total HA-FAM40A, HA-FAM40B and HA-14-3-3 were similar, this suggests the 
method might not be working as anticipated. However, HA-TrkA could not be consistently 
isolated by streptavidin pulldown. Further experiments with this construct need to be 
performed to determine if HA-TrkA is expressed at the cell surface. Taken together, these 
results indicate there is a possibility of the FAM40 proteins being transmembrane. 
FACS analysis was also performed to determine whether FAM40A or FAM40B were 
expressed at the cell surface. COS7 cells were transfected with HA-FAM40A or HA-
FAM40B, and HA-TrkA expressing cells were used as positive controls. An example FACS 
plot is shown in (Figure 3.4). HA-TrkA was detected, but FAM40A and FAM40B were not 
detected on the cell surface. Hence, this technique did not result in the reproducible 
detection of surface FAM40A and FAM40B which conflicts with results obtained with the 
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Figure 3.3 FAM40A and FAM40B are putative transmembrane proteins 
(A) SecretomeP predictions for FAM40A and FAM40B are shown. MEMSAT-SVM 
predictions for (B) FAM40A and (C) FAM40B are shown. (D) COS7 cells were transfected 
with pHA-FAM40A, pHA-FAM40B, pHA-14-3-3 (used as a negative control) or pHA-TrkA 
(used as a positive control). After 48 h cells were lysed and cell surface proteins labelled 
with biotin. Cell lysates were subsequently incubated with streptavidin agarose beads. 
Overexpressed protein was detected by immunoblotting with an antibody against the HA 
epitope. The immunoblot shown is representative of 3 independent experiments (except for 
pHA-TrkA, for which an example immunoblot is shown). 
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Figure 3.4 FACS does not detect surface FAM40A and FAM40B 
COS7 cells were transfected with pDESTHA (empty vector), pHA-FAM40A, pHA-FAM40B or 
pHA-TrkA (a neurotrophin receptor used as a positive control). After either 24 h or 48 h, cells 
were harvested non-enzymatically and stained with anti-HA antibody followed by Alexa-488 
conjugated secondary antibody. Control samples were stained only with the secondary 
antibody. Samples were analyzed using a FACSCalibur machine and Cell Quest Pro 
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3.2.4 Localisation of FAM40A and FAM40B 
The cellular localisations of FAM40A and FAM40B were determined by immunofluorescence 
and confocal microscopy. PC3 cells were transfected with pHA-FAM40A or pHA-FAM40B, 
and stained for the HA epitope and F-actin. PC3 cells grow as individual cells and exhibit F-
actin-rich protrusions at the cell edge (Vega et al., 2011). Both FAM40A and FAM40B 
showed diffuse localisation in the cytoplasm and were enriched in F-actin-rich protrusions 
(Figure 3.5). This is suggestive of the FAM40 proteins being proximal to the plasma 
membrane. However, as cell protrusions can be thicker than adjacent regions of the cell 
(Abercrombie et al., 1971), it is possible that this contributes to the apparent enrichment of 
FAM40A and FAM40B in these areas.  
In addition, staining for the HA epitope was performed using unpermeabilised cells to 
determine if the HA tag was present at the cell exterior. Epitope tagging and subsequent 
assessment of epitope accessibility by immunofluorescence can be used to determine 
transmembrane protein topology (Covitz et al., 1998).  The cells were not permeabilised with 
detergent to prevent staining of internal HA epitope. Strong foci of staining were observed at 
F-actin-rich protrusions (Figure 3.6). Negligible staining was observed in the rest of the cell. 
As the HA tag is present at the N-terminus of FAM40A and FAM40B, these results suggest 
that the N-terminus of FAM40A and FAM40B is exposed to the cell exterior, and lend 
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Figure 3.5 Staining for overexpressed FAM40A and FAM40B in permeabilised PC3 
cells 
PC3 cells on glass coverslips were transfected with pHA-FAM40A or pHA-FAM40B and 
fixed after 24 h. Cells were stained for F-actin and the HA epitope. Asterisks indicate areas 
where the HA staining is localised to F-actin-rich protrusions. Scale bar = 20 µm. Images are 
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Figure 3.6 Staining for overexpressed FAM40A and FAM40B in unpermeabilised PC3 
cells 
PC3 cells on glass coverslips were transfected with pHA-FAM40A or pHA-FAM40B and 
fixed after 24 h. Cells were stained for F-actin and the HA epitope without permeabilisation 
with Triton. Asterisks indicate areas where the HA staining is localised to F-actin-rich 




Overall, the results on FAM40A and FAM40B localisation suggest that a portion of total 
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3.2.5 The FAM40 proteins do not function as cell-cell adhesion proteins 
FAM40A and FAM40B form homo- and hetero- dimers and are possible transmembrane 
proteins. Hence, it was tested if they are capable of trans-dimerisation or of facilitating cell-
cell adhesions. Their capacity to form interactions between two adjacent cells is of further 
interest as they interact with the CCM3 protein (section 3.2.1). CCM3 has been implicated in 
the pathogenesis of CCM and is known to be important for maintaining endothelial junction 
integrity (Zheng et al., 2010). The functions of FAM40A and FAM40B in endothelial cells are 
presented in chapter 5. To determine if the FAM40 proteins can act as cell-cell adhesion 
proteins, CHO (chinese hamster ovary) cell aggregation assays were carried out. CHO cells 
stably expressing HA-FAM40A or HA-FAM40B were tested for their capacity to aggregate. 
Control cells did not clump together and grew as single cells. The presence of a cell 
adhesion molecule can be detected by the induction of CHO cell clumping (Katsamba et al., 
2009). Furthermore, CHO cells can be maintained as suspension cultures making them ideal 
for this assay. CHO cells were transfected with pHA-FAM40A, pHA-FAM40B or EGFP-E-
cadherin (used as a positive control). Cells stably expressing these proteins were selected 
and validated using immunofluorescence staining and western blotting (Figure 3.7). Both 
FAM40A and FAM40B exhibited diffuse localisation with enrichment at the cell cortex. 
Conversely, E-cadherin localised to regions corresponding to cell-cell contacts (Figure 3.7A).  
Aggregation assays were carried out with control cells and cells stably expressing HA-
FAM40A, HA-FAM40B and EGFP-E-cadherin to determine if these proteins are capable of 
trans homo-dimerisation. A sample containing a 1:1 mix of HA-FAM40A:HA-FAM40B 
expressing cells was also included to detect trans hetero-dimerisation. As shown in Figure 
3.8, only cells expressing EGFP-E-cadherin aggregated. Hence, neither FAM40A nor 
FAM40B are capable of acting as cell-cell adhesion proteins. However, this result does not 
preclude them from being transmembrane proteins. 
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Figure 3.7 Validation of stable CHO cells expressing HA-FAM40A, HA-FAM40B and 
EGFP-E-cadherin 
CHO cells stably expressing HA-FAM40, HA-FAM40B or EGFP-E-cadherin were generated 
for use in a CHO cell aggregation assay. (A) Expression of HA-FAM40A and HA-FAM40B 
was confirmed by immunofluorescence staining with an antibody against the HA epitope. 
Expression of EGFP-E-cadherin was confirmed by similarly detecting GFP fluorescence. 
Scale bar = 50 µm. (B) Cell lysates from HA-FAM40A/HA-FAM40B and EGFP-E-cadherin 
expressing cells were immunoblotted with anti-HA and anti-GFP antibodies respectively to 
confirm expression of the indicated proteins. 
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Figure 3.8 The FAM40 proteins do not form cell-cell adhesions as determined by a 
CHO cell aggregation assay 
CHO cells stably expressing HA-FAM40, HA-FAM40B, EGFP-E-cadherin (used as a positive 
control) and control CHO cells were tested for cell aggregation (8 h aggregation at 37⁰C). A 
sample consisting of a 1:1 mix of cells expressing HA-FAM40A and HA-FAM40B was 
included to test for trans hetero-dimerisation. Images in (A) are representative of 3 
independent experiments. Scale bar = 50 µm. Data shown in (B) quantify aggregation by a 
measure of N0 (number of ‘particles’ at time=0 h) divided by N8 (number of particles at 
time=8 h), and are the mean of 3 independent experiments ± SEM. Data are presented 
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3.2.6 The FAM40 proteins are ubiquitinated 
Protein modification by ubiquitination is an important determinant in protein degradation and 
cell signalling. In addition to ubiquitination resulting in the targeting of proteins to degradation 
either via the proteasome or lysosomes, it plays a central role in other signalling cascades 
including those implicated in cytoskeletal dynamics, cell adhesion and migration (Schaefer et 
al., 2012). The presence of higher molecular weight bands in western blots for 
overexpressed FAM40A and FAM40B, suggest post-translational modifications. Moreover, 
published proteomic analysis reveals that FAM40A is ubiquitinated on Lysines 742 and 828 
while FAM40B is ubiquitinated on Lysine 738 (obtained from PhosphoSitePlus (Hornbeck et 
al., 2012)). Co-immunoprecipitation assays were carried out with lysates from COS7 cells 
co-transfected with pHA-ubiquitin and pmyc-FAM40A or pmyc-FAM40B. The ‘IB HA’ lanes 
show overexpressed ubiquitin protein (Figure 3.9). Ubiquitin is capable of multimerisation 
which explains the presence of a smear in these lanes. Both FAM40A and FAM40B were 
co-immunoprecipitated along with ubiquitin indicating that they are capable of undergoing 
ubiquitination. Non-ubiquitinated FAM40A and FAM40B are indicated by the asterisk in 
Figure 3.9. Higher molecular weight bands in the ‘IP HA:IB myc’ lanes  correspond to 
ubiquitinated FAM40A and FAM40B. Multiple higher molecular weight bands were detected 
which imply poly-ubiquitination and/or ubiquitination at multiple sites. 
It will be additionally important to show that HA-ubiquitin co-immunoprecipitates with myc-
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Figure 3.9 FAM40A and FAM40B are ubiquitinated 
COS7 cells were co-transfected with pDESTHA (empty vector) or pHA-ubiquitin and pmyc-
FAM40A or pmyc-FAM40B. After 48 h cells were lysed and incubated with anti-HA agarose 
beads. Myc-FAM40A and myc-FAM40B were detected by immunoblotting with an anti-myc 
antibody. The asterisks indicates signal corresponding to non-ubiquitinated FAM40 protein, 
while the arrows in the anti-HA blots indicate signal corresponding to monomeric ubiquitin. 
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3.2.7 The FAM40 proteins are phosphorylated 
Protein phosphorylation is another post-translational modification that can regulate protein 
function. Phosphorylated amino acids serve to diversify the topology and binding properties 
of protein surfaces. By doing so, phosphorylation acts as a signalling switch, allowing 
inducible protein binding and so is a fundamental concept in signal transduction and protein 
function (Hunter, 2012). The FAM40 proteins reside in a complex that also contains a 
phosphatase and multiple kinases (Goudreault et al., 2009), and as a consequence 
phosphorylation may be a mechanism by which FAM40 function is regulated.  
Phosphoproteins resolved by gel electrophoresis can be detected by the ProQ staining 
procedure (Invitrogen) (Schulenberg et al., 2004). Lysates from COS7 cells overexpressing 
HA-FAM40A or HA-FAM40B were immunoprecipitated with anti-HA epitope agarose beads, 
and ProQ staining of these samples revealed that both FAM40A and FAM40B are 
phosphoproteins (Figure 3.10). Proteomic analysis to identify phosphorylated residues on 
FAM40A and FAM40B was not carried out. However, multiple proteomic studies have been 
published that document phospho-peptides from which likely phospho-sites may be inferred. 
FAM40A phospho-sites (Figure 3.11) and FAM40B phospho-sites (Figure 3.12) were 
compiled from PhosphoSitePlus (Hornbeck et al., 2012). The number of individual 
experiments which report a particular site, as well as the extent of its evolutionary 
conservation, indicate the likelihood of it being biologically relevant. 
 
Figure 3.10 FAM40A and FAM40B are phosphorylated as determined by ProQ staining 
COS7 cells were transfected with pDESTHA (empty vector), pHA-FAM40A or pHA-FAM40B. 
After 48 h cells were lysed and cell lysates were incubated with anti-HA agarose beads. 
ProQ (Invitrogen) staining was done to detect phosphorylated protein. Results are 
representative of 3 independent experiments.  
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Figure 3.11 Phospho-sites on FAM40A detected by proteomic analysis 
Example phospho-sites on human FAM40A (sequence in bold) detected by proteomic 
analysis experiments are highlighted in red. These experiments (number of experiments 
indicated in brackets) have been compiled in PhosphoSitePlus, an online resource for 
protein modification (www.phosphosite.org). Multiple sequence alignments (generated by 
MUSCLE (Edgar, 2004)) of homologous sequences indicate the level of evolutionary 
conservation. 
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Figure 3.12 Phospho-sites on FAM40B detected by proteomic analysis 
Example phospho-sites on human FAM40B (sequence in bold) detected by proteomic 
analysis experiments are highlighted in red. These experiments (number of experiments 
indicated in brackets) have been compiled in PhosphoSitePlus, an online resource for 
protein modification (www.phosphosite.org). Multiple sequence alignments (generated by 
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3.2.8 The GCKIII kinase MST4 phosphorylates FAM40A, FAM40B and CCM3 
The GCKIII kinase MST4 is a member of the STRIPAK complex and interacts with both 
FAM40A and FAM40B (section 3.2.1), and with CCM3 (Ceccarelli et al., 2011; Ma et al., 
2007). While the GCKIII kinases are downstream mediators of CCM3 function (Ma et al., 
2007; Zheng et al., 2010), STK25 (a GCKIII family kinase) has been shown to phosphorylate 
CCM3 (Voss et al., 2007). Hence, it is possible that CCM3, FAM40A and FAM40B are MST4 
substrates. Additionally, determining this would provide a mechanism by which observations 
in section 3.2.7 could be explained and could have implications for FAM40 cell signalling.  
In vitro kinase assays with recombinant MST4 enzyme were carried out using 
immunoprecipitated HA-FAM40A, HA-FAM40B and myc-CCM3. Recombinant MST4 was 
found to be able to phosphorylate FAM40A, FAM40B and CCM3 (Figure 3.13). A signal was 
detected for FAM40B and CCM3 even in the absence of MST4, probably due to association 
with endogenous kinases. The level of auto-phosphorylated MST4 was reduced in the 
presence of the substrates FAM40A, FAM40B and CCM3. This could be because of 
competition with its substrates (FAM40A, FAM40B and CCM3). In summary, these results 
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Figure 3.13 In vitro kinase assays reveal that MST4 phosphorylates FAM40A, FAM40B 
and CCM3 
COS7 cells were transfected with pHA-FAM40A, pHA-FAM40B or pmyc-CCM3. Cells were 
lysed 48 h later and cell lysates were incubated with anti-HA agarose beads to precipitate 
HA-FAM40A and HA-FAM40B or with anti-myc agarose beads to precipitate myc-CCM3. 
Immunoprecipitated proteins were used in in vitro kinase assays with recombinant MST4 
and [γ-32 P]-ATP. Asterisks indicate signal corresponding to phosphorylated protein while 
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3.2.9 Synthesis and purification of anti-FAM40A and anti-FAM40B antibodies 
produced in rabbit 
To facilitate the characterisation of endogenous FAM40A and FAM40B, antibodies against 
these proteins were generated by immunising rabbits against peptide haptens (generated by 
Genosphere Biotechnologies, Paris, France (www.genosphere-biotech.com)). Total rabbit 
antisera obtained were tested by immunoblotting (Figure 3.14) and immunofluorescence 
staining (Figure 3.15). 
 For immunoblotting testing (Figure 3.14), lysates from COS7 cells overexpressing HA-
FAM40A or HA-FAM40B were used. Incubation of western blots with the antisera had to be 
performed in the presence of BSA to obtain specific bands with minimal background. Anti-
FAM40A antisera detected a major band corresponding to a molecular weight of about 100 
kDa. Anti-FAM40B antisera detected a pair of bands proximal to each other at approximately 
100 kDa. This molecular weight matches that of full length FAM40A and FAM40B. A number 
of additional lower molecular weight bands were observed which could be protein 
degradation products or non-specific bands. A high molecular weight smear was observed in 
the ‘IB FAM40A’ lanes which could correspond to protein modifications. Both antisera were 
specific in that anti-FAM40A antisera did not cross-react with overexpressed FAM40B and 
vice versa. 
Testing of the antisera for immunofluorescence staining (Figure 3.15) was carried out using 
PC3 cells transfected with pHA-FAM40A or pHA-FAM40B plasmids. The staining pattern of 
both anti-FAM40A and anti-FAM40B antisera matched very closely that of the respective 
anti-HA staining pattern. This indicates that these antibodies are capable of recognising their 
target proteins in their native conformation. Furthermore, staining was detected in cells not 
expressing HA-tagged protein implying the detection of endogenous protein. However, the 
specificity of this staining was not checked by knocking down FAM40A and FAM40B by 
RNAi. Taken together, these results suggest that the generated antisera are suitable for the 
detection of overexpressed protein in western blots and whole cells. 
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Figure 3.14 Testing anti-FAM40A and anti-FAM40B serum on overexpressed protein 
for immunoblotting 
COS7 cells were transfected with pDESTHA (empty vector), pHA-FAM40A or pHA-FAM40B. 
Cells were lysed 48 h later and cell lysates incubated with anti-HA agarose beads. 
Immunoprecipitated protein was used to test anti-FAM40A and anti-FAM40B rabbit sera in 




























Chapter 3                                                   FAM40 proteins – biochemistry and bioinformatics 
120 
   
 
 
Figure 3.15 Testing anti-FAM40A and FAM40B serum on overexpressed protein for 
immunofluorescence staining 
PC3 cells on glass coverslips were transfected with pHA-FAM40A or pHA-FAM40B. Cells 
were fixed 24 h later and stained for F-actin, the HA epitope and for FAM40A and FAM40B 
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While the generated anti-FAM40A and anti-FAM40B antisera were capable of recognising 
overexpressed protein, they were unable to detect endogenous protein in western blots. 
Hence, anti-FAM40A and anti-FAM40B antibodies were purified from total rabbit serum 
using peptide affinity chromatography. A schematic of the method used is shown in Figure 
3.16. 
 
Figure 3.16 Schematic of protocol used to purify anti-FAM40A and anti-FAM40B 
antibodies from whole rabbit serum 
Rabbit antiserum was subjected to affinity chromatography using FAM40A and FAM40B 
immunisation peptides as the ‘bait’ to purify anti-FAM40A and anti-FAM40B antibodies. A 
batch binding technique was used and peptides used for purification were coupled to the 
chromatography resin by means of a terminal cysteine residue. Eluted antibody was 
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Coomassie staining of the purified antibodies (Figure 3.17A) allowed the determination of 
their purity and concentration. The concentration of purified anti-FAM40A was approximately 
100 µg/ml while that of purified anti-FAM40B was 40 µg/ml. Both antibodies were able to 
react specifically with their intended targets as determined by immunoblotting for 
overexpressed HA-FAM40A and HA-FAM40B (Figure 3.17B). However, the purified 
antibodies were unable to specifically detect endogenous protein. This was determined by 
using lysates from HUVECs (Figure 3.17C). Samples in which either FAM40A or FAM40B 
were depleted by RNAi were included to determine the specificity of the antibodies to their 
targets. A specific interaction would have resulted in a reproducible decrease in the intensity 
of the corresponding band in the RNAi lanes. Such a decrease is observed with the oligo 
siFAM40B-1 in the blot shown in Figure 3.17C but could not be reproduced. The efficiency of 
knockdown was not confirmed at the mRNA level in these experiments. 
In summary, purified anti-FAM40A and anti-FAM40B antibodies were not able to target 
endogenous protein. However, the generated antiserum contained anti-FAM40A and anti-
FAM40B antibodies at an acceptable ELISA (enzyme-linked immunosorbent assay) titre (≥ 
1:10,000) which were able to specifically target their intended antigens. A better purification 
strategy resulting in a more concentrated antibody preparation may yield antibodies that are 
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Figure 3.17 Purification and testing of anti-FAM40A and anti-FAM40B antibodies 
(A) shows coomassie-stained gels containing purified anti-FAM40A and anti-FAM40B 
antibodies compared to a BSA protein standard. These gels were used to confirm the purity 
of the obtained antibody and to determine their concentration. (B) COS7 cells were 
transfected with pHA-FAM40A or pHA-FAM40B. Cells were lysed 48 h later and HA-
FAM40A and HA-FAM40B immunoprecipitated using anti-HA agarose beads were used to 
test purified anti-FAM40A and anti-FAM40B in western blots. (C) Lysates from HUVECs 
depleted of FAM40A or FAM40B using three individual siRNAs for each protein were used to 
determine the specificity of the purified antibodies by immunoblotting. Blotting for GAPDH or 
tubulin was used as a loading control. Example immunoblots are shown in (C).  
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3.3 Discussion  
Results presented in this chapter highlight FAM40 interacting partners and provide 
information on their fundamental biochemical features. These data provide a significant 
indication of how the FAM40 proteins may function in cells. 
3.3.1 FAM40A and FAM40B potentially signal with other members of the STRIPAK 
complex 
A previous biochemical study has shown that both FAM40A and FAM40B are members of 
the STRIPAK complex (Goudreault et al., 2009). This information was used to provide a first 
indication of potential signalling partners and to generate hypotheses on how the FAM40 
proteins may carry out their cellular functions. Results presented in this chapter indicate that 
both FAM40A and FAM40B interact with CCM3 and the GCKIII kinases STK25 and MST4 
(section 3.2.1), all of which are members of the STRIPAK complex. This is in agreement with 
previously published data that documents FAM40A interacting partners (Goudreault et al., 
2009). Furthermore, FAM40A was reported to interact with other members of the STRIPAK 
complex including STRN, STRN3, STRN4, Mob3, CTTNBP2, CTTNBP2NL and the GCKIII 
kinase STK24. The experimental method in this study differs from that used in this thesis in 
that it utilised affinity chromatography using FAM40A as bait, followed by mass spectrometry 
to identify interacting partners. Subsequently, these interactions were validated using 
immunoprecipitation and western blotting. A similar analysis for FAM40B was not performed 
in this study, and it would be interesting to see if FAM40B also interacts with these proteins. 
These data and the results presented in this thesis cannot be used to conclude that these 
interactions occur directly without the aid of adaptor proteins. Future experiments should 
attempt to investigate if these interactions occur directly or indirectly. Alternative methods to 
investigate protein interactions include yeast two-hybrid screening, and GST-pulldown 
analysis using recombinant protein. These methods have the advantage that they test for 
direct protein interactions. Furthermore, interactions have been probed so far using 
overexpressed proteins and future experiments should validate these findings using 
endogenous proteins. If antibodies targeting only one of the interacting partners are 
available, an alternative approach in the immunoprecipitation experiments can be used 
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wherein its interaction with overexpressed, tagged protein is assessed. A drawback with 
using overexpressed protein is that protein interactions observed may not be physiologically 
relevant, due to the expression level of the tagged, overexpressed protein being higher than 
that of endogenous protein. A further disadvantage is that the tag may affect interaction 
between proteins by decreasing the affinity between individual proteins, or by causing 
mislocalisation of protein.  
These interactions raise several questions as to how FAM40A and FAM40B function in cells. 
For example, CCM3-GCKIII kinase signalling is known to be required for maintaining 
junction integrity in endothelial cells and contributes to the development of a mature vascular 
network (Zheng et al., 2010). This line of thought led to FAM40 function being studied in 
endothelial cells and is the basis of the work presented in chapter 5. Do FAM40A and 
FAM40B exist together in the same complex or exist in distinct sub-complexes that carry out 
different functions? Exogenously expressed FAM40A and FAM40B can form homodimers as 
well as interact with each other. This is consistent with previously published data in which 
affinity precipitation/mass spectrometry analysis using FAM40A as a bait resulted in the 
identification of peptides corresponding to FAM40B (Goudreault et al., 2009). This would 
suggest that both FAM40 proteins occur in the same complex. However, future experiments 
will need to show this for endogenous proteins. It would be interesting to determine what 
consequence dimerisation has for FAM40 function. Perhaps dimerisation results in 
autoinhibition which is relieved by binding to other interacting partners. Conversely, 
dimerisation and resultant clustering could enhance FAM40 function. 
While both FAM40A and FAM40B share the same overall domain architecture, the N-
terminus of FAM40 is proline rich, a feature lacking in FAM40B. Features such as this may 
be important for determining binding specificities of interacting partners and may explain 
functional differences between the two FAM40 proteins. For example, affinity 
precipitation/mass spectrometry using STRN4 and various PP2A subunits as ‘baits’ only 
identify FAM40A as ‘prey’ while doing the same with Mob3 identifies both FAM40 proteins as 
prey (Goudreault et al., 2009). It will be important to determine the binding specificities of the 
two individual domains in FAM40 proteins (N1221-like and DUF3402) as these domains 
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have not been characterised. The occurrence of these domains in the same order and 
conservation in FAM40 homologues across different species imply that they perform a role 
in cells.  The roles of these domains can be determined by creating deletion constructs that 
contain the individual domains, or by performing yeast two-hybrid screens using these 
domains as baits. 
Are any of these interactions mutually exclusive? For example, multiple GCKIII kinases bind 
to both FAM40 proteins. It is possible that binding to different kinases offers different 
functionalities to these proteins. Furthermore, what is the stoichiometry of FAM40A and 
FAM40B in the STRIPAK complex? This may help to explain FAM40 protein function by 
understanding them as units of a larger multi-protein entity.  
In summary, the finding that FAM40A and FAM40B interact with various members of the 
STRIPAK complex offers important insights into their possible physiological roles and is the 
impetus for further research into their functions. 
3.3.2 FAM40A and FAM40B are putative transmembrane proteins 
The subcellular localisation of proteins has consequences for their functions and so 
significant attention was given to determining the localisation pattern of FAM40A and 
FAM40B. A combination of biochemical and immunofluorescence analysis in addition to 
predictions using bioinformatics programs was used. Previous reports suggest that FAM40 
homologues in S. cerevisae and N. crassa are transmembrane proteins (Kemp and 
Sprague, 2003; Xiang et al., 2002). Hence, bioinformatics software was used to test if the 
human FAM40 proteins are predicted to be transmembrane. A major concern in using 
bioinformatics is that of false positives. For example, predicted transmembrane regions may 
actually be amphipathic helices (Nugent and Jones, 2009). However, this strategy was not 
used to produce conclusive data on FAM40 localisation but to provide a first indication to 
complement further analysis.  
Transmembrane proteins are commonly targeted to membranes by the presence of a signal 
peptide sequence (von Heijne and Gavel, 1988). No signal peptides were detected for either 
FAM40A or FAM40B by using sequence based prediction programs (SignalP and MEMSAT-
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SVM). Transmembrane proteins with a signal peptide enter the classical secretory pathway 
and their translocation occurs via the ER-Golgi network ending with secretory vesicle fusion 
to the membrane (Bendtsen et al., 2004). However, some secreted proteins can bypass this 
pathway and enter a non-classical secretory pathway. An example of such a mechanism is 
where insertion of the protein into the plasma membrane can be mediated solely by 
transmembrane helices (Renthal, 2010). Hence, the absence of a signal peptide may not 
preclude the possibility of the FAM40 proteins being transmembrane. FAM40A was 
predicted to enter this pathway using the program SecretomeP. Immunofluorescence 
staining of overexpressed FAM40A and FAM40B in PC3 cells showed a diffused staining 
pattern in the cytoplasm with enrichment in F-actin-rich protrusions. This staining pattern is 
consistent with proteins that undergo non-classical secretion as a vesicular and/or reticular 
staining pattern was not observed. Furthermore, enriched localisation in protrusions could 
imply that the FAM40 proteins are at least proximal to the plasma membrane if not 
transmembrane. Staining in unpermeabilised cells showed that FAM40 proteins localised at 
F-actin-rich protrusions, suggesting they could be inserted into the membrane with their N-
terminus exposed to the cell exterior. However, the fixation step can produce small holes in 
the membrane that allow antibody entry and subsequent staining of internal protein. These 
holes are sufficient to allow phalloidin entry for F-actin staining. Strong foci of FAM40 
staining with negligible staining elsewhere in the cells suggests that such non-specific 
staining was minimal (compared to the F-actin staining). It will be important for future 
experiments to show that staining in unpermeabilised cells does not stain internal protein, by 
using a cytoplasmic protein as a negative control. Furthermore, it will be important to 
determine if the enriched staining observed in F-actin-rich protrusions is an artefact of the 
staining procedure and/or cell structure. This can be achieved by using a cytoplasmic protein 
that is known to localise to F-actin-rich protrusions as a negative control. An example is 
WAVE1 which is known to localise to the edge of cell protrusions (Cory and Ridley, 2002). 
Additionally, an improved protocol where live cells are stained without fixation can be used. 
In addition to these analyses, COS7 cells overexpressing FAM40A or FAM40B were used in 
surface biotinylation assays and FACS staining to detect surface protein. Positive results 
were obtained in the biochemical analysis while the FACS data yielded variable results. For 
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the FACS experiment, cells had to be detached which could have caused internalisation of 
the protein of interest. A concern with the biotinylation assay is that the experimental 
manipulation of cells could have compromised their permeability and/or caused lysis of a 
subset of cells leading to non-specific labelling. A subset of experiments did yield a positive 
result even with the negative control. This was attributed to non-specific labelling and the 
experiment was not analysed further. A further concern is that the negative control (HA-14-3-
3) being a lower molecular weight protein than HA-FAM40A and HA-FAM40B, is less 
susceptible to biotinylation. A key assumption made in these experiments was that COS7 
cells (derived from monkey cells) contain the necessary cellular machinery to target human 
FAM40A and FAM40B to the plasma membrane.  
While it is tempting to hypothesize the FAM40 proteins as being the transmembrane 
receptors targeting the STRIPAK signalling complex to the membrane, further experiments 
need to be done to yield a conclusive result. As a first step cell fractionation experiments can 
be performed to determine if the FAM40 proteins are present in the membrane fraction. 
Additionally, the surface biotinylation assay performed can be coupled to mass spectrometry 
analysis to determine sites of biotin coupling, which can then be concluded to be present at 
the cell exterior yielding information on protein topology. Other more established techniques 
can be used to confirm the presence of transmembrane segments. An example is Cys-
labelling in which chemical modification of cysteine residues introduced in different regions 
of the protein using membrane permeable and impermeable reagents is used to deduce 
topology (Kimura et al., 1997). Another approach to prove that the FAM40 proteins are 
transmembrane could be to identify extracellular ligands if present.  
3.3.3 The FAM40 proteins are post-translationally modified 
Both FAM40A and FAM40B are phosphoproteins which suggests that their functions may be 
regulated by phosphorylation. For example, FAM40 binding to other STRIPAK complex 
members could be affected by phosphorylation. PP2A and the GCKIII family kinases are 
members of the STRIPAK complex (Goudreault et al., 2009), and hence the FAM40 proteins 
could be their substrates. In vitro kinase assays revealed that MST4 is able to phosphorylate 
FAM40A, FAM40B and CCM3. While MST4 shares homology with STK24 and STK25 (other 
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GCKIII family members) these enzymes can function in distinct ways. For example, CCM3 
can be phosphorylated by STK25 but not STK24 (Voss et al., 2007). Hence, it will be 
important to determine if the other GCKIII kinases can phosphorylate the FAM40 proteins 
too. The GCKIII kinases have been suggested to be downstream of CCM3 (Zheng et al., 
2010) and CCM3 is needed for their stabilisation in cells by preventing their degradation 
(Fidalgo et al., 2010). Furthermore, CCM3 can increase MST4 kinase activity in vitro (Ma et 
al., 2007). The fact that MST4 can phosphorylate CCM3 indicates there might be a feedback 
loop. It will be interesting to see if in a similar fashion, the FAM40 proteins can modulate 
GCKIII kinase activity. This connectivity between different partners by means of 
phosphorylation may imply shared signalling networks and so is important when considering 
FAM40 function. While MST4 has been shown to phosphorylate the FAM40 proteins in vitro, 
it will be important to demonstrate this activity in vivo. This could be achieved by depleting 
MST4 using siRNA and assessing FAM40 phosphorylation, or by conducting kinase assays 
using co-expressed MST4 instead of recombinant enzyme. Finally, the functional 
consequences of MST4 phosphorylation will need to be studied.  
Mass spectrometry analysis was not performed to identify FAM40 phospho-sites and could 
be considered for future work. However, previously published proteomics data allow the 
deduction of phospho-sites by detection of FAM40 phospho-peptides (compiled in 
PhosphoSitePlus (Hornbeck et al., 2012)). To understand how these sites contribute to 
FAM40 function, phospho-mimetic and phospho-dead mutants can be used. For example, 
the capacity of these mutants to interact with other STRIPAK complex family members or 
effects of their overexpression in cells can be tested. The context of the experiments in 
which these phospho-sites have been reported may offer clues as to how they are important 
for FAM40 function. A significant number of experiments involved the analysis of the 
proteome in cancers of different origin (PhosphoSItePlus (Hornbeck et al., 2012)). This may 
be indicative of FAM40 phosphorylation being involved in or at least a feature of cancer 
progression. Phosphorylation of the S335 site on FAM40A was detected in studies analysing 
the mTOR regulated phosphoproteome and phosphorylation dynamics during the DNA 
damage response (PhosphoSitePlus (Hornbeck et al., 2012)). Interestingly, the S. cerevisae 
FAM40 homologue, Far11 has been shown to be involved in the regulation of the DNA 
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damage response (Lisa-Santamaria et al., 2012) while the Far complex is implicated in 
TORC2 signalling (Pracheil et al., 2012). These features point towards the possibility of the 
FAM40 proteins having functions in the mTOR signalling network. 
The FAM40 proteins are also ubiquitinated and this modification may be important for 
determining FAM40 stability. However, ubiquitination is involved in cellular pathways other 
than those that mediate protein degradation, including the regulation of protein interactions 
and signal transduction (Schaefer et al., 2012). Experiments in which cells were treated with 
MG132 (a proteasome inhibitor) and protein levels subsequently analysed were performed 
to assess if FAM40A and/or FAM40B are degraded via the proteasome. However, results 
were variable and hence have not been shown. Future experiments should attempt to 
identify the functional implications of FAM40 ubiquitination. 
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4 FAM40 function in prostate cancer cells 
4.1 Introduction 
FAM40A and FAM40B were identified as novel regulators of cell morphology and migration 
in an RNAi screen conducted using PC3 cells (Bai et al., 2011).  Both FAM40A and FAM40B 
knockdown were reported to result in morphological changes. FAM40A knockdown resulted 
in less spread cells while FAM40B knockdown resulted in elongated cells. The control of cell 
morphology involves dynamic changes to the cytoskeleton (Ridley et al., 2003), and hence 
the FAM40 proteins could regulate the cytoskeleton. Furthermore, the GCKIII kinase MST4, 
which interacts with and phosphorylates the FAM40 proteins (section 3.2.7), has been 
implicated in prostate cancer progression. MST4 has been shown to promote the 
proliferation of prostate cancer cells (Sung et al., 2003). Additionally, FAM40A expression is 
increased in primary prostate cancer samples (defined as being clinically localised), as 
compared to its expression in benign prostate samples (NCBI GEO database, Profile: 
GDS1439 / 225226_at / FAM40A). This could implicate FAM40A in prostate cancer 
progression by facilitating the conversion of benign prostate cells to cancerous lesions. 
Gene function in PC3 cells was primarily studied by depletion of gene expression by RNAi 
and the subsequent analysis of phenotypes in cell biological assays. As the Rho GTPases 
are central regulators of the cytoskeleton, biochemical assays to detect changes in their 
activity were also performed.   
PC3 cells are androgen insensitive and were established from prostate cancer metastasis to 
the bone (Logothetis and Lin, 2005). Their morphology can be described to be mesenchymal 
and they have been shown to have a high invasive and metastatic potential (Aalinkeel et al., 
2004). This feature combined with their androgen insensitivity make them a good system for 
the study of prostate cancer in its advanced stages. Cancer progression is a heterogeneous 
process and is dependent on the cellular origin of particular tumours (Nguyen et al., 2009). 
Hence, results presented in this chapter can only confidently be extrapolated to FAM40 
function in prostate cancer cell lines. However, they may be suggestive of wider roles in 
other cancer cells and more importantly, of fundamental protein function in regulating 
aspects of cell migration and morphology. 
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4.2 Results 
4.2.1 Verification of siRNA-mediated knockdown of FAM40A and FAM40B in PC3 
cells 
The functions of FAM40A and FAM40B in PC3 cells were studied using siRNA to 
knockdown their expression. Individual siRNA oligonucleotides and pools containing a mix of 
four individual siRNA oligonucleotides were tested for each gene. A control non-targeting 
siRNA control was used too. Efficient reduction of gene expression was observed after 72 h 
siRNA transfection for both FAM40A and FAM40B. As antibodies capable of detecting 
endogenous FAM40A and FAM40B were not available, expression was determined using Q-
PCR to quantify relative mRNA levels in control and siRNA-treated samples. 
 
Figure 4.1 siRNA-mediated depletion of FAM40A and FAM40B by quantitative PCR 
PC3 cells were transfected with individual and pooled siRNAs for FAM40A or FAM40B. After 
72 h, mRNA from these cells was extracted and used to synthesize cDNA. The amount of 
(A) FAM40A and (B) FAM40B cDNA was determined by quantitative PCR. Values were 
normalised to GAPDH cDNA levels. Data are the mean of 3 independent experiments ± 
SEM. * p < 0.05, ** p < 0.01 compared to siControl determined by Student’s t-test. 
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4.2.2 Knockdown of FAM40A and FAM40B results in distinct morphological 
phenotypes in PC3 cells 
PC3 cells grew as single cells and did not appear to form stable cell-cell contacts (Figure 
4.2). Control cells showed variable morphology with a subset of cells being naturally more 
elongated. Their morphology can be described to be mesenchymal and multiple F-actin-rich 
protrusions and enrichment of F-actin staining at the cell edge were observed. Stress fibres 
were rarely observed. 
Knockdown of FAM40A with two individual siRNAs and a siRNA pool reduced cell spread 
area (Figure 4.2). Targeting FAM40A with the siRNA pool also resulted in a ring of intensely 
staining cortical F-actin in a subset of cells. This phenotype was not distinguished when 
using individual siRNAs and may be due to off-target effects. Quantification of cell 
morphology using Cell Profiler software showed a significant reduction of cell area (Figure 
4.3). Knockdown of FAM40B resulted in a reduction in cell area only with one siRNA oligo 
(siFAM40B-1).  
Knockdown of FAM40B with two individual siRNAs and a siRNA pool led to a different 
phenotype to FAM40A. Cells depleted of FAM40B were elongated and the nucleus was 
observed to be placed centrally in the elongated cell (Figure 4.2). Quantification of cell 
morphology using Cell Profiler software showed an increase in cell eccentricity (a measure 
of elongation) (Figure 4.3), consistent with the observed phenotype. Knockdown of FAM40A 
with only one oligo (siFAM40A-1) led to a significant reduction in eccentricity, suggesting 
these cells were more circular in shape compared to control cells. DAPI staining did not 
show an increased incidence of multi-nucleate cells or other alterations to nuclear structure 
in either FAM40A or FAM40B knockdown. These results indicate that FAM40A and FAM40B 
regulate cell morphology and may have distinct cellular functions. 
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Figure 4.2 Effect of FAM40A and FAM40B depletion on PC3 cell morphology 
PC3 cells were transfected with siRNAs for FAM40A or FAM40B. After 24 h cells were 
harvested and seeded onto glass coverslips coated with Matrigel. After another 48 h, cells 
were fixed and stained for F-actin and with DAPI. Confocal images were acquired to analyse 
the effects of FAM40 knockdown on cell morphology and F-actin. Scale bars = 50 µm. 
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Figure 4.3 Quantification of the morphology of FAM40-depleted PC3 cells  
(A) The Cell Profiler software was used to detect individual cells automatically and compute 
their morphological parameters. DAPI staining was used to identify positions and numbers of 
individual cells in the images. This positional cue along with the F-actin staining was used to 
detect cell boundaries. Graphs in (B) show computed morphological parameters of the 
identified cells. The eccentricity has a value between 0 and 1 with a circle having an 
eccentricity of 0 and a line segment having an eccentricity of 1. n > 50 cells per condition 
from 3 independent experiments. Boxes of box and whisker plots show median, 25th and 75th 
percentile. Whiskers show minimum to maximum values. * p < 0.05, *** p < 0.001 compared 
to siControl determined by Student’s t-test. 
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4.2.3 The FAM40 proteins affect PC3 cell adhesion and spreading 
To test if the FAM40 proteins affect cell adhesion to the substrate, adhesion assays were 
carried out on uncoated plastic, and Matrigel-coated plastic (Figure 4.4A and B). Matrigel is 
a basement membrane preparation containing numerous proteins that are constituents of 
the ECM including collagen IV and laminin (BD Biosciences).  
Depletion of FAM40B with a siRNA pool resulted in reduced cell adhesion to both uncoated 
plastic and Matrigel-coated plastic at 15 min (Figure 4.4A and B). The effect of FAM40A 
knockdown using a siRNA pool on cell adhesion to uncoated plastic was variable and no 
significant effect was observed (Figure 4.4A). However, FAM40A depletion resulted in a 
significant reduction in adhesion to Matrigel-coated plastic (Figure 4.4B). In addition to 
assays testing for changes in cell adhesion, spreading assays were performed (Figure 4.4C 
and D). Adhesion and spreading are linked (Price et al., 1998) and possibly reinforce each 
other. Cells need to adhere to the substrate in order to spread, and reciprocally spreading 
facilitates cell adhesion. PC3 cells were depleted of FAM40A or FAM40B using siRNA pools 
and allowed to spread onto Matrigel-coated plastic. The cell spread area was determined 
after 30 min. Depletion of FAM40A did not change cell spreading despite having caused a 
reduction of cell area in fully spread cells (Figure 4.2). In contrast, FAM40B depletion 
reduced cell spreading at 30 min, and it is interesting to note that its depletion led to fully 
spread cells being elongated (Figure 4.3). These experiments were performed only using 
siRNA pools and it will be important to additionally test individual siRNAs to validate these 
results. 
In summary, the FAM40 proteins regulate cell adhesion and spreading. 
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Figure 4.4 Depletion of the FAM40 proteins affects cell adhesion and depletion of 
FAM40B reduces cell spreading 
PC3 cells were transfected with siRNA pools targeting FAM40A or FAM40B. (A) and (B) 
show results from adhesion assays. 48 h after transfection cells were labelled with Cell 
Tracker CMFDA and added onto uncoated plastic (A) or onto Matrigel-coated plastic (B). 
After 15 min adhesion cells were washed to remove unadhered cells and a fluorescence 
reading was taken as a readout of adhesion capacity. Results in (A) are the mean of 4 
independent experiments while (B) shows the mean 3 independent experiments. (C) 72 h 
after transfection cells were seeded onto Matrigel-coated plastic and allowed to spread for 
30 min. Cells were then fixed, stained with Phalloidin-Alexa546 and imaged to determine the 
extent of spreading by measuring cell area. Scale bar = 50 µm. Atleast 50 cells were 
considered per condition in each experiment. Results presented in (D) are the mean of 3 
independent experiments and normalised to siControl (siControl = 100). Error bars indicate 
SEM values. * p < 0.05 compared to siControl determined by Student’s t-test.  
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4.2.4 Effects of FAM40 knockdown on PC3 cell migration 
The changes in cell morphology upon FAM40A and FAM40B depletion suggest changes in 
the regulation of the cytoskeleton and/or associated proteins. These functions may be 
necessary for cell migration too as there is significant overlap in signalling networks that 
affect cell morphology and migration. Interestingly, members of the STRIPAK complex, of 
which the FAM40 proteins are also a part of, have been suggested to regulate cell migration 
by controlling Golgi orientation and organisation (Fidalgo et al., 2010; Kean et al., 2011).  
The effects of the FAM40 proteins on PC3 cell migration were tested using two independent 
methods, the ORIS assay (Figure 4.5), and time-lapse imaging of randomly migrating cells 
(Figure 4.6). In the ORIS assay PC3 cells were transfected with siRNA pools targeting 
FAM40A or FAM40B, and were analysed for their capacity to migrate into a central annular 
migration zone (described in section 2.3.7.2). Depletion of FAM40A did not affect cell 
migration in this assay. However, FAM40B knockdown impaired cell migration (Figure 4.5), 
once again suggesting that the two proteins have distinct functions. Individual siRNAs will 
have to be tested in future experiments to validate these results.  
To understand in more detail how FAM40B knockdown leads to this phenotype, time-lapse 
movies of PC3 cells depleted of the FAM40 proteins were generated (supplementary 
movies, movies 1 to 5). Results obtained in this assay matched closely those obtained in the 
ORIS assay. While FAM40A depletion caused cells to be smaller in size, no observable 
changes to cell migration were noticed. However, FAM40B knockdown caused a significant 
reduction in the speed of migrating cells (Figure 4.6). Movies showed that cells appeared 
elongated and largely oscillated along their axis, resulting in impaired migration capacity. 
From these observations it can be concluded that FAM40B is required for the efficient 
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Figure 4.5 FAM40B depletion reduces PC3 cell migration in the ORIS assay 
PC3 cells were transfected with siRNA pools targeting FAM40A or FAM40B. After 24 h cells 
were harvested and seeded onto Matrigel-coated ORIS plates with seeding stoppers. 24 h 
after cell seeding the stoppers were removed, and the capacity of the cells to migrate was 
quantified by measuring the percentage area of the central, annular ‘detection’ zone that 
cells had migrated into after 24 h (% area of migration). (A) shows representative images 
taken of the ORIS plate at t=0 h and after 24 h migration. Data in (B) are the mean of 4 
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Figure 4.6 Depletion of FAM40B reduces the speed of randomly migrating PC3 cells 
PC3 cells were transfected with individual siRNA targeting FAM40A or FAM40B. After 24 h 
cells were harvested and seeded onto Matrigel-coated plastic. After a further 24 h, time-
lapse movies were initiated at 1 frame per 10 min for 14 h (supplementary movies, movies 1 
to 5). Data in (A) shows speeds of randomly migrating cells determined using ImageJ 
software. n > 60 cells per condition from 3 independent experiments. Boxes of box and 
whisker plots show median, 25th and 75th percentile. Whiskers show minimum to maximum 
values. *** p < 0.001 compared to siControl determined by Student’s t-test. (B) shows 
frames taken at the indicated time points to illustrate the motility of FAM40B-depleted cells. 
Scale bar = 100 µm. 
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4.2.5 Activity levels of the Rho GTPases RhoA and Rac1 upon FAM40 depletion  
The Rho GTPases contribute to cell signalling pathways that regulate the cytoskeleton, cell 
morphology and migration (Ridley et al., 2003). In order to explain the effects of FAM40 
depletion on PC3 cell morphology, migration and adhesion/spreading, Rho GTPase activity 
assays were carried out. The activity of RhoA, Rac1 and Cdc42 on FAM40A and FAM40B 
knockdown in PC3 cells was determined using a biochemical pulldown approach. In this 
technique, effectors of the Rho proteins are used to specifically isolate and quantify the 
active GTP-bound form from whole cell lysates (Ren et al., 1999; Sander et al., 1999; 
Sander et al., 1998). 
Results from the GST-RBD pulldown assay used to quantify RhoA activity were variable and 
a significant change in RhoA activity was not observed upon either FAM40A or FAM40B 
knockdown (Figure 4.7B). Only two experiments were carried out to determine RhoA activity 
on FAM40B knockdown. Further experiments including individual siRNAs need to be 
conducted before a conclusion can be made on RhoA activity. Knockdown of FAM40B 
expression with two individual siRNAs resulted in a reduction of Rac1 activity (Figure 4.7C 
and D) as determined by a GST-PBD pulldown assay. No change in Cdc42 activity was 
observed upon depletion of FAM40A or FAM40B (assessed using GST-PBD pulldown, 
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Figure 4.7 Effects of FAM40 knockdown on RhoA and Rac1 activity 
PC3 cells were transfected with siRNA targeting FAM40A or FAM40B as indicated. After 72 
h cells were lysed and whole cell lysates used in a GST-RBD or GST-PBD pulldown assay 
to determine levels of GTP-loaded RhoA or Rac1 respectively. (A) shows a representative 
immunoblot for total and GTP-loaded RhoA while (C) shows the same for total and GTP-
loaded Rac1. Quantification of RhoA and Rac1 activity was performed by normalising the 
signal from the ‘RhoA/Rac1 GTP’ lane with that of the ‘Total RhoA/Rac1’ lane. The graphs 
represent this normalised signal relative to siControl (siControl = 100) Quantified active 
RhoA is shown in (B). Data shown are the mean of 3 independent experiments for 
siFAM40A and 2 experiments for siFAM40B. Error bars indicate SD values. Rac1 activity 
quantification is shown in (D). Data shown are the mean of 4 independent experiments ± 
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4.2.6 Overexpression of FAM40A and FAM40B in PC3 cells 
To complement the functional analysis done by siRNA-mediated knockdown of FAM40A and 
FAM40B, effects of their overexpression were analysed. PC3 cells were transfected with 
plasmids coding for HA-FAM40A or HA-FAM40B. After 24 h, cells were fixed and stained for 
the HA epitope. Endogenous FAM40A and FAM40B could not be visualised due to the 
unavailability of suitable antibodies. Both FAM40A and FAM40B showed diffuse localisation 
in the cytoplasm and were enriched in F-actin-rich protrusions at the cell edge (Figure 4.8). 
Neither FAM40A nor FAM40B led to any observable changes to F-actin organisation. 
Furthermore, no obvious effects on cell morphology were observed. Despite no obvious 
morphological phenotype being observed, these results provided information on FAM40 
localisation within cells (section 3.2.4). 
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Figure 4.8 Staining for overexpressed FAM40A and FAM40B in PC3 cells 
PC3 cells on Matrigel-coated glass coverslips were transfected with pHA-FAM40A or pHA-
FAM40B and fixed after 24 h. Cells were stained for F-actin and the HA epitope. Asterisks 
indicate areas where the HA staining is localised to F-actin-rich protrusions. Scale bar = 20 
µm. Images are representative of 3 independent experiments. 
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4.3 Discussion 
This chapter investigated the roles of human FAM40A and FAM40B in PC3 cells, a human 
prostate cancer cell line. Previously published data used depletion of FAM40A and FAM40B 
with siRNA pools to suggest that the FAM40 proteins are novel regulators of PC3 migration 
and morphology (Bai et al., 2011). Here, these results were extended and included analysis 
using individual siRNAs. Results presented in this chapter show that the FAM40 proteins 
regulate PC3 cell morphology, migration and adhesion to the substrate. In the light of the 
biochemical data presented in the previous chapter, mechanisms by which the FAM40 
proteins may mediate their functions are proposed. In addition, these results allow the 
comparison of protein function in two major cell types, epithelial cells and endothelial cells 
(data presented in chapter 5). 
4.3.1 The FAM40 proteins are regulators of PC3 function 
FAM40A and FAM40B protein function was studied primarily by using an RNAi approach in 
PC3 cells. Both individual siRNAs and pools of siRNA were used. Not all experiments were 
done with the same sets of siRNA, and in some experiments only siRNA pools or individual 
siRNA were used. In spite of this, these results can be compared as gene expression 
knockdown was confirmed for all sets of siRNA used. Furthermore, as an indication of 
different siRNA sets behaving similarly, knockdown of FAM40 function using both a siRNA 
pool and individual siRNAs resulted in the same morphological phenotype. Future 
experiments should aim to reproduce these results using individual siRNAs.  
Depletion of FAM40A and FAM40B results in distinct morphological phenotypes. FAM40A 
knockdown using both siRNA pools and individual siRNA caused cells to become less 
spread with a reduction in cell area, whereas FAM40B knockdown caused cells to become 
elongated. The different phenotypes suggest functional specialisation. This may be 
explained by each protein having different signalling partners. For example, only FAM40A is 
capable of interacting with STRN4 (Goudreault et al., 2009). It was hypothesised that an 
increase in contractility due to upregulation of RhoA activity could explain the FAM40A 
depletion phenotype. Additionally, depletion of RhoA in PC3 cells resulted in an elongated 
phenotype that resembles the FAM40B depletion phenotype (Vega et al., 2011).  In a subset 
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of experiments depletion of FAM40A resulted in an increase in RhoA activity. However, the 
extent of this effect was variable and no significant difference was obtained. It is likely that 
more experiments need to be carried out. Nevertheless, it suggests that RhoA activity may 
be regulated by FAM40A. It might be that RhoA activity is only spatially regulated and hence 
no strong differences were observed in experiments that analysed activity in whole cell 
lysates. Imaging using FRET (fluorescence resonance energy transfer) probes may be used 
to determine spatial regulation of RhoA activity (Nakamura et al., 2006). While only two 
experiments were performed, no changes in RhoA activity upon FAM40B depletion were 
observed. The activity of other Rho subfamily members needs to be assessed. For example, 
depletion of RhoB in PC3 cells results in less spread cells which is similar to the FAM40A 
phenotype (Vega et al., 2012). Interestingly, similar phenotypes were observed upon FAM40 
depletion in MDA-MB-231 cells (epithelial breast cancer cell line) indicating that at least in 
cancer cells derived from the epithelia, the FAM40 proteins have conserved functions 
(results not shown). Overexpression of either HA-FAM40A or HA-FAM40B in PC3 cells did 
not result in any morphological changes. However, overexpression of GFP-FAM40A has 
been shown to reduce PC3 cell area (Bai et al., 2011). This difference may be due to 
different tags being utilised. For example, GFP-FAM40A may function as a dominant-
negative form, and so lead to a phenotype that resembles the FAM40A depletion phenotype. 
FAM40B is required for PC3 cell migration and depletion of FAM40B reduced migration in 
the ORIS assay and in randomly migrating cells. Time-lapse movies revealed that the cells 
were elongated, and migration largely occurred along the cell axis. No significant changes to 
directionality were observed (data not shown), but there was a reduction in mean speed. 
Depletion of FAM40B resulted in a reduction of Rac1 activity. Rac1 activity is important at 
the leading edge of cells in regulating actin polymerisation and adhesions (Ridley, 2011). It 
is possible that the migration defect observed upon FAM40B depletion is due to reduced 
Rac1 activity. However, the morphology of PC3 cells depleted of Rac1 does not resemble 
that of FAM40B-depleted cells (Vega et al., 2011). Future experiments should attempt to 
assess the activity of the other Rac subfamily members, Rac2 and Rac3. 
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CCM3-GCKIII kinase (STK25, MST4) signalling has been shown to be important for the 
regulation of Golgi positioning and cell polarisation (Fidalgo et al., 2010; Kean et al., 2011) 
which is needed for effective cell migration (Mellor, 2004). Additionally, depletion of STK24 
(Lu et al., 2006) and STK25 (Chen and Cho, 2011) using RNAi has been shown to enhance 
the migration of MCF7 breast cancer cells while MST4 overexpression reduces invasion of 
HEK293T cells into collagen I (Preisinger et al., 2004). In general, GCKIII kinase activity 
appears to antagonize cell migration and/or invasion. These data suggest that FAM40B 
signalling could regulate cell migration via CCM3 and/or the GCKIII kinases. For example, 
FAM40B-depleted cells were elongated and largely exhibited migration along a single axis. 
Their inability to change their direction of migration could be a result of defects in Golgi 
positioning. Future experiments should attempt to assess effects of FAM40 depletion on 
Golgi positioning and localisation. 
Depletion of FAM40B resulted in an adhesion defect on both uncoated plastic and Matrigel-
coated plastic. FAM40A depletion only caused an adhesion defect on Matrigel. However, 
results for FAM40A depletion on uncoated plastic were variable and more experiments need 
to be conducted to determine significance of differences. Moreover, these experiments were 
performed 48 h after siRNA transfection while mRNA knockdown was only verified after 72 
h. Future experiments should verify mRNA depletion at 48 h or these adhesion assays 
should be reproduced 72 h after transfection. Depletion of FAM40B (72 h after siRNA 
transfection) additionally resulted in a cell spreading defect on Matrigel-coated plastic, which 
could cause or be due to the adhesion defect. Further experiments need to be done to tease 
out how these processes affect each other. Does spreading contribute to adhesion or vice 
versa, or do both processes reinforce each other?  
The reduction in Rac1 activity observed in FAM40B-depleted cells could explain the 
spreading phenotype as Rac1 has been shown to mediate cell spreading by extension of a 
broad lamellipodium around the cell edge (Ridley et al., 1992). Interestingly, several 
members of the STRIPAK complex have been shown to be linked to focal adhesion proteins. 
Depletion of STK24 leads to a decrease in paxillin phosphorylation at Y118 (Lu et al., 2006) 
while STK25 depletion leads to an increase in phosphorylation of FAK at Y861 (Chen and 
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Cho, 2011). Paxillin phosphorylation at Y118 has been linked to integrin activation 
(Nakamura et al., 2000). Cell adhesion and integrin clustering leads to FAK 
autophosphorylation and subsequent recruitment of Src kinase which in turn phosphorylates 
FAK Y861 (Calalb et al., 1996). Additionally, CCM3 can interact with paxillin (Li et al., 2010). 
These data raise further possibilities as to how the FAM40 proteins may mediate cell 
adhesion and/or spreading. These roles in mediating cell adhesion could also be behind 
FAM40 effects on cell migration as the dynamic turnover of cell-substrate adhesions is 
needed during cell migration (Ridley et al., 2003). Both FAM40A and FAM40B were present 
in F-actin-rich protrusions where multiple adhesion proteins are localised. Vinculin (results 
not shown), paxillin (Vega et al., 2012) and β1-integrin (Reymond et al., 2012) are present at 
these protrusions in PC3 cells. Hence, they are ideally placed to regulate aspects of 
protrusion and/or adhesion at the leading edge that could affect cell migration. It would be 
interesting to determine if FAM40A and/or FAM40B can themselves act as adhesion 
molecules as results presented in chapter 3 (section 3.2.3) suggest that they could be 
transmembrane proteins.  
In summary, these results suggest that the FAM40 proteins could play a role in cancer 
progression by regulating cell adhesion and migration. Furthermore, the FAM40 proteins 
may act via members of the STRIPAK complex in mediating their functions in PC3 cells. 
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5 FAM40 function in endothelial cells 
5.1 Introduction 
Along with FAM40A and FAM40B, CCM3 and all members of the GCKIII kinase family are 
components of the STRIPAK complex (Goudreault et al., 2009). In addition, data presented 
in this thesis demonstrate that both FAM40 proteins can interact with CCM3, STK25 and 
MST4 (section 3.2.1), and are substrates for the MST4 enzyme (section 3.2.8). FAM40A has 
also been shown to bind to STK24 (Goudreault et al., 2009). This connectivity as a result of 
protein interactions and phosphorylation suggests a link between the functions of 
CCM3/GCKIII kinases and the FAM40 proteins. The CCM3-GCKIII signalling axis has been 
shown to be important for the maintenance of endothelial junction integrity by reducing RhoA 
activity and the associated increase in stress fibres (Zheng et al., 2010). CCM3-GCKIII 
signalling is also important for the development of the vascular network as determined by 
studies in zebrafish (Yoruk et al., 2012; Zheng et al., 2010). CCM3 is one of the genes 
implicated in CCM pathogenesis and these studies offer insight into how altered CCM3 
signalling leads to disease.  
As proteins associated with CCM3 and the GCKIII kinases, FAM40A and FAM40B could 
have functions in the regulation of endothelial physiology. This chapter tests this hypothesis. 
HUVECs were used as a model system and an RNAi approach was primarily used to study 
gene function. Their effects on F-actin organisation, endothelial permeability and 
angiogenesis were assessed. All cases of CCM cannot be explained by the presence of 
mutations in one of the three identified CCM genes (CCM1, CCM2 and CCM3). In addition, 
variations are seen in different familial forms of CCM, suggesting that there might be 
additional genes that contribute to the CCM disease process (Riant et al., 2010). Hence, 
results presented in this chapter may also have relevance for the understanding of the 
genetic basis of CCM. 
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5.2 Results 
5.2.1 Verification of siRNA-mediated knockdown of FAM40A and FAM40B in 
HUVECs 
 The functions of FAM40A and FAM40B were studied in HUVECs using RNAi-mediated 
knockdown of gene function. At least two individual siRNA oligonucleotides were used to 
target each gene. This was done to ensure that phenotypes observed upon gene expression 
knockdown were not solely due to off-target effects. A control non-targeting siRNA was used 
too. Antibodies capable of detecting endogenous FAM40 proteins were not available initially, 
and hence validation of siRNA-mediated knockdown of gene expression was performed by 
quantifying mRNA levels in control and siRNA-treated samples. Efficient reduction of 
FAM40A mRNA levels was observed 72 h after siRNA transfection (Figure 5.1A). Reduction 
of FAM40B mRNA levels could not be detected after siRNA treatment (Figure 5.1B) in 
contrast to experiments in PC3 cells (section 4.2.1). Multiple pairs of Q-PCR primers and 
conditions were attempted. It could be that FAM40B siRNAs act differently in endothelial 
cells compared to PC3 cells. For example, RNA nucleotides can cause translational arrest 
instead of mRNA degradation (Deleavey and Damha, 2012). 
A commercially available antibody (Sigma-Aldrich) that became available subsequently was 
used to verify FAM40B protein depletion after treatment with siRNAs. HUVECs were 
transfected with siRNAs targeting FAM40A and FAM40B, and after 72 h protein from whole 
cell lysates were immunoblotted for FAM40B. A reduction in FAM40B protein levels was 
observed (Figure 5.1C). This result could only be reproduced twice due to the antibody 
failing to detect specific bands in subsequent experiments. Further experiments would have 
to be performed to optimise detection of FAM40B. 
To show that siRNAs could reduce protein levels, knockdown of epitope-tagged proteins 
was tested. COS7 cells were double transfected with siRNAs targeting FAM40A or FAM40B 
and pHA-FAM40A or pHA-FAM40B. Immunoblotting for the HA tag using whole cell lysates 
showed that both FAM40A and FAM40B protein levels were efficiently knocked down 
(Figure 5.1D). Taken together these results suggest that the siRNA oligonucleotides are able 
to specifically target their intended genes.  
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Figure 5.1 siRNA-mediated depletion of FAM40A and FAM40B 
HUVECs were transfected with siRNAs targeting FAM40A or FAM40B. After 72 h, mRNA 
was extracted and used to synthesize cDNA. The amount of (A) FAM40A and (B) FAM40B 
cDNA was determined by quantitative PCR. Data are normalised to GAPDH cDNA levels. 
Data in (A) are the mean of 3 independent experiments ± SEM. Data in (B) are the mean of 
2 independent experiments ± SD. * p < 0.05, ** p < 0.01 compared to siControl determined 
by Student’s t-test. (C) Representative immunoblot of HUVECs at 72 h after transfection with 
indicated siRNAs (n=2). Cell lysates were immunoblotted for FAM40B and GAPDH as a 
loading control. The asterisk indicates signal corresponding to FAM40B protein. (D) COS7 
cells were double transfected with siRNAs targeting FAM40A or FAM40B and pHA-FAM40A 
or pHA-FAM40B. Cell lysates were immunoblotted for the HA epitope, and GAPDH as a 
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5.2.2 The FAM40 proteins do not affect HUVEC migration 
Depletion of FAM40B in PC3 cells results in a migration defect (section 4.2.4). In addition, 
other members of the STRIPAK complex have been suggested to regulate cell migration by 
controlling Golgi orientation and organisation (Fidalgo et al., 2010; Kean et al., 2011). 
Migration of endothelial cells is an essential part of vascular development (Potente et al., 
2011) and hence is relevant when considering the basis of CCM. As the FAM40 proteins 
could be functionally linked to CCM3, their effects on endothelial cell migration were tested. 
Single cell random migration assays like those carried out with PC3 cells are not 
physiologically relevant as endothelial cells do not usually exist individually in the body. 
Hence, the ORIS assay (described in section 2.3.7.2) was used as it provides a better 
representation of endothelial physiology during processes such as wound healing. HUVECs 
were transfected with siRNAs targeting FAM40A or FAM40B and assessed for their capacity 
to migrate into a central annular migration zone in the ORIS plate. FAM40A or FAM40B 
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Figure 5.2 Depletion of the FAM40 proteins does not affect HUVEC migration in the 
ORIS assay 
HUVECs were transfected with siRNA targeting FAM40A or FAM40B. After 24 h cells were 
harvested and seeded onto fibronectin-coated ORIS plates with seeding stoppers. 24 h after 
cell seeding, the stoppers were removed and the capacity of the cells to migrate was 
quantified by measuring the area of the central, annular ‘detection’ zone obscured in 24 h. 
The graph shows the mean of data from 3 independent experiments for siFAM40A and 2 
independent experiments for siFAM40B. Error bars indicate SD values. Student’s t-test 
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5.2.3 Depletion of FAM40A and FAM40B in HUVECs increases stress fibres 
Knockdown of CCM3 expression in endothelial cells results in an increase in stress fibres 
(Zheng et al., 2010). This function of CCM3 in regulating stress fibres and contractility has 
been proposed to be behind its involvement in CCM. Hence, the effect of the FAM40 
proteins on stress fibres and endothelial junctions was tested. HUVECs were transfected 
with siRNAs targeting FAM40A or FAM40B and stained for F-actin and VE-cadherin (Figure 
5.3A). Control cells exhibited enriched F-actin staining at cell-cell boundaries. These sites 
were not continuous along cell-cell junctions. Control cells contained few stress fibres 
traversing the length of the cell. However, a number of stress fibres were present proximal to 
the cell boundaries. VE-cadherin staining revealed that junctions between adjacent control 
cells largely occurred as linear, continuous structures. Adjacent cells overlapped in certain 
regions indicated by a web-like, reticular VE-cadherin staining pattern (Fernandez-Martin et 
al., 2012).  
Depletion of both FAM40A and FAM40B resulted in an increase in stress fibres that 
traversed the length of the cell (Figure 5.3A and B). The percentage of cells with higher 
stress fibre content was increased upon FAM40 knockdown (Figure 5.3C). No observable 
changes to cortical F-actin were observed. VE-cadherin staining revealed regions where 
cell-cell junctions were discontinuous after FAM40 depletion (prominent with FAM40B 
depletion (Figure 5.3A)). This occurred at sites where the direction of the stress fibres was 
perpendicular to the cell edge, and could be indicative of impaired barrier function. Double 
knockdown of FAM40A and FAM40B resulted in an increase in stress fibres too (Figure 5.4), 
but it was not higher than single knockdown (Figure 5.4B). Efficiency of siRNA-mediated 
knockdown of gene expression was not determined in cells double transfected with siRNAs 
targeting FAM40A and FAM40B, and would have to be performed in future experiments. 
In summary, these results indicate that the FAM40 proteins regulate stress fibres in 
endothelial cells, and suggest a possible functional link between CCM3 and the FAM40 
proteins. 
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Figure 5.3 FAM40 knockdown increases the number of stress fibres  
(A) HUVECs were transfected with siRNAs targeting FAM40A or FAM40B and seeded onto 
fibronectin-coated glass coverslips to form confluent monolayers. 72 h after transfection cells 
were fixed and stained for F-actin and VE-cadherin to visualise junctions. Images are 
compressed stacks of 10-15 z-sections. Scale bar = 40 µm. Asterisks indicate discontinuous 
adherens junctions. (B) Quantification was done by assigning a score to each cell based on 
the stress fibre content in the centre of the cell; 0 – few or no stress fibres, 1 – upto 50% of 
the cell centre contains stress fibres, 2 – 50% to 75% of the cell centre contains stress 
fibres, 3 – greater than 75% of the cell centre contains stress fibres. Results shown are from 
at least 150 cells per condition from 3 independent experiments. Error bars depict SEM 
values. *** p < 0.001 compared to siControl determined by Student’s t-test. The graph in (C) 
represents this data as percentage distributions. 
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Figure 5.4 Double knockdown of FAM40A and FAM40B increases the number of 
stress fibres  
(A) HUVECs were transfected with siRNAs targeting FAM40A and/or FAM40B as indicated 
and seeded onto fibronectin-coated glass coverslips to form confluent monolayers. 72 h after 
transfection cells were fixed and stained for F-actin. Images are compressed stacks of 10-15 
z-sections. Scale bar = 40 µm. (B) Quantification was done by assigning a score to each cell 
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based on the stress fibre content in the centre of the cell; 0 – few or no stress fibres, 1 – 
upto 50% of the cell centre contains stress fibres, 2 – 50% to 75% of the cell centre contains 
stress fibres, 3 – greater than 75% of the cell centre contains stress fibres. Results shown 
are from at least 150 cells per condition from 3 independent experiments. Error bars depict 
SEM values. *** p < 0.001 compared to siControl determined by Student’s t-test.  
 
 
5.2.4 Effect of FAM40 knockdown on the permeability of HUVEC monolayers 
Stress fibres are linked to adherens junctions in confluent endothelial cells. This provides a 
mechanical linkage between the actin cytoskeleton and cell-cell junctions, and suggests how 
contractile force within cells can be transmitted to cell junctions (Millan et al., 2010). It was 
hypothesised that the increase in stress fibres induced upon FAM40 knockdown leads to 
increased tensile force, and subsequently could cause a physical breakdown of junctions. 
Furthermore, depletion of CCM3 and STK25 leads to an increase in endothelial permeability 
and is associated with an increase in stress fibres (Zheng et al., 2010). Hence, junction 
function was measured by assessing the permeability of confluent HUVEC monolayers upon 
FAM40 knockdown. A transwell assay was used in which the amount of FITC-dextran that 
passes across an endothelial monolayer was used as a readout of endothelial permeability 
(Figure 5.5A). FAM40B depletion led to an increase in endothelial permeability (Figure 
5.5B). However, no significant effects were observed when FAM40A was depleted at 40 min 
or 80 min after addition of FITC-dextran. These results imply that FAM40B but not FAM40A 
is needed for the maintenance of HUVEC monolayer integrity. 
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Figure 5.5 FAM40B knockdown increases the permeability of confluent HUVEC 
monolayers 
A transwell permeability assay was used to study effects on cell permeability upon FAM40A 
and FAM40B depletion (A). HUVECs were depleted of FAM40A and FAM40B using siRNAs 
and plated at confluency onto transwell inserts. 72 h after transfection, FITC-dextran was 
added to the upper chamber. After a further 80 min the fluorescence of media in the lower 
chamber was determined as a measure of permeability. (B) shows permeability normalised 
to siControl (siControl=100). Data are means of 3 independent experiments for siFAM40A 
and 5 independent experiments for siFAM40B. Error bars indicate SEM values. * p < 0.05, ** 
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5.2.5 The increase of stress fibres upon FAM40 knockdown is reduced by treatment 
with ROCK inhibitor and C3 transferase 
The Rho-ROCK signalling axis is important for stress fibre formation (Hall and Nobes, 2000). 
Activated ROCK increases the pool of phosphorylated MLC and causes the assembly of 
actomyosin filaments (Watanabe et al., 2007). Importantly, all three Rho proteins (RhoA, 
RhoB and RhoC) can induce the formation of stress fibres in endothelial cells (Gottesbuhren 
et al., 2013). To determine whether Rho-ROCK signalling mediates induction of stress fibres 
upon FAM40 depletion, cells were treated with the ROCK inhibitor H-1152 and C3 
transferase. The Rho inhibitor C3 transferase is commonly used to study Rho protein 
function and inhibits Rho proteins by ADP-ribosylation. It specifically inhibits RhoA, RhoB 
and RhoC and does not target other related GTPases such as Rac1 or Cdc42 (Aktories and 
Barbieri, 2005). 
Treatment with H-1152 reduced the FAM40 depletion-induced increase in stress fibres 
(Figure 5.6A and B). Different treatment times were tested and 10 min was found to be the 
optimal time-point. Incubation for longer periods resulted in severe effects on cell 
morphology and F-actin organisation, while incubation for a shorter time was not sufficient to 
affect the FAM40 depletion-induced stress fibre response.  
Treatment with membrane permeable C3 transferase decreased stress fibres induced by 
FAM40 depletion (Figure 5.7). The concentration and incubation time used were that 
described by Cytoskeleton (http://www.cytoskeleton.com/) to yield a ‘moderate phenotype’ 
(cells retain a well spread morphology in spite of stress fibre disruption). While both H-1152 
and C3 transferase treatment resulted in a loss of stress fibres, important differences 
between the two treatments exist. C3 transferase treatment relatively conserved cell 
morphology. However, a decrease in F-actin content was observed on C3 transferase 
treatment. This could be attributed to Rho proteins having other effects in addition to acting 
on ROCKs. Taken together these results show that inhibition of the Rho-ROCK signalling 
pathway reduces the induction of stress fibres and associated cell contractility that occurs 
upon FAM40 depletion. 
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Figure 5.6 Treatment with the ROCK inhibitor H-1152, reduces the increase of stress 
fibres observed upon FAM40 depletion 
(A) HUVECs were transfected with siRNAs targeting FAM40A or FAM40B and seeded onto 
fibronectin-coated glass coverslips to form confluent monolayers. 72 h after transfection cells 
were treated with 5 µM H-1152 for 10 min, after which they were fixed and stained for F-
actin. Images are compressed stacks of 10-15 z-sections. Scale bar = 40 µm. (B) 
Quantification was done by assigning a score to each cell based on the stress fibre content 
in the centre of the cell; 0 – few or no stress fibres, 1 – upto 50% of the cell centre contains 
stress fibres, 2 – 50% to 75% of the cell centre contains stress fibres, 3 – greater than 75% 
of the cell centre contains stress fibres. Results shown are from at least 150 cells per 
condition from 3 independent experiments. Error bars depict SEM values. *** p < 0.001 
determined by Student’s t-test. 
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Figure 5.7 Treatment with C3 transferase reduces the increase of stress fibres 
observed upon FAM40 depletion 
(A) HUVECs were transfected with siRNAs targeting FAM40A or FAM40B and seeded onto 
fibronectin-coated glass coverslips to form confluent monolayers. 72 h after transfection cells 
were treated with 4 µg/ml C3 transferase for 2 h after which they were fixed and stained for 
F-actin. Images are compressed stacks of 10-15 z-sections. Scale bar = 40 µm. (B) 
Quantification was done by assigning a score to each cell based on the stress fibre content 
in the centre of the cell; 0 – few or no stress fibres, 1 – upto 50% of the cell centre contains 
stress fibres, 2 – 50% to 75% of the cell centre contains stress fibres, 3 – greater than 75% 
of the cell centre contains stress fibres. Results shown are from at least 150 cells per 
condition from 3 independent experiments. Error bars depict SEM values. *** p < 0.001 
determined by Student’s t-test.  
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5.2.6 Effect of FAM40 depletion on RhoA and Rac1 activity 
An increase in RhoA activity is known to cause induction of stress fibres (Ridley and Hall, 
1992). Rac1 too has been shown to contribute to stress fibre assembly (Ridley et al., 1992). 
Furthermore, both RhoA and Rac1 are important for mediating endothelial cell permeability 
(Wojciak-Stothard et al., 2001). The CCM proteins regulate RhoA activity in endothelial cells 
(Fischer et al., 2013), while previously described results show that FAM40B knockdown in 
PC3 cells affects Rac1 activity (section 4.2.5). These facts prompted experiments to 
determine if either RhoA or Rac1 activity was affected upon FAM40 depletion in HUVECs.   
HUVECs were transfected with siRNAs targeting the FAM40 proteins and whole cell lysates 
were used in biochemical pulldown assays to determine levels of active RhoA and Rac1. 
RhoA activity was found to be variable within and between individual experiments and no 
reproducible effect was observed. An example blot is shown in Figure 5.8A. Further 
experiments to optimise experimental conditions could be performed. However, with the data 
obtained it was concluded that FAM40 depletion does not affect RhoA activity. Furthermore, 
depletion of FAM40A or FAM40B did not result in significant changes to Rac1 activity 
(Figure 5.8B). In two out of five experiments, a reduction in Rac1-GTP levels on FAM40B 
depletion was observed. In summary, these data suggest that FAM40A and FAM40B 
regulate stress fibre formation and endothelial permeability by mechanisms other than the 








Chapter 5                                                                            FAM40 function in endothelial cells 
163 
   
 
Figure 5.8 FAM40 knockdown does not affect RhoA or Rac1 activity 
HUVECs were transfected with siRNA targeting FAM40A or FAM40B. (A) After 72 h cells 
were lysed and whole cell lysates used in a GST- RBD pulldown assay to determine levels 
of GTP-loaded RhoA (n=3). An example immunoblot for total and GTP-loaded RhoA is 
shown. (B) After 72 h cells were lysed and whole cell lysates used in a GST-PBD pulldown 
assay to determine levels of GTP-loaded Rac1 (n=5). An example immunoblot for total and 
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5.2.7 Effect of FAM40A and FAM40B depletion on p-MLC2 
The phosphorylation level of MLC2 is an indication of cell contractility and is associated with 
the assembly of stress fibres. MLC2 lies downstream of Rho-ROCK and activated ROCK 
phosphorylates MLC phosphatase and MLC2 at Serine 19. MLC can also be phosphorylated 
by MLCK at Serine 19 and Threonine 18 (Watanabe et al., 2007). To assess if 
phosphorylation of MLC2 is affected by FAM40 proteins, lysates from HUVECs depleted of 
FAM40A and FAM40B were probed for p-MLC2 (serine 19/threonine 18). Neither FAM40A 
nor FAM40B knockdown resulted in a reproducible effect on p-MLC2 (S/T) levels (Figure 
5.9C and D). To ensure that the cells were responsive to p-MLC2 changes, a control 
experiment was performed in which HUVECs were treated with thrombin which increases p-
MLC2 levels (van Nieuw Amerongen et al., 1998) (Figure 5.9A and B). In summary, 
depletion of FAM40A or FAM40B does not result in changes to p-MLC2 levels, and so MLC2 
phosphorylation does not explain the induction of stress fibres. 
To complement this analysis, the localisation and distribution of p-MLC2 in FAM40-depleted 
cells was assessed by immunofluorescence. This experiment was done only twice using one 
siRNA each for FAM40A and FAM40B, and hence, a definitive conclusion cannot be 
reached. Moreover, it is difficult to use these images to comment on changes in total p-
MLC2 levels as the staining pattern was largely grainy and diffuse. However, these images 
indicated that p-MLC2 is enriched along stress fibres (Figure 5.10). This is consistent with p-
MLC2 causing contractility by stimulating cross-linking of myosin II with actin filaments 
(Watanabe et al., 2007). 
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Figure 5.9 FAM40 knockdown does not affect levels of p-MLC2 
(A) HUVECs treated with 1 U/ml thrombin for 10 min were used as a control for the p-MLC2 
response of cells and immunoblot procedure. After thrombin treatment cells were lysed and 
lysates used to immunoblot for p-MLC2, MLC2 and GAPDH. (B) Quantification was done by 
first individually normalising p-MLC2 and MLC2 levels to GAPDH levels. The ratio of the 
normalised p-MLC2 level to the normalised MLC2 level was used as a measure of MLC2 
phosphorylation. Data are the mean of 3 independent experiments ± SEM. Statistical 
significance was determined using Student’s t-test. (C) HUVECs were transfected for 
siRNAs targeting FAM40A and FAM40B. 72 h after transfection, cells were lysed and lysates 
used to immunoblot for p-MLC2, MLC2 and GAPDH. Quantification shown in (D) was done 
as for the thrombin control experiment (described in (B)). Data are means of 3 independent 
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Figure 5.10 Immunofluorescence staining for p-MLC2 in FAM40-depleted HUVECs 
HUVECs were transfected with siRNAs targeting FAM40A or FAM40B. 72 h after 
transfection cells were fixed and stained for p-MLC2 Ser19 and F-actin. Asterisks indicate 
regions were the p-MLC2 staining co-localises with stress fibres. Representative images 
from 2 independent experiments are shown. Images shown are compressed stacks of 10-15 
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5.2.8 The FAM40 proteins do not affect focal adhesion density 
Focal adhesions are found at the ends of stress fibres in sub-confluent endothelial cells but 
few are present in confluent endothelial cells (Millan et al., 2010). Focal adhesions serve to 
tether stress fibres and are important for the transduction of contractile forces generated 
within the cell. A correlation is seen between Rho-induced stress fibre assembly and focal 
adhesion formation (Ridley and Hall, 1992). Contractility generated as a result of stress fibre 
induction has been suggested to promote focal adhesion assembly (Chrzanowska-Wodnicka 
and Burridge, 1996).  
HUVECs depleted of FAM40A or FAM40B were grown at sub-confluence, and stained for 
the focal adhesion marker vinculin to assess changes to focal adhesion assembly. Stress 
fibre content in sub-confluent FAM40-depleted HUVECs was not quantified and would have 
to be performed in future experiments. However, it was observed that stress fibre induction 
upon FAM40 depletion was not as pronounced in sub-confluent cells as compared to 
confluent cells. Vinculin was excluded from the nucleus and exhibited a diffuse staining 
pattern in the perinuclear region. Additionally, punctate foci of vinculin staining were 
observed which correspond to cell-substrate adhesions. These puncta were commonly 
associated with the ends of stress fibres. A large fraction of the stress fibres were linked to 
vinculin foci at either end suggesting they are ventral stress fibres (Tojkander et al., 2012). 
No changes to focal adhesion density (number of vinculin puncta per cell normalised to total 
cell area) were observed on either FAM40A or FAM40B depletion (Figure 5.12). This result 
indicates that the increase in stress fibre content observed upon FAM40 depletion does not 
correlate with an increase in focal adhesion assembly as represented by focal adhesion 
density. 
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Figure 5.11 Visualising focal adhesions in FAM40-depleted HUVECs by vinculin 
staining 
HUVECs were transfected with siRNAs targeting FAM40A or FAM40B. Cells were then 
seeded onto fibronectin-coated glass coverslips at sub-confluence. 72 h after transfection 
cells were fixed and stained for F-actin, vinculin and with DAPI to stain nuclei. Scale bar = 
40 µm. Images are compressed stacks of 10-15 z-sections and are representative of 3 
independent experiments. 
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Figure 5.12 Quantification of focal adhesion density in FAM40-depleted HUVECs 
(A) Schematic of the pipeline used to calculate focal adhesion density by the software Cell 
Profiler. DAPI and F-actin staining were used to locate individual cells while the vinculin 
staining was used to identify individual adhesions. These two parameters were used to link 
identified adhesions to a particular cell (B). The graph in (C) shows the calculated focal 
adhesion density which is defined as the number of adhesions per cell normalised to total 
cell area. n ≥ 24 cells per condition from 3 independent experiments. Boxes of box and 
whisker plots show median, 25th and 75th percentile. Whiskers show minimum to maximum 
values. Student’s t-test showed no statistical significance compared to siControl. 
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5.2.9 The FAM40 proteins do not affect the levels of active or total β1-integrin 
To substantiate the analysis performed on focal adhesion density on FAM40 depletion 
(section 5.2.8), the levels of total and active β1-integrin were assessed. Previous studies 
have implicated β1-integrin in CCM pathogenesis. ICAP1 (integrin cytoplasmic-associated 
protein 1) associates with the cytoplasmic region of β1-integrin and suppresses its function 
(Bouvard et al., 2003). CCM1 competitively binds to ICAP1, restoring β1-integrin function 
(Liu et al., 2013). As the FAM40 proteins are associated with a CCM protein, effects on β1-
integrin function were investigated. 
Sub-confluent FAM40-depleted HUVECs were stained with an antibody that specifically 
detects the activated form of β1-integrin (Figure 5.13A). Active β1-integrin localised to 
discrete structures in all regions of the cell. These structures commonly had an elongated 
morphology and many associated with the ends of stress fibres. No differences in the 
staining pattern could be observed upon FAM40 knockdown though a subset of cells did 
exhibit small variations in staining intensity. As this experiment was only performed twice, 
additional experiments would need to be carried out for quantification. FAM40 depletion did 
not alter the total levels of β1-integrin by immunoblotting (Figure 5.13B and C). In summary, 
these results suggest that the FAM40 proteins do not regulate the physiology of endothelial 
cells by modulating β1-integrin levels or activity. 
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Figure 5.13 Depletion of the FAM40 proteins does not change levels of active or total 
β1-integrin 
(A) HUVECs were transfected with siRNAs targeting FAM40A or FAM40B and seeded onto 
fibronectin-coated glass coverslips at sub-confluence. 72 h after transfection cells were fixed 
and stained for F-actin, active β1-integrin (12G10 antibody, Abcam) and with DAPI. Scale 
bar = 40 µm. Images are compressed stacks of 10-15 z-sections and are representative of 2 
independent experiments. (B) Total β1-integrin levels on FAM40 depletion was assessed by 
western blot. 72 h after siRNA transfection, HUVECs were lysed and whole cell lysates used 
to immunoblot for total β1-integrin and GAPDH (loading control). An example immunoblot 
from 3 independent experiments is shown. Data in (C) show quantification of immunoblots 
normalised to siControl (siControl=100) and are the mean of 3 independent experiments ± 
SEM. Student’s t-test showed no statistical significance compared to siControl. 
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5.2.10 Overexpression of FAM40A and FAM40B in HUVECs 
The subcellular localisation of proteins can provide an indication of their function. HUVECs 
were transfected with expression vectors containing HA-FAM40A or HA-FAM40B. After 24 
h, cells were stained for the HA epitope and F-actin. Suitable antibodies capable of staining 
endogenous protein were not available. This experiment also served to identify any cellular 
effects of FAM40 overexpression. Sub-confluent HUVECs exhibited membrane F-actin-rich 
protrusions (Figure 5.14A). Both FAM40A and FAM40B were enriched in these regions, and 
were excluded from the nucleus. Confluent HUVECs do not usually exhibit F-actin-rich 
membrane protrusions, and in these cells both FAM40A and FAM40B showed a diffuse 
localisation pattern (Figure 5.14B). Neither FAM40 protein was enriched at cell-cell 
junctions. No observable changes to VE-cadherin distribution and/or localisation were 
observed. In addition, no clear changes to F-actin organisation were observed in either sub-
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Figure 5.14 Staining for overexpressed FAM40A and FAM40B in HUVECs 
HUVECs were transfected with pHA-FAM40A or pHA-FAM40B, seeded onto fibronectin-
coated glass coverslips and fixed after 24 h. (A) shows FAM40 localisation in sub-confluent 
cells. Cells were stained for F-actin and the HA epitope. Asterisks indicate regions where the 
HA staining is localised to F-actin-rich protrusions. (B) shows FAM40 localisation in 
confluent cells. Cells were stained for F-actin, the HA epitope and VE-cadherin to visualise 
junctions. Images are compressed stacks of 15-20 z-sections and are representative of 2 
independent experiments (VE-cadherin staining is from 1 experiment). Scale bars = 20 µm.  
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5.2.11 Verification of siRNA-mediated knockdown of CCM3 in HUVECs  
CCM3 interacts with both FAM40A and FAM40B (section 3.2.1) and as a possible FAM40 
signalling partner, its functions in endothelial cells were investigated. Efficient knockdown of 
CCM3 mRNA by siRNAs was obtained as determined by Q-PCR (Figure 5.15). 
 
 
Figure 5.15 Verification of siRNA-mediated depletion of CCM3  
HUVECs were transfected with siRNAs targeting CCM3 or with a control siRNA. After 72 h, 
mRNA from these cells was extracted and used to synthesize cDNA. The amount of CCM3 
cDNA was determined by quantitative PCR. Data are normalised to GAPDH cDNA levels 
and are the mean of 3 independent experiments ± SEM. ** p < 0.01, *** p < 0.001 compared 
to siControl determined by Student’s t-test.   
 
5.2.12 Knockdown of CCM3 results in an increase in stress fibres in HUVECs 
The CCM proteins have been shown to be important for maintaining endothelial 
homeostasis by regulating cell contractility. Previously published results show that depletion 
of CCM3 leads to an induction of stress fibres in endothelial cells (Zheng et al., 2010). 
Consistent with this, HUVECs depleted of CCM3 exhibited increased stress fibres (Figure 
5.16, results generated by Joanna Furmston). No observable changes in VE-cadherin 
localisation or distribution were apparent.  
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Figure 5.16 CCM3 knockdown increases the number of stress fibres 
(Experiment performed by Joanna Furmston) (A) HUVECs were transfected with siRNAs 
targeting CCM3 and seeded onto fibronectin-coated glass coverslips to form confluent 
monolayers. 72 h after transfection cells were fixed and stained for F-actin, VE-cadherin to 
visualise junctions and with DAPI. Images are compressed stacks of 10-15 z-sections. Scale 
bar = 40 µm. (B) Quantification was done by assigning a score to each cell based on the 
stress fibre content in the centre of the cell; 0 – few or no stress fibres, 1 – upto 50% of the 
cell centre contains stress fibres, 2 – 50% to 75% of the cell centre contains stress fibres, 3 
– greater than 75% of the cell centre contains stress fibres. Results shown are from at least 
150 cells per condition from 3 independent experiments. Error bars depict SEM values.      
*** p < 0.001 compared to siControl determined by Student’s t-test.  
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5.2.13 Overexpression of CCM3 does not rescue the increase of stress fibres 
induced upon FAM40 depletion 
As both FAM40 proteins interact with CCM3 and depletion of all three proteins leads to a 
similar stress fibre induction phenotype, it is possible that they are functionally linked in 
endothelial cells. In order to determine if such functional coupling exists in cells, CCM3 was 
overexpressed against a background of FAM40 depletion.  
HUVECs were transfected with siRNAs targeting FAM40A or FAM40B and subsequently 
transfected with an expression vector containing myc-CCM3. Double transfection with 
targeting siRNA and plasmid expression vector led to a lower cell density (Figure 5.17A). 
Experiments with an optimised protocol might reduce the observed loss of cells. 
Overexpression of CCM3 did not lead to an observable rescue of the stress fibre induction 
phenotype obtained upon either FAM40A or FAM40B depletion (Figure 5.17B). CCM3 
expression did not lead to a reduction in cells with a high stress fibre score. This experiment 
also provided information on CCM3 localisation in cells. CCM3 was diffusely localised in 
cells and enriched at F-actin-rich protrusions. No changes in stress fibre content were 
observed upon CCM3 overexpression. 
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Figure 5.17 FAM40 depletion-induced increase in stress fibres is not rescued by 
CCM3 overexpression 
(A) HUVECs were transfected with siRNAs targeting FAM40A or FAM40B. After 48 h these 
cells were transfected with pmyc-CCM3 and seeded onto fibronectin-coated glass 
coverslips. Cells were fixed after 24 h and stained for F-actin and the myc epitope. Images 
shown are compressed stacks of 10-15 z-sections. Scale bar = 40 µm. (B) Quantification 
was done by assigning a score to each cell based on the stress fibre content in the centre of 
the cell; 0 – few or no stress fibres, 1 – upto 50% of the cell centre contains stress fibres, 2 – 
50% to 75% of the cell centre contains stress fibres, 3 – greater than 75% of the cell centre 
contains stress fibres. Results are shown as percentage distributions and are from at least 
100 cells from 2 independent experiments. 
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5.2.14 Knockdown of CCM3 results in defects in the loop formation angiogenesis 
assay 
In addition to their roles in maintaining vascular permeability, the CCM proteins are involved 
in vascular development (Fischer et al., 2013). Hence, HUVECs depleted of CCM3 were 
used in in vitro loop formation assays on Matrigel to provide an indication of their possible 
roles in angiogenesis. The in vitro loop formation assay provides a simplified simulation of 
angiogenesis and tests the capacity of endothelial cells to network and interact with each 
other to form ordered loop-like structures. This assay is considered to be representative of 
the cord formation step in sprouting angiogenesis (Goodwin, 2007). The capacity of CCM3-
depleted HUVECs to form loops was severely affected (Figure 5.18).  
 
Figure 5.18 Depletion of CCM3 results in defects in the loop formation angiogenesis 
assay 
(A) HUVECs were transfected with siRNAs targeting CCM3. 48 h after transfection cells 
were seeded onto a gel consisting of polymerised Matrigel. Loops were allowed to form for 
24 h. Scale bar = 100 µm. (B) Loop formation was quantified by fixing and staining cells with 
phalloidin-Alexa546, and scoring the number of loops per field using fluorescence images. 6 
fields were scored per condition in each experiment. Results are shown normalised to 
siControl (siControl = 100). Data are the mean of 3 independent experiments ± SEM values. 
*** p < 0.001 compared to siControl determined by Student’s t-test. 
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5.2.15 The FAM40 proteins as mediators of angiogenesis as determined by an in 
vitro loop formation assay  
The potential of FAM40A or FAM40B to be regulators of angiogenesis was tested using the 
in vitro loop formation assay. Time-lapse movies were made to monitor loop formation in real 
time (supplementary movies, movies 6 to 11).  
Movies showed that over 24 h control cells were able to interact with each other and form 
closed loops. After cells were seeded onto Matrigel, they rapidly spread and were highly 
motile, ‘seeking’ out other cells to form a well organised network of cells. A subset of cells 
remained spread and did not acquire a morphology that resembled cords. Depletion of both 
FAM40A and FAM40B resulted in a more poorly connected network of cells (Figure 5.19A). 
These cells appeared to have defects in their capacity to spread and adhere to the matrix, 
and even after 24 h some cells had not spread completely (visualised as being ‘phase 
bright’). While a fraction of cells were able to migrate and associate with other cells to form 
cords, these networks were largely unstable and significant cell retraction was observed. 
Interestingly, at some sites of retraction, deformation of the Matrigel substrate could be 
observed (indicated by arrows in Figure 5.19B). Cells appeared to be contractile, exerting a 
deforming force on the substrate. The number of loops formed by FAM40-depleted HUVECs 
was significantly reduced (Figure 5.19C).  
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Figure 5.19 Depletion of FAM40A and FAM40B results in defects in the loop formation 
angiogenesis assay 
(A) HUVECs were transfected with siRNAs targeting FAM40A and FAM40B. 48 h after 
transfection cells were seeded onto a gel consisting of polymerised Matrigel. Loops were 
allowed to form for 24 h. Scale bar = 200 µm. Arrows in images shown in (B) highlight 
deformation of the Matrigel substrate by FAM40-depleted cells. Scale bars = 200 µm. (C) 
Loop formation was quantified by scoring the number of loops per field. At least 5 fields were 
scored per condition in each experiment. n=4 for siFAM40A-3, siFAM40A-5 and siFAM40B-
1. n=3 for siFAM40B-5. Data show mean ± SEM values and are normalised to siControl 
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Retraction of FAM40-depleted HUVECs observed in movies suggests increased cell 
contractility. Furthermore, depletion of both FAM40A and FAM40B resulted in the formation 
of contractile stress fibres in cells (section 5.2.3). The regulation of contractility is important 
during cell sprouting, and an increase in actomyosin contractility has been shown to cause 
cessation of sprouting (Abraham et al., 2009). HUVECs depleted of FAM40A or FAM40B 
were treated with the ROCK inhibitor Y-27632 in an attempt to rescue loop formation 
defects. Time-lapse movies were made to monitor loop formation in real time 
(supplementary movies, movies 12 to 17). Treatment of control cells with Y-27632 led to 
increased loop formation (Figure 5.20), consistent with previously published results that 
show increased tube formation on Y-27632 treatment (Mavria et al., 2006). Cells also 
appeared flatter as determined by them being less ‘phase-bright’. Treatment of FAM40-
depleted HUVECs with Y-27632 was able to rescue their loop formation defects (Figure 
5.20B). This result suggests that increased actomyosin contractility upon FAM40 depletion 
contributes to defects in loop formation. 
To complement these analyses, cells forming loops on Matrigel were stained for F-actin and 
with DAPI to highlight nuclei, and imaged (Figure 5.21). These images showed that cords 
were composed of multiple endothelial cells arranged linearly. The arrangement of cells was 
organised and periodic. ‘Nodes’ in the cell network consisted of multiple cells occurring in 
groups. Enriched F-actin staining was observed at cell-cell boundaries and at cell tips 
(indicated by asterisks in Figure 5.21A). Cells in this assay did not form stress fibres, unlike 
cells cultured in 2D. Depletion of FAM40A and FAM40B resulted in cell cords appearing 
more disorganised with clumping being regularly observed (Figure 5.21B). The periodic, 
linear arrangement of cells in cords was disturbed and some cells exhibited micro-spikes 
(shown in boxed areas in Figure 5.21B), which could be a consequence of cell retraction and 
collapse.  
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Figure 5.20 FAM40 depletion-induced loop formation defect is rescued by treatment 
with the ROCK inhibitor, Y-27632 
(A) HUVECs were transfected with siRNAs targeting FAM40A and FAM40B. 48 h after 
transfection cells were seeded onto a gel consisting of polymerised Matrigel. Loops were 
allowed to form for 24 h. Treatment with 10 µM Y-27632 was done for 24 h. Scale bar = 200 
µm. (B) Loop formation was quantified by scoring the number of loops per field. At least 4 
fields were scored per condition in each experiment. Data are the mean of 3 independent 
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Figure 5.21 Morphology of FAM40-depleted HUVECs forming loops on Matrigel 
HUVECs were transfected with siRNAs targeting FAM40A and FAM40B and after 48 h were 
seeded on polymerised Matrigel for 24 h. Cells were fixed and stained for F-actin and with 
DAPI to visualise nuclei. Images in (A) shows loops formed by control HUVECs and are 
compressed stacks of 30 z-sections. Asterisks indicate regions of F-actin enrichment at cell 
tips and cell-cell junctions. Scale bar = 40 µm. Images in (B) show loops formed by FAM40-
depleted HUVECs. Images are sections taken at a single z-position and are representative 
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HUVECs depleted of FAM40A or FAM40B appeared to exhibit defects in cell spreading and 
adhesion to the Matrigel substrate, which might subsequently contribute to defects in loop 
formation. The ability of HUVECs depleted of FAM40A or FAM40B to adhere to polymerised 
Matrigel was tested. Knockdown of FAM40B resulted in an adhesion defect only with one 
siRNA oligonucleotide and so could be an off-target effect. However, depletion of FAM40A 
using two individual siRNAs led to an adhesion defect (Figure 5.22). This reduced adhesion 




Figure 5.22 FAM40A knockdown affects HUVEC adhesion to Matrigel 
HUVECs were transfected with siRNA targeting FAM40A or FAM40B. 72 h after transfection 
cells were labelled with Cell Tracker CMFDA and added onto a gel of polymerised Matrigel. 
After 5 min cells were washed to remove unadhered cells and a fluorescence reading was 
taken as a readout of adhesion. Data are the mean of 3 independent experiments ± SEM 
values and are normalised to siControl (siControl = 100). ** p < 0.01, *** p < 0.001 compared 
to siControl determined by Student’s t-test.  
 
 
In summary, these results show that FAM40A and FAM40B may regulate angiogenesis as 
determined by the in vitro loop formation assay. 
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5.3 Discussion 
The functions of human FAM40A and FAM40B are largely unknown, and analyses 
presented in this chapter provide for the first time a functional characterisation of these 
genes in endothelial cells. An RNAi approach was primarily used to asses FAM40 function in 
HUVECs which were used as an experimental model. Results show that FAM40A and 
FAM40B are novel regulators of endothelial physiology and affect F-actin organisation, 
endothelial permeability and angiogenesis. 
5.3.1 The FAM40 proteins mediate F-actin organisation 
Actomyosin contractility is important in endothelial cells for resisting shear stress and is 
involved in mediating endothelial permeability. Impaired regulation is implicated in 
pathological conditions such as oedema, haemorrhagic stroke and vascular malformations 
(Dejana et al., 2009). Cerebral cavernous malformation is a pathology of the vasculature and 
is characterised by defects in vascular permeability and development. CCM3 is one of the 
genetic loci mutated in CCM and depletion of CCM3 in cultured endothelial cells leads to an 
induction of stress fibres and increased endothelial permeability (Zheng et al., 2010). This 
phenotype suggested a possible role for the FAM40 proteins in endothelial cells. HUVECs 
depleted of FAM40A or FAM40B exhibited an increase in stress fibres that traverse the 
length of the cell. This result combined with the fact that both FAM40A and FAM40B 
associate with CCM3 (section 3.2.1) provides a strong indication that these genes may be 
functionally linked in endothelial cells. Overexpression of either FAM40A or FAM40B did not 
lead to a reduction in stress fibres as would be predicted. Control cells contain few stress 
fibres that traverse the length of the cell, and so detection of a decrease in stress fibre 
content would have been difficult to observe. Future work could attempt to ‘sensitize’ the 
system in order to overcome this limitation. For example, overexpression could be 
performed in a background of TNFα or thrombin stimulation which are known to increase 
stress fibre assembly (McKenzie and Ridley, 2007; Wojciak-Stothard et al., 2001). Another 
explanation is that the FAM40 proteins need to signal with other proteins to regulate stress 
fibres, and so overexpression of FAM40A or FAM40B alone does not lead to a decrease in 
stress fibre content. 
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Multiple signalling pathways are involved in the formation of stress fibres in endothelial cells, 
including Rho, Rac1 (Tzima et al., 2002; Wojciak-Stothard et al., 2001) and Rnd 
(Gottesbuhren et al., 2013) signalling. As a consequence, a stress fibre phenotype cannot in 
itself be used to conclude functional links between two different genes, making it challenging 
to uncover underlying mechanisms behind FAM40 function. The Rho-ROCK signalling 
pathway is pivotal in the regulation of stress fibres and RhoA, RhoB and RhoC are capable 
of inducing stress fibres when overexpressed in endothelial cells (Gottesbuhren et al., 2013). 
No reproducible changes to RhoA activity were observed. It might be that RhoA activity is 
only spatially regulated and hence it would be interesting to carry out FRET analysis to 
determine localised changes in activity (Nakamura et al., 2006). For example, stimulation of 
endothelial cells with thrombin leads to localised activation of RhoA along stress fibres and 
is associated with their contraction (Szulcek et al., 2013). It is also possible that RhoA 
activity is temporally regulated. For example, TNFα only transiently activates RhoA in 
HUVECs, with RhoA activity subsequently returning to basal levels despite the presence of 
stress fibres (McKenzie and Ridley, 2007). A similar scenario might exist with FAM40 
regulation of stress fibres. As cells were only analysed at 72 h after siRNA treatment, a 
transient change could have been missed. It would be interesting to conduct a time course 
experiment of stress fibre induction/RhoA activity after FAM40 siRNA transfection. 
Furthermore, the activity levels of RhoB and RhoC should be checked as previous studies 
have reported examples of specific responses to closely related proteins in endothelial cells. 
Rnd3-mediated induction of stress fibres occurs through RhoB (Gottesbuhren et al., 2013), 
while it has been suggested that VE-cadherin-mediated regulation of contractility occurs via 
RhoC during tube formation in culture (Abraham et al., 2009).  
Rac1 activity is also implicated in the formation of stress fibres in endothelial cells (Tzima et 
al., 2002; Wojciak-Stothard et al., 2001) and was assessed after FAM40 depletion. FAM40B 
depletion resulted in reduced Rac1 activity only in a subset of experiments. Further 
experiments to assess localised changes of Rac1-GTP levels could be considered. An 
alternative approach to functionally link these Rho family members with the FAM40 proteins 
would be to use RNAi to simultaneously deplete either FAM40A or FAM40B along with the 
Rho GTPase of interest, and assess if the stress fibre phenotype was reversed. 
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Rho signalling is known to mediate stress fibre assembly by the cooperative activity of two 
downstream effectors, ROCK and mDia (Watanabe et al., 1999). Activated ROCK has 
several targets in cells that affect stress fibre formation and the stability of actin filaments, 
including MLC2 (Riento and Ridley, 2003). Mono and diphosphorylation of MLC2 regulates 
myosin II-associated contractile activity and so can be used as a measure of contractility 
(Watanabe et al., 2007). Surprisingly, depletion of FAM40A or FAM40B did not increase p-
MLC2 levels. Two extraction strategies using RIPA and Laemmli lysis buffer were performed 
to ensure that extraction of protein was not a limiting factor in experiments. 
Immunofluorescence staining for p-MLC2 revealed localisation along stress fibres consistent 
with its role in mediating contractility. Similar arguments as those used for RhoA activity 
could explain these results. Like RhoA activity, levels of p-MLC2 are not an absolute 
indicator of cell contractility and stress fibre induction. TNFα stimulation of endothelial cells 
leads to only a transient increase in p-MLC2 levels in spite of the presence of stress fibres at 
later time-points (McKenzie and Ridley, 2007). Another possibility is that the FAM40 proteins 
affect localised changes to p-MLC2 levels. Activated ROCK also leads to phosphorylation 
and inactivation of cofilin via LIMK. This activity could additionally stabilise actin filaments as 
cofilin causes severing of actin filaments (Oser and Condeelis, 2009). Future experiments 
should investigate if depletion of FAM40A and/or FAM40B alters cofilin phosphorylation. In 
addition, future experiments should assess effects of FAM40 depletion on mDia signalling. 
Treatment with the ROCK inhibitor H-1152, and the Rho inhibitor C3 tranferase reduced 
stress fibres in FAM40-depleted cells. This result suggests that Rho-ROCK signalling is 
involved in FAM40 function. While this scenario is consistent with this result, it is not the only 
explanation. The Rho-ROCK signalling axis is a crucial regulator of contractility and 
actomyosin filament assembly in endothelial cells. Hence, it is possible that perturbation of 
its activity would lead to abrogation of stress fibre induction irrespective of the conditions or 
stimulus. This result therefore cannot be used to conclude that the FAM40 proteins are 
linearly linked to the Rho-ROCK signalling axis. A compatible alternative is that the Rho-
ROCK pathway acts in parallel to FAM40 signalling.  
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FAM40 depletion did not lead to an increase in focal adhesion density in sub-confluent 
endothelial cells. This is surprising as in sub-confluent endothelial cells stress fibres are 
anchored at focal adhesions (Millan et al., 2010). Stress fibre content in sub-confluent 
HUVECs depleted of FAM40A and FAM40B was not quantified and would have to be 
performed in future experiments. However, it was observed that stress fibre induction upon 
FAM40 depletion was not as pronounced in sub-confluent cells as compared to confluent 
cells, and could explain why no increase in focal adhesion density was observed. Another 
explanation could be that by using vinculin as a marker for focal adhesions, nascent 
adhesions may not have been visualised. Vinculin recruitment to focal adhesions lags 
behind that of paxillin, a marker for nascent adhesions (Pasapera et al., 2010). 
In summary, the mechanisms by which the FAM40 proteins regulate stress fibres in cells are 
not clear and further investigation is needed to resolve this question. It is possible that the 
FAM40 proteins represent a novel signalling pathway by which contractility and stress fibre 
assembly is regulated in endothelial cells. 
5.3.2 Depletion of FAM40B increases the permeability of endothelial monolayers 
Perturbations to the actin cytoskeleton can affect the integrity of endothelial monolayers. 
Stress fibres in confluent endothelial cells are predominantly linked to adherens junctions 
(Millan et al., 2010), explaining how tensile force can be communicated to cell-cell junctions. 
Knockdown of FAM40B resulted in an increase in endothelial permeability. The increase in 
tensile force as a consequence of stress fibre induction could lead to a physical disruption of 
junctions. This is supported by discontinuous VE-cadherin staining upon FAM40B depletion. 
However, depletion of FAM40A did not lead to an increase in endothelial permeability in 
spite of inducing stress fibre assembly. While a positive correlation exists between stress 
fibre induction and increased endothelial permeability, this need not be so. For example, 
TNFα stimulation of endothelial cells leads to stress fibre induction, but long term 
permeability changes correlate with loss of tight junction proteins (McKenzie and Ridley, 
2007). It would therefore be interesting to determine if FAM40 depletion affects tight 
junctions. This is relevant as endothelial cell interfaces in CCM lesions display a loss of tight 
junctions (Clatterbuck et al., 2001).  
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In addition to RhoA and Rac1, Rap1 activity has been reported to be an important regulator 
of cell-cell junctions in endothelial cells (Kooistra et al., 2007). Interestingly, Rap1 is a CCM1 
effector (Glading et al., 2007). However, a preliminary experiment revealed that FAM40 
depletion did not change Rap1 activity (results not shown). Neither FAM40A nor FAM40B 
showed enrichment at cell-cell junctions as determined by immunofluorescence staining of 
epitope-tagged protein, making it unlikely that they act as cell-cell adhesion proteins. 
5.3.3 FAM40A and FAM40B as regulators of angiogenesis 
An in vitro loop formation angiogenesis assay was used to determine if either FAM40A or 
FAM40B may regulate angiogenesis in vivo. This assay simulates angiogenesis by testing 
the capacity of endothelial cells to organise into stable networks resulting in the formation of 
loop-like structures when plated onto polymerised Matrigel.  
Angiogenesis in vivo involves matrix degradation, endothelial cell proliferation, migration and 
lumen formation (reviewed in (Potente et al., 2011)). HUVECs in the loop assay form 
coalesced chains of cells as revealed by staining for F-actin. These structures resemble 
cords formed in vivo, and it is not clear if cells form lumens (Goodwin, 2007). The migration 
of endothelial cells can be studied by generating time-lapse movies of loop formation. The 
assay does not test for matrix degradation as plated endothelial cells do not need to invade 
into the matrix to form loops. The duration of the experiment (24 h) is too short to allow for 
significant changes in proliferation to be observed. In summary, this assay represents only a 
part of the process of angiogenesis and so has to be interpreted carefully. 
Depletion of both FAM40A and FAM40B led to HUVECs forming fewer loops when plated 
onto Matrigel. Furthermore, F-actin staining of FAM40-depleted cords revealed a high level 
of disorganisation, with the ordered periodic arrangement of cells being lost. It is likely that 
this would impair subsequent tube formation in vivo. An inverse correlation between 
angiogenic sprouting and cell contractility has been shown, and the cessation of sprouting is 
reliant on MLC2 phosphorylation (Abraham et al., 2009). This could explain the defects in 
loop formation on FAM40 depletion. Indeed, treatment of FAM40-depleted cells with the 
ROCK inhibitor Y-27632 rescued loop formation defects. It can be inferred that an optimum 
degree of contractility is needed during sprouting angiogenesis. Too little leads to excessive 
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sprouting and increased angiogenesis, while too much leads to a premature abrogation of 
sprouting. A preliminary experiment probing p-MLC2 levels in FAM40-depleted endothelial 
cords yielded no observable changes (results not shown). While further experiments will 
have to be performed to confirm this result, it strengthens the hypothesis that the FAM40 
proteins mediate cell contractility by an alternate mechanism. In addition, the coordinated 
temporal regulation of RhoA and Rac1 activity has been shown to be important during loop 
formation (Cascone et al., 2003), and it will be interesting to study variations in their activities 
upon FAM40 depletion in future experiments. 
Other processes such as adhesion to the substrate and migration could contribute to defects 
observed in the loop assay. FAM40A depletion resulted in a reduced capacity of endothelial 
cells to adhere to the Matrigel matrix. It is likely that this is not a consequence of increased 
contractility as FAM40B depletion did not cause an adhesion defect. Future experiments 
should attempt to probe mechanisms underlying FAM40A control of endothelial adhesion to 
the surrounding matrix. Migration of endothelial cells is important during angiogenesis but 
neither FAM40A nor FAM40B depletion resulted in migration defects in the ORIS assay. 
This assay tested migration on fibronectin-coated plastic while loop assays were carried out 
on polymerised Matrigel. To be comparable, ORIS assays on Matrigel-coated plastic will 
have to be performed.  
The subcellular localisation of FAM40A and FAM40B in subconfluent HUVECs could be 
extrapolated to localisation in endothelial tip cells leading an angiogenic sprout, as in both 
scenarios individual cells are not completely surrounded by other cells. Both FAM40A and 
FAM40B were enriched in F-actin-rich protrusions as determined by immunofluorescence 
staining of epitope-tagged protein. These regions being located at cell peripheries are 
involved in the establishment of cell-cell contacts and are sites of junction formation in 
sprouting cells. It would be interesting to determine if the FAM40 proteins mediate these 
functions during angiogenesis. 
Taken together, these results identify the FAM40 proteins as being novel mediators of 
sprouting angiogenesis as determined by an in vitro loop formation assay, by regulating 
contractility in endothelial cells. It will be important to use in vivo approaches to fully 
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understand the roles of FAM40A and FAM40B during angiogenesis by addressing questions 
such as their roles in regulating angiogenesis during embryogenesis, and in maintaining the 
quiescence of an established vascular network.   
5.3.4 FAM40 gene function in endothelial cells in the context of CCM  
CCM is a disease of the vasculature of the CNS while results presented in this chapter are 
based on endothelial cells derived from umbilical veins. Different endothelial cell subtypes 
may exhibit distinct behaviour. However, assuming that fundamental aspects of cell function 
such as barrier regulation are conserved across different subtypes, links between the 
FAM40 proteins and the CCM disease process may be drawn.  
Depletion of FAM40A, FAM40B or CCM3 in HUVECs using RNAi led to similar phenotypes 
in multiple assays. Like with FAM40 depletion, CCM3 depletion resulted in an increase in 
stress fibres that traversed the length of cells. This is consistent with previously published 
experiments (Zheng et al., 2010). MST4 was shown to phosphorylate both FAM40 proteins 
and CCM3 (section 3.2.8). Preliminary experiments revealed that depletion of MST4 by 
RNAi did not cause induction of stress fibres in HUVECs (results not shown). However, 
depletion of STK24 and STK25 induces stress fibres in endothelial cells (Zheng et al., 2010). 
To test for a possible functional link between CCM3 and the FAM40 proteins, 
overexpression of CCM3 was used to assess if a rescue of the FAM40 depletion-induced 
stress fibre phenotype occurred. No rescue was observed and if the FAM40 proteins and 
CCM3 signal together in cells, this result is compatible with two possible scenarios. One 
possibility is that both CCM3 and FAM40A/FAM40B signal at the same level/node, and so 
the presence of both proteins is required to prevent excessive stress fibre formation. The 
other possibility is that CCM3 lies upstream of FAM40A/FAM40B and so in the absence of 
FAM40A/FAM40B, expression of CCM3 does not affect the numbers of stress fibres.  
Furthermore, depletion of CCM3 and STK25 increases endothelial permeability (Zheng et 
al., 2010), similar to that observed upon FAM40B depletion. This same study showed that 
depletion of CCM3 or STK25 leads to elevated RhoA activity and uses this to explain CCM3 
function in cells. However, it is not entirely clear if elevated RhoA activity is a hallmark of 
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CCM3 signalling as another study could not reproduce this (Chan et al., 2011). No change to 
RhoA activity was reproducibly observed upon FAM40 depletion. 
The CCM proteins appear to have dual functions as regulators of cell contractility and as 
mediators of vascular development and angiogenesis. Dysregulation of these functions has 
been suggested to precipitate CCMs. In vivo work using zebrafish has shown that inhibition 
of CCM3, STK24 and STK25 function leads to vascular anomalies during development 
(Yoruk et al., 2012; Zheng et al., 2010). Depletion of FAM40A, FAM40B or CCM3 resulted in 
defects in in vitro loop angiogenesis assays. CCM is a disease of endothelial quiescence 
where cells break free of controls that keep proliferation and neo-angiogenesis in check. 
Hence, it might be expected that CCM3 depletion would have led to an increase in loop 
formation. Indeed, endothelial cells derived from CCM patient samples exhibit higher rates of 
tube formation and express higher levels of VEGF in vitro (Zhao et al., 2007). Additionally, 
knockdown of CCM3 by RNAi causes enhanced migration and sprouting of HUVECs 
depleted of CCM3 (You et al., 2013). These studies differ from the analyses presented in 
this chapter in that they assessed angiogenic function in a 3D collagen I tube formation 
assay and a sprouting assay in fibrin gels respectively. However, another study using 3D 
collagen tube formation assays reported that HUVECs depleted of CCM3 fail to organise 
into lumenised networks (Chan et al., 2011), suggesting that CCM3 depletion may result in 
cells being more angiogenic, but leads to poorly formed vascular networks. One way of 
reconciling these results with the data presented in this chapter is based on experimental 
variations due to different assays used. For example, it may be that increased contractility 
would be perceived as a loop formation defect in the assay used here irrespective of other 
background factors, such as expression of angiogenic cytokines and/or receptors. In 
summary, while results from the loop angiogenesis assay highlight a possible functional link 
between the FAM40 proteins and CCM3, it also underscores the importance of utilising other 
assays to study angiogenesis in the future.  
CCM3 is the least understood of the three CCM genes and appears to signal in a distinct 
manner. Results presented in this chapter suggest why this may be so. Perhaps the FAM40 
proteins are novel, specific signalling partners for CCM3. Depletion of either FAM40 protein 
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did not lead to changes in the total or active levels of β1-integrin in endothelial cells, a 
consequence of CCM1 gene function (Liu et al., 2013). This is relevant here as it 
strengthens the hypothesis that the FAM40 proteins signal specifically with CCM3, and not 
with other CCM proteins. If this is so, the FAM40 proteins are novel determinants of the 
CCM disease process and hence future research should be aimed at fully understanding 
their contributions to CCM pathogenesis. To further this goal, a more detailed functional 
analysis of the GCKIII kinases will have to be performed. This is especially true for MST4 
whose functions in endothelial cells are the least understood. Uncovering their roles in F-
actin organisation, regulation of endothelial permeability and angiogenesis will help in 
comprehending the roles of the CCM3-GCKIII signalling axis, and the FAM40 proteins in 
CCM. It would be interesting to screen for mutations in the FAM40A and FAM40B genes in 
CCM patient samples in order to establish genetic links between the FAM40 and CCM 
genes. 
The following model (Figure 5.23) summarises the functional roles of FAM40A and FAM40B 
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Figure 5.23 Model of FAM40 function in endothelial cells 
FAM40A and FAM40B are important for regulating contractility in endothelial cells 
independently of the regulation of RhoA activity. Loss of their function contributes to stress 
fibre induction, defects in the in vitro loop formation angiogenesis assay and in the case of 
FAM40B, a decrease in endothelial barrier integrity. In addition to being novel regulators of 
endothelial cell physiology, the FAM40 proteins may be implicated in CCM pathogenesis by 
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6 Concluding remarks 
The Drosophila FAM40 orthologue was identified in a genome-wide RNAi screen in S2 cells 
assessing cell morphology (Rohn et al., 2011). Subsequent cell morphology and migration 
screens in PC3 cells (Bai et al., 2011) led to the identification of human FAM40A and 
FAM40B as putative novel regulators of the cytoskeleton. FAM40 proteins are present in 
species ranging from unicellular yeasts to complex higher eukaryotes. Additionally, 
conservation of their domain architecture points to these proteins carrying out an as yet 
unidentified role in cells. This study presents for the first time a detailed analysis of FAM40 
function. Their roles have been studied in an epithelial cancer cell line (PC3) and in primary 
endothelial cells (HUVECs). In addition to providing insight on cell specific function, these 
analyses also allow for the hypothesis of a general role for the FAM40 proteins. 
6.1 Comparison of FAM40 function in PC3 cells and HUVECs 
Depletion of the FAM40 proteins in PC3 cells and HUVECs affects aspects of cell function 
as discussed in chapter 4 and chapter 5 respectively. These analyses highlight cell specific 
functions of the FAM40 proteins in prostate cancer and endothelial cells. It is also of interest 
to compare their functions in these two different cell types. 
PC3 cells and HUVECs differ in several significant ways. PC3 cells are derived from 
prostate epithelial cells while HUVECs are endothelial cells. Another important difference is 
that PC3 cells are a cancer-derived cell line while HUVECs are primary cells. These 
differences may impinge on gene function. 
Depletion of the FAM40 proteins in PC3 cells did not cause the induction of stress fibres. 
Conversely, depletion of the FAM40 proteins in HUVECs caused a marked increase in 
stress fibre content. From these observations one conclusion that may be reached is that the 
FAM40 proteins signal by independent means in these two cell types. This could be 
explained by the presence of cell specific signalling partners. For example, HEG1 is an 
endothelial specific molecule involved in CCM1/CCM2 signalling (Kleaveland et al., 2009). 
Another example is that of VE-cadherin which is specific to endothelial cells. However, it 
may also be that different cell environments cause proteins to express their functions 
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differently even in the presence of similar signalling partners. If this is true, it serves to 
highlight how the reduction of gene function may not account fully for an 
environment/process centric view of gene function (Lippincott-Schwartz, 2000). For 
example, CCM3 regulation of Golgi positioning may regulate migration in PC3 cells but be 
important for the establishment of stable cell-cell contacts in HUVECs. 
 
 
Figure 6.1 A model to explain variable gene function 
Proteins may mediate different functions due to the presence of (A) different signalling 
partners, and/or (B) different cell environments. 
 
 
6.2 The FAM40 proteins may contribute to disease 
Analysis of FAM40 functions in PC3 cells suggest that they might contribute to prostate 
cancer progression by regulating cell migration and adhesion. It will be important for future 
experiments to build on this study by examining FAM40 function in cancers of different 
origin. Furthermore, in vivo models of cancer progression or 3D models for cell 
migration/invasion will define better the roles of FAM40A and FAM40B in various steps of 
cancer progression.   
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Depletion of both FAM40A and FAM40B caused induction of stress fibres in endothelial 
cells, caused defects in the loop angiogenesis assay, and in the case of FAM40B increased 
endothelial permeability. These roles fit the functional profiles of the CCM genes (CCM1, 
CCM2 and CCM3) (Fischer et al., 2013) and both FAM40 proteins interact with CCM3 
(section 3.2.1). As discussed in chapter 5, FAM40A and FAM40B may be novel CCM genes. 
The ‘two-hit hypothesis’ offers an explanation as to how mutations in the CCM genes 
manifests specifically as a disorder of the brain endothelium (Gault et al., 2005). According 
to this, a germline mutation in one CCM allele is augmented by a somatic mutation in the 
other allele. It would be interesting to ascertain if loss of FAM40 function can act as a ‘2nd 
hit’. The FAM40 genes could have roles in endothelium other than that of the CNS. For 
example, CCM1 mutations can cause cutaneous venous malformations (Toll et al., 2009) 
showing that CCM patients can display vascular anomalies at secondary sites. Another 
possibility is that the FAM40 genes are involved in inflammatory responses in endothelial 
cells. Interestingly, a role for inflammation in CCMs has been proposed (Shenkar et al., 
2007). 
The interaction of tumour cells with the endothelium is vital to cancer progression and in this 
context it is interesting that the FAM40 genes have roles in both these cell types. 
Experiments to probe how the FAM40 genes affect this interaction have not been performed 
and should be considered for future work. It might be that the FAM40 proteins regulate 
intravasation and/or extravasation by regulating cancer cell migration/invasion and/or 
endothelial barrier integrity. Another possibility is that of the FAM40 proteins mediating the 
vascularisation of tumours. Results presented in this thesis indicate that FAM40 function in 
endothelial cells might regulate angiogenesis. It will also be important to determine if their 
functions in cancer cells can cause tumour neovascularisation. A relevant example is that of 
ROCK function in tumour cells which induces angiogenesis and tumour cell invasion (Croft 
et al., 2004).  
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6.3 Why two FAM40 proteins? 
The presence of two FAM40 genes in humans (FAM40A and FAM40B) suggests functional 
specialisation. While it is possible that the two genes have mostly redundant functions, it is 
important to address this question as differences in functions have been noted in 
experiments performed. In this thesis depletion of FAM40A and FAM40B in PC3 cells 
resulted in distinct morphological phenotypes. Furthermore, only FAM40B depletion affected 
cell migration, spreading and Rac1 activity. A similar functional dichotomy can be observed 
in HUVECs. Only FAM40B depletion affected endothelial permeability while depletion of only 
FAM40A resulted in adhesion defects to Matrigel. It might be that FAM40A depletion only 
induces stress fibres, while FAM40B depletion induces stress fibres and affects junctional 
proteins. This may explain why only FAM40B depletion caused an increase in permeability. 
The fact that both FAM40A and FAM40B depletion resulted in stress fibre induction may 
suggest that both genes signal together to bring about this phenotype. However, endothelial 
cells have multiple signalling pathways that regulate stress fibre formation.  
Taken together, these results suggest that FAM40A and FAM40B may have evolved to fulfil 
different functions in cells. These differences may be explained by each protein having 
different signalling partners. For example, only FAM40A is capable of interacting with 
STRN4 (Goudreault et al., 2009). It is possible that the monomeric form of FAM40A and/or 
FAM40B represents the functional unit, which is compatible with these observations. 
However, biochemical analyses presented in chapter 3 indicate that in addition to forming 
homodimers, both FAM40A and FAM40B are able to interact with each other. This result has 
to be reconciled with the possibility of FAM40A and FAM40B having independent roles in 
cells. How can two proteins interact, but yet fulfil individual roles? One possibility is that 
FAM40A negatively regulates FAM40B signalling and/or vice versa. In this scenario, 
depletion of FAM40A would lead to increased FAM40B function and/or vice versa. Another 
possibility is that there is a dynamic equilibrium between FAM40 homodimeric and 
heterodimeric complexes which form functional units. Depletion of FAM40A would lead to an 
increase in FAM40B homodimers and associated signalling, and vice versa. 
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Figure 6.2 A model to explain the divergent roles of FAM40A and FAM40B  
FAM40A and FAM40B may associate with each other and still perform independent 
functions. This can occur by (A) FAM40 heterodimerisation being inhibitory, and/or (B) the 
existence of a dynamic equilibrium between FAM40 homodimers/heterodimers. 
 
 
6.4 A general model for FAM40 gene function 
A model for FAM40 function in endothelial cells has been presented in chapter 5 while their 
roles in cancer cells have been discussed in chapter 4. Based on these findings and data 
from the literature, can a general model for FAM40 function be put forward? 
FAM40A has been shown to interact with members of the STRIPAK complex including 
CCM3, GCKIII kinases, STRN, STRN3, STRN4, Mob3 and CTTNBP2NL (Goudreault et al., 
2009). A common denominator among several of these interacting partners is that they are 
important for neuronal function. The Drosophila Mob3 homologue is needed for synapse 
formation and axonal transport (Schulte et al., 2010). Striatins are highly expressed in 
dendritic spines and have been suggested to function as Ca2+ sensors (Benoist et al., 2006), 
while CTTNBP2 mediates dendritic spinogenesis (Chen et al., 2012). Taken together, these 
findings imply a role for the STRIPAK complex in synapse formation and signalling. 
Additionally, FAM40A is highly expressed in the foetal brain (NCBI GEO database, Profile: 
GDS3113 / 151060 / FAM40A) while FAM40B is upregulated in the retina (NCBI GEO 
database, Profile: GDS3113 / 152911 / FAM40B). Hence, it would be interesting to study the 
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functions of FAM40A and FAM40B in neurons and specifically in steps leading to synapse 
formation.   
It has been previously proposed that FAM40B affects endothelial permeability via CCM3 
signalling (chapter 5). At the fundamental level, both synapse formation and maintenance of 
endothelial junction integrity share a common feature – they both involve formation of 
contacts between adjacent cells. Examples in the literature exist that suggest a role for the 
STRIPAK complex in mediating cell fusion (section 1.6.2). Perhaps the FAM40 proteins play 
a fundamental role in mediating cell-cell contact formation in multiple cell types and 
conditions. It might be that cells use the STRIPAK complex and/or the FAM40 proteins as 
part of a common tool-kit to facilitate interactions with other cells. Individual components of 
the complex may have evolved to perform cell specific functions. For example, CCM3 may 
be important in this respect for contact between endothelial cells, while CTTNBP2NL may 
act similiarly in neurons. This hypothesis of FAM40 function is supported by the fact that 
FAM40B depletion in HeLa cells leads to a loss of cell-cell adhesions (Bai et al., 2011). 
Depletion of CCM3 in neuroglia has been suggested to lead to CCM by affecting interactions 
within the neurovascular unit (Louvi et al., 2011). In this context, it would be interesting to 
test if the FAM40 proteins can regulate interactions between the vasculature and neuroglial 
cells. 
The following model presents this hypothesis of FAM40 function, and summarises results 
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Figure 6.3 A model for FAM40 function 
The FAM40 proteins interact with CCM3 and are phosphorylated by MST4 which are 
components of the STRIPAK complex. It will be important to determine if the FAM40 
proteins function only as part of the STRIPAK complex or if they also have independent 
functions. In scenarios where cell-cell contacts are present, the FAM40 proteins may 
mediate their maintenance/establishment. Both FAM40 proteins regulate contractility in 
endothelial cells. A role for FAM40B in endothelial permeability has been demonstrated, 
while both FAM40A and FAM40B may be important for mediating angiogenesis. FAM40A is 
important for endothelial cell adhesion to the substrate. In addition, analyses of their 
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